Unnamed: 0,action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
20000,,,2572718,[],CHEMBL990099,Effect on phage-mediated lysis of shiga toxin 2 producing HUS-associated Escherichia coli isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155166,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,743410,=,1,0,=,,Activity,%,,50.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,50.0
20001,,,2572719,[],CHEMBL990932,Antimicrobial activity against Streptococcus pneumoniae L5 with parE Ile460Val mutation by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
20002,,,2572720,[],CHEMBL990933,"Antimicrobial activity against Streptococcus pneumoniae L6 with gyrA Ser81Phe, parC Lys137Asn and parE Ile460Val mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
20003,,,2572721,[],CHEMBL990934,"Antimicrobial activity against Streptococcus pneumoniae L12 with gyrA Ser81Phe, parC Ser79 Phe and parE Ile460Val mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
20004,,,2572722,[],CHEMBL990935,Antimicrobial activity against Streptococcus pneumoniae L13 with parC Asp83Tyr and parE Ile460Val mutation by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
20005,,,2572723,[],CHEMBL990936,Antimicrobial activity against Streptococcus pneumoniae L14 with parC Lys137Asn and parE Ile460Val mutation by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
20006,,,2572724,[],CHEMBL990937,Antimicrobial activity against Streptococcus pneumoniae L15 with parC Asp83Asn Lys137Asn and parE Ile460Val mutation by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
20007,,,2572725,[],CHEMBL990938,Antimicrobial activity against Streptococcus pneumoniae L22 with parC Lys137Asn and parE Ile460Val mutation by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
20008,,,2572726,[],CHEMBL990939,"Antimicrobial activity against Streptococcus pneumoniae L24 with gyrA Ser81Phe, gyrB Ser494Thr, parC Asp83Asn, Lys137Asn and parE Ile460Val mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,>=,1,1,>=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
20009,,,2572727,[],CHEMBL990940,"Antimicrobial activity against Viridans streptococcus L2 with gyrA Ser114Gly, gyrB Ser494Thr and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC,ug ml-1,UO_0000274,,4.0
20010,,,2572728,[],CHEMBL990941,"Antimicrobial activity against Viridans streptococcus L7 with gyrA Ser114Gly, gyrB Ser494Thr and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC,ug ml-1,UO_0000274,,4.0
20011,,,2572729,[],CHEMBL990942,"Antimicrobial activity against Viridans streptococcus L16 with gyrA Ser114Gly, gyrB Ser494Thr and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC,ug ml-1,UO_0000274,,4.0
20012,,,2572730,[],CHEMBL990943,"Antimicrobial activity against Viridans streptococcus L17 with gyrA Ser114Gly, gyrB Ser494Thr and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC,ug ml-1,UO_0000274,,4.0
20013,,,2572731,[],CHEMBL990944,"Antimicrobial activity against Viridans streptococcus L18 with gyrA Ser114Gly, Asp142Asn, gyrB Ser494Thr and parE Ile460Val mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC,ug ml-1,UO_0000274,,4.0
20014,,,2572732,[],CHEMBL990945,"Antimicrobial activity against Viridans streptococcus L19 with gyrA Ser114Gly, gyrB Ser494Thr, parC Ser52Gly, Asn91Asp and parE Ile460Val mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC,ug ml-1,UO_0000274,,4.0
20015,,,2572733,[],CHEMBL990946,"Antimicrobial activity against Viridans streptococcus L20 with gyrB Ser494Thr, parC Ser52Gly and Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC,ug ml-1,UO_0000274,,8.0
20016,,,2572734,[],CHEMBL990947,Antimicrobial activity against Viridans streptococcus L21 with gyrB Ser494Thr and parC Lys137Asn mutation by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC,ug ml-1,UO_0000274,,16.0
20017,,,2572735,[],CHEMBL990948,Antimicrobial activity against Viridans streptococcus L26 gyrA Ser81Phe and parC Lys137Asn mutation by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC,ug ml-1,UO_0000274,,16.0
20018,,,2572736,[],CHEMBL990949,Antimicrobial activity against atypical Streptococcus pneumoniae L3 with parC Lys137Asn mutation by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
20019,,,2572737,[],CHEMBL990950,"Antimicrobial activity against atypical Streptococcus pneumoniae L8 with parC Ser52Gly, Phe55His, Ser58Gly, Asn91Asp, Lys197Asn mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
20020,,,2572738,[],CHEMBL990951,"Antimicrobial activity against atypical Streptococcus pneumoniae L9 with gyrA Ser114Gly, gyrB Ser494Thr and parC Lys137Asn mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
20021,,,2572739,[],CHEMBL990952,Antimicrobial activity against atypical Streptococcus pneumoniae L10 with gyrA Ser81Phe and parC Lys197Asn mutation by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
20022,,,2572740,[],CHEMBL990953,Antimicrobial activity against atypical Streptococcus pneumoniae L4 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
20023,,,2572741,[],CHEMBL990954,"Antimicrobial activity against atypical Streptococcus pneumoniae L1 with gyrA Ser81Phe and parC Ser79Phe, Glu96Asp, Lys197Asn mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
20024,,,2572742,[],CHEMBL988220,Antimicrobial activity against atypical Streptococcus pneumoniae L25 with parC Lys137Asn mutation by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
20025,,,2572743,[],CHEMBL988221,"Antimicrobial activity against atypical Streptococcus pneumoniae L27 with parC Ser52Gly, Asn91Asp, Glu135Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
20026,,,2572744,[],CHEMBL988222,"Antimicrobial activity against atypical Streptococcus pneumoniae L11 with parC Ser52Gly, Asn91Asp, Glu135Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
20027,,,2572771,[],CHEMBL988223,Antimicrobial activity against Streptococcus pneumoniae R6 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
20028,,,2572772,[],CHEMBL988224,"Antimicrobial activity against Streptococcus oralis ATCC 10557 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC,ug ml-1,UO_0000274,,2.0
20029,,,2572773,[],CHEMBL988225,"Antimicrobial activity against Streptococcus oralis HK575 with gyrA Ser114Gly, Leu155Val and parC Ser52Gly, Asn91Asp, Pro140Ser mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC,ug ml-1,UO_0000274,,1.0
20030,,,2572774,[],CHEMBL988226,"Antimicrobial activity against Streptococcus oralis HK232 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC,ug ml-1,UO_0000274,,2.0
20031,,,2572775,[],CHEMBL988227,"Antimicrobial activity against Streptococcus oralis HK417 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC,ug ml-1,UO_0000274,,2.0
20032,,,2572776,[],CHEMBL988228,"Antimicrobial activity against Streptococcus oralis HK496 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC,ug ml-1,UO_0000274,,2.0
20033,,,2572777,[],CHEMBL988229,"Antimicrobial activity against Streptococcus oralis HK553 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC,ug ml-1,UO_0000274,,2.0
20034,,,2572778,[],CHEMBL988230,"Antimicrobial activity against Streptococcus oralis HK62 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC,ug ml-1,UO_0000274,,4.0
20035,,,2572779,[],CHEMBL988231,"Antimicrobial activity against Streptococcus oralis HK122 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC,ug ml-1,UO_0000274,,4.0
20036,,,2572780,[],CHEMBL988232,"Antimicrobial activity against Streptococcus oralis HK123 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC,ug ml-1,UO_0000274,,4.0
20037,,,2572781,[],CHEMBL988233,"Antimicrobial activity against Streptococcus oralis HK271 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC,ug ml-1,UO_0000274,,4.0
20038,,,2572782,[],CHEMBL988234,"Antimicrobial activity against Streptococcus oralis HK300 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC,ug ml-1,UO_0000274,,4.0
20039,,,2572783,[],CHEMBL988235,"Antimicrobial activity against Streptococcus oralis HK312 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC,ug ml-1,UO_0000274,,4.0
20040,,,2572784,[],CHEMBL988236,"Antimicrobial activity against Streptococcus oralis HK51with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC,ug ml-1,UO_0000274,,4.0
20041,,,2572785,[],CHEMBL988237,"Antimicrobial activity against Streptococcus oralis HK299 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC,ug ml-1,UO_0000274,,4.0
20042,,,2572786,[],CHEMBL988238,"Antimicrobial activity against Streptococcus oralis HK579 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC,ug ml-1,UO_0000274,,4.0
20043,,,2572787,[],CHEMBL988239,"Antimicrobial activity against Streptococcus oralis HK587 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC,ug ml-1,UO_0000274,,4.0
20044,,,2572788,[],CHEMBL988240,"Antimicrobial activity against Streptococcus oralis HK386 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC,ug ml-1,UO_0000274,,4.0
20045,,,2572789,[],CHEMBL988241,"Antimicrobial activity against Streptococcus oralis HK619 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC,ug ml-1,UO_0000274,,4.0
20046,,,2572790,[],CHEMBL988242,"Antimicrobial activity against Streptococcus oralis HK574 with gyrA Ser114Gly, Leu155Val, gyrB Ile385Val, Met483Thr, Ser494Thr and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC,ug ml-1,UO_0000274,,8.0
20047,,,2572791,[],CHEMBL988243,"Antimicrobial activity against Streptococcus oralis HK816 with gyrA Ser81Leu, Ser114Gly and parC Ser52Gly, Ser79Tyr, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC,ug ml-1,UO_0000274,,32.0
20048,,,2572792,[],CHEMBL988244,"Antimicrobial activity against Streptococcus oralis HK754 with gyrA Ser81Leu, Ser114Gly, gyrB Ser494Thr, parC Ser52Gly, Asp83Tyr, Asn91Asp and parE Arg447Ser mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC,ug ml-1,UO_0000274,,128.0
20049,,,2572793,[],CHEMBL988245,"Antimicrobial activity against Streptococcus mitis ATCC 49456 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp, Glu135Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC,ug ml-1,UO_0000274,,1.0
20050,,,2572794,[],CHEMBL988246,"Antimicrobial activity against Streptococcus mitis HK260 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,<,1,1,<,,MIC,ug.mL-1,,0.5,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC,ug ml-1,UO_0000274,,0.5
20051,,,2572795,[],CHEMBL988247,"Antimicrobial activity against Streptococcus mitis HK141 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC,ug ml-1,UO_0000274,,1.0
20052,,,2572796,[],CHEMBL988248,"Antimicrobial activity against Streptococcus mitis HK188 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp, Glu135Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC,ug ml-1,UO_0000274,,1.0
20053,,,2572797,[],CHEMBL988249,"Antimicrobial activity against Streptococcus mitis HK651 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC,ug ml-1,UO_0000274,,1.0
20054,,,2572798,[],CHEMBL988250,"Antimicrobial activity against Streptococcus mitis HK137453 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC,ug ml-1,UO_0000274,,2.0
20055,,,2572799,[],CHEMBL989132,"Antimicrobial activity against Streptococcus mitis HK680 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC,ug ml-1,UO_0000274,,2.0
20056,,,2572800,[],CHEMBL989133,"Antimicrobial activity against Streptococcus mitis HK125807 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC,ug ml-1,UO_0000274,,2.0
20057,,,2572801,[],CHEMBL989134,"Antimicrobial activity against Streptococcus mitis HK467 with gyrA Ser114Gly, Leu155Val and parC Ser52Gly, Asn91Asp, mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC,ug ml-1,UO_0000274,,2.0
20058,,,2572802,[],CHEMBL989135,"Antimicrobial activity against Streptococcus mitis HK666 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp, Glu135Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC,ug ml-1,UO_0000274,,2.0
20059,,,2572803,[],CHEMBL989136,"Antimicrobial activity against Streptococcus mitis HK135786 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC,ug ml-1,UO_0000274,,4.0
20060,,,2572804,[],CHEMBL989137,"Antimicrobial activity against Streptococcus mitis HK29 with gyrA Ser114Gly, and parC Ser52Gly, Asn91Asp mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC,ug ml-1,UO_0000274,,4.0
20061,,,2572805,[],CHEMBL989138,"Antimicrobial activity against Streptococcus mitis HK677 with gyrA Ser81Leu, Ser114Gly, gyrB Ser494Thr, parC Ser52Gly, Asp83Tyr, Asn91Asp and parE Arg447Ser mutation by broth dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155167,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743412,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC,ug ml-1,UO_0000274,,128.0
20062,,,2573952,[],CHEMBL990972,Antimicrobial activity against CTX-M extended-spectrum beta-lactamase producing commensal Escherichia coli isolates from healthy children assessed as percent resistant isolates by disc diffusion method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155170,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,742628,=,1,0,=,,Activity,%,,54.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,54.0
20063,,,2573954,[],CHEMBL990973,Antimicrobial activity against CTX-M-15 extended-spectrum beta-lactamase producing commensal Escherichia coli isolates from healthy children assessed as percent resistant isolates by disc diffusion method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155170,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,742628,=,1,0,=,,Activity,%,,93.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,93.0
20064,,,2574964,[],CHEMBL983704,Antimicrobial activity against Enterobacter isolates producing extended-spectrum beta-lactamase assessed as percent resistant isolates by agar dilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155137,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,742484,=,1,0,=,,Activity,%,,50.0,CHEMBL614439,Enterobacter,Enterobacter,547.0,,,Activity,%,UO_0000187,,50.0
20065,,,2576273,[],CHEMBL992870,Antimicrobial activity against wild type vancomycin-intermediate resistant Staphylococcus aureus Mu50 by microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155143,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742979,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
20066,,,2576290,[],CHEMBL992872,Antimicrobial activity against vancomycin-intermediate resistant Staphylococcus aureus Mu50 vraG mutant microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155143,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742979,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
20067,,,2576307,[],CHEMBL992871,Antimicrobial activity against vancomycin-intermediate resistant Staphylococcus aureus Mu50 graR mutant microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155143,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742979,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
20068,,,2576542,[],CHEMBL988174,Antibacterial activity against metallo-beta-lactamase VIM12 expressing Escherichia coli 28 isolate from decubitus ulcer infection patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155151,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742617,=,1,1,=,,MIC,ug.mL-1,,0.047,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.047
20069,,,2576553,[],CHEMBL988175,Antibacterial activity against Escherichia coli transconjugant carrying pEC28 isolate eby Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155151,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742617,=,1,1,=,,MIC,ug.mL-1,,0.047,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.047
20070,,,2576564,[],CHEMBL988176,Antibacterial activity against Escherichia coli 26R793 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155151,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742617,=,1,1,=,,MIC,ug.mL-1,,0.047,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.047
20071,,,2576596,[],CHEMBL993638,"Antibacterial activity against carbapenem-resistant Klebsiella pneumoniae 469 isolate producing KPC2, OXA4 and CTX-M-10 carbapenemases",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155771,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742647,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.25
20072,,,2576607,[],CHEMBL993639,"Antibacterial activity against carbapenem-resistant blaKPC-encoding plasmid harboring Klebsiella pneumoniae 469 transformants producing KPC2, OXA4 and CTX-M-10 carbapenemases",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155771,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742647,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.25
20073,,,2576618,[],CHEMBL993640,Antibacterial activity against carbapenem-resistant Klebsiella pneumoniae 490 isolate producing KPC3 and TEM1 carbapenemases,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155771,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742647,>,1,1,>,,MIC,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,4.0
20074,,,2576629,[],CHEMBL993641,Antibacterial activity against carbapenem-resistant blaKPC-encoding plasmid harboring Klebsiella pneumoniae 490 isolate producing KPC3 and TEM1 carbapenemases,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155771,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742647,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.25
20075,,,2576640,[],CHEMBL993642,Antibacterial activity against sEscherichia coli GeneHogs harboring blaKPC-encoding plasmids,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155771,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742647,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
20076,,,2603103,[],CHEMBL1023878,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136842,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,807784,=,1,1,=,,MIC,nM,,4710.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,4.71
20077,,,2603124,[],CHEMBL1023879,Antimycobacterial activity against Mycobacterium smegmatis ATCC 14468 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136842,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,807784,=,1,1,=,,MIC,nM,,2350.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,uM,UO_0000065,,2.35
20078,,,2603145,[],CHEMBL1023880,Antimycobacterial activity against Mycobacterium microti MTCC 1727 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136842,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,807784,=,1,1,=,,MIC,nM,,2350.0,CHEMBL612960,Mycobacterium tuberculosis variant microti,Mycobacterium tuberculosis variant microti,1806.0,,,MIC,uM,UO_0000065,,2.35
20079,,,2603166,[],CHEMBL1023881,Antimycobacterial activity against Mycobacterium fortuitum MTCC 951 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136842,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,807784,=,1,1,=,,MIC,nM,,4710.0,CHEMBL614983,Mycolicibacterium fortuitum,Mycolicibacterium fortuitum,1766.0,,,MIC,uM,UO_0000065,,4.71
20080,,,2603187,[],CHEMBL1023882,Antimycobacterial activity against Mycobacterium phlei MTCC 1724 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136842,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,807784,=,1,1,=,,MIC,nM,,4710.0,CHEMBL614985,Mycolicibacterium phlei,Mycolicibacterium phlei,1771.0,,,MIC,uM,UO_0000065,,4.71
20081,,,2603208,[],CHEMBL1023883,Antimycobacterial activity against Mycobacterium vaccae MTCC 997 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136842,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,807784,=,1,1,=,,MIC,nM,,4710.0,CHEMBL613224,Mycolicibacterium vaccae,Mycolicibacterium vaccae,1810.0,,,MIC,uM,UO_0000065,,4.71
20082,,,2603229,[],CHEMBL1023884,Antimycobacterial activity against Mycobacterium kansasii MTCC 3058 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136842,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,807784,=,1,1,=,,MIC,nM,,9450.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,uM,UO_0000065,,9.45
20083,,,2603250,[],CHEMBL1023885,Cytotoxicity against african green monkey Vero cells after 72 hrs by MTT assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1136842,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,807784,>,1,1,>,,IC50,nM,,188500.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,IC50,uM,UO_0000065,,188.5
20084,,,2604498,[],CHEMBL1033182,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 to 24 hrs by tube dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136859,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,806940,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
20085,,,2604523,[],CHEMBL1033183,Antibacterial activity against methicillin-resistant Staphylococcus aureus 431300 after 18 to 24 hrs by tube dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136859,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,806940,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,6.25
20086,,,2604548,[],CHEMBL1033184,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate after 18 to 24 hrs by tube dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136859,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,806940,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,12.5
20087,,,2604573,[],CHEMBL1033185,Antibacterial activity against Escherichia coli 25922 after 18 to 24 hrs by tube dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136859,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,806940,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.39
20088,,,2604598,[],CHEMBL1033186,Antibacterial activity against Bacillus subtilis 6633 after 18 to 24 hrs by tube dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136859,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,806940,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.19
20089,,,2610256,[],CHEMBL1012510,Inhibition of Escherichia coli recombinant DNA gyrase-mediated supercoiling of relaxed pRSET A-DNA by agarose gel electrophoresis,B,,,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152821,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,5.92,0,http://www.openphacts.org/units/Nanomolar,732428,=,1,1,=,,IC50,nM,,1200.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,1.2
20090,,,2610360,[],CHEMBL1015965,Antibacterial activity against Pseudomonas aeruginosa clinical isolate by macrodilution technique,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152825,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,731839,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC50,ug ml-1,UO_0000274,,0.25
20091,,,2610361,[],CHEMBL1015965,Antibacterial activity against Pseudomonas aeruginosa clinical isolate by macrodilution technique,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152825,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,731839,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,32.0
20092,,,2610362,[],CHEMBL1015965,Antibacterial activity against Pseudomonas aeruginosa clinical isolate by macrodilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152825,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,731839,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.06
20093,,,2612208,[],CHEMBL1015964,Antibacterial activity against Pseudomonas aeruginosa clinical isolates assessed as resistant rate by macrodilution technique,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152825,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,731839,=,1,0,=,,Activity,%,,28.3,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,28.3
20094,,,2612218,[],CHEMBL1016799,Antibacterial activity against Pseudomonas aeruginosa clinical isolates assessed as susceptible rate by macrodilution technique,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152825,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,731839,=,1,0,=,,Activity,%,,69.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,69.2
20095,,,2612225,[],CHEMBL1016794,Antibacterial activity against fluoroquinolone-resistant Pseudomonas aeruginosa isolate by macrodilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152825,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,731839,>=,1,1,>=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
20096,,,2612226,[],CHEMBL1015966,Antibacterial activity against wild type Pseudomonas aeruginosa PAO1 by macrodilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152825,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,731839,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.06
20097,,,2612227,[],CHEMBL1016795,Antibacterial activity against fluoroquinolone-resistant Pseudomonas aeruginosa isolate with GyrA/ParC double mutant by macrodilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152825,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,731839,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
20098,,,2612228,[],CHEMBL1016796,Antibacterial activity against fluoroquinolone-resistant Pseudomonas aeruginosa isolate with GyrA mutant by macrodilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152825,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,731839,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
20099,,,2612229,[],CHEMBL1016797,"Antibacterial activity against fluoroquinolone-resistant Pseudomonas aeruginosa isolate expressing MexXY-OprM pump, ParC mutant by macrodilution technique",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152825,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,731839,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
20100,,,2614040,[],CHEMBL1011609,Antitrypanosomal activity against wild type Trypanosoma brucei brucei s427 after 48 hrs by alamar blue assay,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152793,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,4.76,0,http://www.openphacts.org/units/Nanomolar,805378,=,1,1,=,,IC50,nM,,17200.0,CHEMBL612851,Trypanosoma brucei brucei,Trypanosoma brucei brucei,5702.0,,,IC50,uM,UO_0000065,,17.2
20101,,,2614157,[],CHEMBL1015091,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152832,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,732038,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
20102,,,2615632,[],CHEMBL1017726,Antibacterial activity against Escherichia coli AG100 by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154468,Eur J Med Chem,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,777983,<=,1,1,<=,,MIC,ug.mL-1,,0.019,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.019
20103,,,2615633,[],CHEMBL1017725,Antibacterial activity against Escherichia coli AG102 overexpressing acrAB by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154468,Eur J Med Chem,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,777983,=,1,1,=,,MIC,ug.mL-1,,0.04,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.04
20104,,,2615634,[],CHEMBL1017724,Antibacterial activity against Pseudomonas aeruginosa PAO1 by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154468,Eur J Med Chem,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,777983,=,1,1,=,,MIC,ug.mL-1,,0.16,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.16
20105,,,2615635,[],CHEMBL1017723,Antibacterial activity against Pseudomonas aeruginosa OCR1 overexpressing mexAB by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154468,Eur J Med Chem,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,777983,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.78
20106,,,2615636,[],CHEMBL1017722,Antibacterial activity against Pseudomonas aeruginosa K1536 overexpressing mexCD by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154468,Eur J Med Chem,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,777983,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.78
20107,,,2615637,[],CHEMBL1017721,Antibacterial activity against Staphylococcus aureus K1902 by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154468,Eur J Med Chem,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,777983,=,1,1,=,,MIC,ug.mL-1,,0.16,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.16
20108,,,2615638,[],CHEMBL1017720,Antibacterial activity against Staphylococcus aureus K2361 overexpressing norA by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154468,Eur J Med Chem,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,777983,=,1,1,=,,MIC,ug.mL-1,,2.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.5
20109,,,2615639,[],CHEMBL1017719,Antibacterial activity against Staphylococcus aureus K1758-P by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154468,Eur J Med Chem,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,777983,=,1,1,=,,MIC,ug.mL-1,,0.16,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.16
20110,,,2615640,[],CHEMBL1017718,Antibacterial activity against Staphylococcus aureus K1758-A overexpressing mepA by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154468,Eur J Med Chem,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,777983,=,1,1,=,,MIC,ug.mL-1,,0.63,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.63
20111,,,2617579,[],CHEMBL1032395,Antibacterial activity against Staphylococcus aureus ATCC 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154532,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,777517,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
20112,,,2625095,[],CHEMBL1008286,Antibacterial activity against Staphylococcus aureus ATCC 25923 at 100 ug/mL after 24 hrs by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1136949,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,785250,=,1,1,=,,IZ,mm,,22.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,22.0
20113,,,2628551,[],CHEMBL945686,Antimalarial activity as 2nd generation ring-stage chloroquine-sensitive Plasmodium falciparum 3D7 after 48 hrs by flow cytometry,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,5.03,0,http://www.openphacts.org/units/Nanomolar,792059,=,1,1,=,,IC50,nM,,9440.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,9.44
20114,,,2628557,[],CHEMBL945687,Antimalarial activity as 3rd generation ring-stage chloroquine-sensitive Plasmodium falciparum 3D7 after 48 hrs dose then 48 hrs drug-free,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,5.52,0,http://www.openphacts.org/units/Nanomolar,792059,=,1,1,=,,IC50,nM,,3040.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,3.04
20115,,,2628563,[],CHEMBL945688,Antimalarial activity as 2nd generation ring-stage chloroquine-resistant Plasmodium falciparum W2 after 48 hrs by flow cytometry,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,4.6,0,http://www.openphacts.org/units/Nanomolar,792059,=,1,1,=,,IC50,nM,,24900.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,24.9
20116,,,2628569,[],CHEMBL945689,Antimalarial activity as 3rd generation ring-stage chloroquine-resistant Plasmodium falciparum W2 after 48 hrs dose then 48 hrs drug-free,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,5.76,0,http://www.openphacts.org/units/Nanomolar,792059,=,1,1,=,,IC50,nM,,1750.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,1.75
20117,,,2628573,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '500.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '500.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL948858,"Cmax in patient with bronchitis at 500 mg, po twice daily for 3 days",A,,,BAO_0002119,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,792059,=,1,1,=,,Cmax,nM,,7600.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,uM,UO_0000065,,7.6
20118,,,2628574,[],CHEMBL948859,"Tmax in patient with bronchitis at 500 mg, po twice daily for 3 days",A,,,BAO_0003037,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,792059,=,1,1,=,,Tmax,hr,,0.6,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Tmax,hr,UO_0000032,,0.6
20119,,,2628575,[],CHEMBL948860,"Half life in patient with bronchitis at 500 mg, po twice daily for 3 days",A,,,BAO_0002115,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,792059,=,1,1,=,,T1/2,hr,,3.3,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,3.3
20120,,Not Active,2628587,[],CHEMBL948849,Antimalarial activity as schizont arrest after 48 hrs in chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes at 6 uM 96 hrs post invasion by Giemsa staining,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,792059,,1,0,,,Activity,,,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,,,,
20121,,,2628600,[],CHEMBL952719,Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 0-12 hrs post infection,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,792059,=,1,0,=,,Activity,%,,80.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,%,UO_0000187,,80.0
20122,,,2628601,[],CHEMBL952720,Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 0-24 hrs post infection,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,792059,=,1,0,=,,Activity,%,,67.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,%,UO_0000187,,67.0
20123,,,2628602,[],CHEMBL952721,Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 0-36 hrs post infection,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,792059,=,1,0,=,,Activity,%,,35.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,%,UO_0000187,,35.0
20124,,,2628603,[],CHEMBL966083,Antimalarial activity as 3rd generation after 96 hrs against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes at 6 uM 0-48 hrs post invasion,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,792059,=,1,0,=,,Activity,%,,13.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,%,UO_0000187,,13.0
20125,,,2628604,[],CHEMBL952723,Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 12-24 hrs post infection,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,792059,=,1,0,=,,Activity,%,,63.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,%,UO_0000187,,63.0
20126,,,2628605,[],CHEMBL952724,Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 12-36 hrs post infection,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,792059,=,1,0,=,,Activity,%,,23.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,%,UO_0000187,,23.0
20127,,,2628606,[],CHEMBL952725,Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 12-48 hrs post infection,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,792059,=,1,0,=,,Activity,%,,24.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,%,UO_0000187,,24.0
20128,,,2628607,[],CHEMBL952726,Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 24-36 hrs post infection,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,792059,=,1,0,=,,Activity,%,,70.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,%,UO_0000187,,70.0
20129,,,2628608,[],CHEMBL952727,Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 24-48 hrs post infection,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,792059,=,1,0,=,,Activity,%,,74.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,%,UO_0000187,,74.0
20130,,,2628609,[],CHEMBL952728,Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 36-48 hrs post infection,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,792059,=,1,0,=,,Activity,%,,108.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,%,UO_0000187,,108.0
20131,,Active,2628646,[],CHEMBL948844,Antimalarial activity as segregation of apicoplasts against chloroquine-sensitive ACP1-GFP-labeled Plasmodium falciparum 3D7 schizont infected human erythrocytes at 6 uM 96 hrs post infection,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,792059,,1,0,,,Activity,,,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,,,,
20132,,Active,2628647,[],CHEMBL945691,Antimalarial activity as segregation of apicoplasts against chloroquine-sensitive Plasmodium falciparum 3D7 infected in human erythrocytes at 6 uM 96 hrs post infection,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,792059,,1,0,,,Activity,,,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,,,,
20133,,,2628651,[],CHEMBL948853,Antimalarial activity as parasitaemia against chloroquine-sensitive ACP1-GFP-labeled Plasmodium falciparum 3D7 trophozoite infected human erythrocytes at 2xIC50 dosed 96 hrs post infection,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,792059,=,1,0,=,,Activity,%,,98.6,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,%,UO_0000187,,98.6
20134,,,2628655,[],CHEMBL948852,Antimalarial activity as abnormal apicoplast morphology in chloroquine-sensitive ACP1-GFP-labeled Plasmodium falciparum 3D7 trophozoite infected human erythrocytes at 2xIC50 dosed 96 hrs post infection,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,792059,=,1,0,=,,Activity,%,,81.4,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,%,UO_0000187,,81.4
20135,,,2630268,[],CHEMBL1001540,Antibacterial activity against vancomycin-resistant Enterococcus faecium ATCC 700221 by NCCLS method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137006,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784696,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,32.0
20136,,,2630297,[],CHEMBL1001542,Antibacterial activity against Bacillus cereus ATCC 11778 by NCCLS method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137006,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784696,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,ug ml-1,UO_0000274,,0.12
20137,,,2630298,[],CHEMBL1001541,Antibacterial activity against Bacillus subtilis ATCC 23857 by NCCLS method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137006,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784696,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.12
20138,,,2630299,[],CHEMBL1001537,Antibacterial activity against methicillin-resistan Staphylococcus epidermidis ATCC 51625 by NCCLS method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137006,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784696,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.12
20139,,,2630300,[],CHEMBL1001536,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 by NCCLS method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137006,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784696,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.12
20140,,,2630301,[],CHEMBL1001535,Antibacterial activity against methicillin-resistan Staphylococcus aureus ATCC 33591 by NCCLS method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137006,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784696,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
20141,,,2630324,[],CHEMBL1001534,Antibacterial activity against multi-drug resistant Staphylococcus aureus BAA-39 by NCCLS method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137006,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784696,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
20142,,,2630375,[],CHEMBL1001543,Antibacterial activity against Bacteroides fragilis ATCC 23745 by NCCLS method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137006,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784696,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,0.5
20143,,,2630376,[],CHEMBL1001539,Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51575 by NCCLS method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137006,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784696,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
20144,,,2630377,[],CHEMBL1001538,Antibacterial activity against Streptococcus pneumoniae ATCC 6301 by NCCLS method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137006,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784696,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
20145,,,2630378,[],CHEMBL1001533,Antibacterial activity against Staphylococcus aureus ATCC 29213 by NCCLS method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137006,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784696,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
20146,,,2630398,[],CHEMBL1001544,Antibacterial activity against Clostridium perfringens ATCC 10388 by NCCLS method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137006,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784696,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC,ug ml-1,UO_0000274,,0.25
20147,,,2631527,[],CHEMBL1008429,Antibacterial activity against imipenem-susceptible Acinetobacter baumannii ATCC 19606 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137650,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783843,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.75
20148,,,2631528,[],CHEMBL1008430,Antibacterial activity against imipenem-susceptible Acinetobacter baumannii ab3 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137650,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783843,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.125
20149,,,2631529,[],CHEMBL1008431,Antibacterial activity against imipenem-susceptible Acinetobacter baumannii ab4 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137650,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783843,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.25
20150,,,2631530,[],CHEMBL1008432,Antibacterial activity against imipenem-susceptible Acinetobacter baumannii ab8 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137650,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783843,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.38
20151,,,2631531,[],CHEMBL1008433,Antibacterial activity against imipenem-susceptible Acinetobacter baumannii ab12 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137650,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783843,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.25
20152,,,2631532,[],CHEMBL1008434,Antibacterial activity against imipenem-susceptible Acinetobacter baumannii ab20 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137650,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783843,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,3.0
20153,,,2631533,[],CHEMBL1008435,Antibacterial activity against imipenem-susceptible Acinetobacter baumannii ab1308 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137650,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783843,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
20154,,,2631534,[],CHEMBL1008436,Antibacterial activity against imipenem-susceptible Acinetobacter baumannii ab1254 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137650,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783843,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
20155,,,2631535,[],CHEMBL1008437,Antibacterial activity against imipenem-susceptible Acinetobacter baumannii ab1316 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137650,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783843,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
20156,,,2631536,[],CHEMBL1008438,Antibacterial activity against imipenem-intermediate Acinetobacter baumannii ab1297 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137650,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783843,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
20157,,,2631537,[],CHEMBL1008439,Antibacterial activity against imipenem-resistant Acinetobacter baumannii ab1265 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137650,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783843,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
20158,,,2631538,[],CHEMBL1008440,Antibacterial activity against imipenem-resistant Acinetobacter baumannii ab1266 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137650,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783843,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
20159,,,2631539,[],CHEMBL1008441,Antibacterial activity against imipenem-resistant Acinetobacter baumannii abh9 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137650,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783843,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
20160,,,2631540,[],CHEMBL1008442,Antibacterial activity against imipenem-resistant Acinetobacter baumannii abh11 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137650,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783843,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
20161,,,2631541,[],CHEMBL1008443,Antibacterial activity against imipenem-resistant Acinetobacter baumannii abh13 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137650,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783843,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
20162,,,2631542,[],CHEMBL1008444,Antibacterial activity against imipenem-resistant Acinetobacter baumannii abh14 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137650,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783843,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
20163,,,2631543,[],CHEMBL1008445,Antibacterial activity against imipenem-resistant Acinetobacter baumannii abh17 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137650,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783843,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
20164,,,2631544,[],CHEMBL1008446,Antibacterial activity against imipenem-resistant Acinetobacter baumannii abh18 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137650,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783843,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
20165,,,2631545,[],CHEMBL1008447,Antibacterial activity against imipenem-resistant Acinetobacter baumannii abh20 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137650,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783843,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
20166,,,2631546,[],CHEMBL1008448,Antibacterial activity against imipenem-resistant Acinetobacter baumannii abh26 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137650,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783843,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
20167,,,2631547,[],CHEMBL1008449,Antibacterial activity against imipenem-resistant Acinetobacter baumannii abh29 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137650,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783843,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
20168,,,2631548,[],CHEMBL1008450,Antibacterial activity against imipenem-resistant Acinetobacter baumannii abh36 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137650,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783843,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
20169,,,2631549,[],CHEMBL1008451,Antibacterial activity against imipenem-resistant Acinetobacter baumannii abh37 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137650,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783843,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
20170,,,2631550,[],CHEMBL1008452,Antibacterial activity against imipenem-resistant Acinetobacter baumannii abh39 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137650,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783843,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
20171,,,2631669,[],CHEMBL1007408,Ratio of MIC for Escherichia coli HB101 harboring aac(6')-Ib-cr gene to MIC for wild type Escherichia coli HB101,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,783939,=,1,0,=,,Ratio,,,3.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,3.0
20172,,,2631670,[],CHEMBL1006595,Ratio of MIC for azide-resistant aac(6')-Ib-cr expressing Escherichia coli J53 qnrA1 bearing pHS3 transconjugant to MIC for azide-resistant Escherichia coli J53,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,783939,=,1,0,=,,Ratio,,,12.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,12.0
20173,,,2631671,[],CHEMBL1006596,Ratio of MIC for azide-resistant aac(6')-Ib-cr deficient Escherichia coli J53 qnrA1 bearing pHS4 transconjugant to MIC for azide-resistant Escherichia coli J53,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,783939,=,1,0,=,,Ratio,,,12.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,12.0
20174,,,2631672,[],CHEMBL1006597,Ratio of MIC for azide-resistant aac(6')-Ib-cr deficient Escherichia coli J53 qnrA1 bearing pHS5 transconjugant to MIC for azide-resistant Escherichia coli J53,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,783939,=,1,0,=,,Ratio,,,12.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,12.0
20175,,,2631673,[],CHEMBL1006598,Ratio of MIC for azide-resistant aac(6')-Ib-cr expressing Escherichia coli J53 qnrA1 bearing pHS6 transconjugant to MIC for azide-resistant Escherichia coli J53,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,783939,=,1,0,=,,Ratio,,,12.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,12.0
20176,,,2631674,[],CHEMBL1006599,Ratio of MIC for azide-resistant aac(6')-Ib-cr expressing Escherichia coli J53 qnrA1 bearing pHS6 transconjugant to MIC for azide-resistant aac(6')-Ib-cr expressing Escherichia coli J53 qnrA1 bearing pHS3 transconjugant,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,783939,=,1,0,=,,Ratio,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,4.0
20177,,,2631681,[],CHEMBL1007404,Ratio of MIC for Escherichia coli harboring plasmid carrying In37 to MIC for Escherichia coli harboring plasmid carrying In36,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,783939,=,1,0,=,,Ratio,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,4.0
20178,,,2631682,[],CHEMBL1006609,Antimicrobial activity against Escherichia coli harboring plasmid carrying In36,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783939,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
20179,,,2631683,[],CHEMBL1007403,Antimicrobial activity against Escherichia coli harboring plasmid carrying In37,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783939,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
20180,,,2631687,[],CHEMBL1007405,Antimicrobial activity against Escherichia coli J53 expressing qnrA gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783939,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
20181,,,2631688,[],CHEMBL1007407,Antimicrobial activity against azide-resistant Escherichia coli J53 transconjugant with qnrA expressing Escherichia coli clinical isolates by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783939,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
20182,,,2631689,[],CHEMBL1007406,Antibacterial activity against Escherichia coli isolate 1B harboring qnrA1 and blaVEB1 genes by by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783939,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
20183,,,2631690,[],CHEMBL1007409,Antimicrobial activity Enterobacter cloacae 63 expressing plasmid-mediated quinolone resistance qnr A gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783939,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,32.0
20184,,,2631691,[],CHEMBL1007410,Antimicrobial activity Enterobacter cloacae 91 expressing plasmid-mediated quinolone resistance qnr A gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783939,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,4.0
20185,,,2631692,[],CHEMBL1007411,Antimicrobial activity Enterobacter cloacae 113 expressing plasmid-mediated quinolone resistance qnr A gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783939,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,128.0
20186,,,2631693,[],CHEMBL1004055,Antimicrobial activity Enterobacter cloacae 641 expressing plasmid-mediated quinolone resistance qnr A gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783939,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,4.0
20187,,,2631694,[],CHEMBL1004056,Antimicrobial activity Escherichia coli 633 expressing plasmid-mediated quinolone resistance qnr A gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783939,>=,1,1,>=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
20188,,,2631695,[],CHEMBL1004057,Antimicrobial activity Escherichia coli 650 expressing plasmid-mediated quinolone resistance qnr A gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783939,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
20189,,,2631696,[],CHEMBL1004058,Antimicrobial activity Citrobacter freundii 64 expressing plasmid-mediated quinolone resistance qnr A gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783939,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC,ug ml-1,UO_0000274,,32.0
20190,,,2631726,[],CHEMBL1004059,Antimicrobial activity against azide-resistant aac(6')-Ib-cr expressing Escherichia coli J53 qnrA1 bearing pHS3 transconjugant from Citrobacter freundii 64 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783939,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
20191,,,2631727,[],CHEMBL1004060,Antimicrobial activity against azide-resistant aac(6')-Ib-cr deficient Escherichia coli J53 qnrA1 bearing pHS4 transconjugant from Enterobacter cloacae 91 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783939,=,1,1,=,,MIC,ug.mL-1,,0.094,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.094
20192,,,2631728,[],CHEMBL1006592,Antimicrobial activity against azide-resistant aac(6')-Ib-cr deficient Escherichia coli J53 qnrA1 bearing pHS5 transconjugant from Enterobacter cloacae 641 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783939,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
20193,,,2631729,[],CHEMBL1006593,Antimicrobial activity against azide-resistant aac(6')-Ib-cr expressing Escherichia coli J53 qnrA1 bearing pHS6 transconjugant from Escherichia coli 650 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783939,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
20194,,,2631730,[],CHEMBL1006594,Antimicrobial activity against azide-resistant Escherichia coli J53 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783939,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
20195,,,2634661,[],CHEMBL1008425,Antimicrobial activity against mupirocin-susceptible methicillin-resistant Staphylococcus aureus by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137649,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783671,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,8.0
20196,,,2634670,[],CHEMBL1008426,Antimicrobial activity against mupirocin-resistant methicillin-resistant Staphylococcus aureus by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137649,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783671,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,8.0
20197,,,2634679,[],CHEMBL1008427,Antimicrobial activity against mupirocin-susceptible methicillin-resistant Staphylococcus aureus assessed as resistant rate by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137649,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,783671,=,1,0,=,,Activity,%,,90.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,90.0
20198,,,2634688,[],CHEMBL1008428,Antimicrobial activity against mupirocin-resistant methicillin-resistant Staphylococcus aureus assessed as resistant rate by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137649,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,783671,=,1,0,=,,Activity,%,,75.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,75.0
20199,,,2634697,[],CHEMBL1008425,Antimicrobial activity against mupirocin-susceptible methicillin-resistant Staphylococcus aureus by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137649,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783671,<=,1,1,<=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
20200,,,2634706,[],CHEMBL1008426,Antimicrobial activity against mupirocin-resistant methicillin-resistant Staphylococcus aureus by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1137649,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783671,>=,1,1,>=,,MIC,ug.mL-1,,512.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,512.0
20201,,,2642631,[],CHEMBL1023440,Antibacterial activity against Staphylococcus aureus at 100 ug/disk after 24 hrs by agar disc-diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158337,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,817146,=,1,1,=,,IZ,mm,,34.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,34.0
20202,,,2642632,[],CHEMBL1023442,Antibacterial activity against Bacillus subtilis at 100 ug/disk after 24 hrs by agar disc-diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158337,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,817146,=,1,1,=,,IZ,mm,,36.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,IZ,mm,UO_0000016,,36.0
20203,,,2642633,[],CHEMBL1023444,Antibacterial activity against Escherichia coli at 100 ug/disk after 24 hrs by agar disc-diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158337,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,817146,=,1,1,=,,IZ,mm,,40.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IZ,mm,UO_0000016,,40.0
20204,,,2642634,[],CHEMBL1023446,Antibacterial activity against Klebsiella pneumoniae at 100 ug/disk after 24 hrs by agar disc-diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158337,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,817146,=,1,1,=,,IZ,mm,,37.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,IZ,mm,UO_0000016,,37.0
20205,,,2642635,[],CHEMBL1023441,Antibacterial activity against Staphylococcus aureus at 200 ug/disk after 24 hrs by agar disc-diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158337,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,817146,=,1,1,=,,IZ,mm,,38.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,38.0
20206,,,2642636,[],CHEMBL1023443,Antibacterial activity against Bacillus subtilis at 200 ug/disk after 24 hrs by agar disc-diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158337,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,817146,=,1,1,=,,IZ,mm,,42.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,IZ,mm,UO_0000016,,42.0
20207,,,2642637,[],CHEMBL1023445,Antibacterial activity against Escherichia coli at 200 ug/disk after 24 hrs by agar disc-diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158337,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,817146,=,1,1,=,,IZ,mm,,45.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IZ,mm,UO_0000016,,45.0
20208,,,2642638,[],CHEMBL1023447,Antibacterial activity against Klebsiella pneumoniae at 200 ug/disk after 24 hrs by agar disc-diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158337,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,817146,=,1,1,=,,IZ,mm,,42.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,IZ,mm,UO_0000016,,42.0
20209,,,2642720,[],CHEMBL1023454,Antibacterial activity against Staphylococcus aureus after 24 hrs by microdilution susceptibility method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158337,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817146,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,6.25
20210,,,2642721,[],CHEMBL1023455,Antibacterial activity against Bacillus subtilis after 24 hrs by microdilution susceptibility method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158337,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817146,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,6.25
20211,,,2642722,[],CHEMBL1023456,Antibacterial activity against Escherichia coli after 24 hrs by microdilution susceptibility method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158337,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817146,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,6.25
20212,,,2642723,[],CHEMBL1023457,Antibacterial activity against Klebsiella pneumoniae after 48 hrs by microdilution susceptibility method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158337,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817146,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,6.25
20213,,,2642783,[],CHEMBL1026121,Antibacterial activity against Pseudomonas aeruginosa ATCC 2853 after 24 hrs by agar streak dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158339,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,813712,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
20214,,,2642796,[],CHEMBL1026120,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by agar streak dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158339,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,813712,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.2
20215,,,2642809,[],CHEMBL1026119,Antibacterial activity against Bacillus cereus ATCC 11778 after 24 hrs by agar streak dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158339,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,813712,=,1,1,=,,MIC,ug.mL-1,,0.3,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,ug ml-1,UO_0000274,,0.3
20216,,,2642822,[],CHEMBL1026118,Antibacterial activity against Micrococcus luteus ATCC 4698 after 24 hrs by agar streak dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158339,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,813712,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,0.1
20217,,,2642835,[],CHEMBL1026117,Antibacterial activity against Staphylococcus epidermidis ATCC 155 after 24 hrs by agar streak dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158339,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,813712,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.39
20218,,,2642848,[],CHEMBL1026116,Antibacterial activity against Staphylococcus aureus ATCC 9144 after 24 hrs by agar streak dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158339,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,813712,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
20219,,,2642863,[],CHEMBL1026113,Antibacterial activity against Klebsiella pneumoniae ATCC 11298 at 100 ug/disk after 24 hrs by paper disk diffusion technique,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158339,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,813712,=,1,1,=,,IZ,mm,,33.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,IZ,mm,UO_0000016,,33.0
20220,,,2642864,[],CHEMBL1023466,Antibacterial activity against Pseudomonas aeruginosa ATCC 2853 at 100 ug/disk after 24 hrs by paper disk diffusion technique,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158339,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,813712,=,1,1,=,,IZ,mm,,33.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,IZ,mm,UO_0000016,,33.0
20221,,,2642865,[],CHEMBL1026112,Antibacterial activity against Escherichia coli ATCC 25922 at 100 ug/disk after 24 hrs by paper disk diffusion technique,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158339,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,813712,=,1,1,=,,IZ,mm,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IZ,mm,UO_0000016,,32.0
20222,,,2642866,[],CHEMBL1026111,Antibacterial activity against Bacillus cereus ATCC 11778 at 100 ug/disk after 24 hrs by paper disk diffusion technique,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158339,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,813712,=,1,1,=,,IZ,mm,,29.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,IZ,mm,UO_0000016,,29.0
20223,,,2642867,[],CHEMBL1026110,Antibacterial activity against Micrococcus luteus ATCC 4698 at 100 ug/disk after 24 hrs by paper disk diffusion technique,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158339,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,813712,=,1,1,=,,IZ,mm,,30.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,IZ,mm,UO_0000016,,30.0
20224,,,2642868,[],CHEMBL1026109,Antibacterial activity against Staphylococcus epidermidis ATCC 155 at 100 ug/disk after 24 hrs by paper disk diffusion technique,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158339,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,813712,=,1,1,=,,IZ,mm,,31.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,IZ,mm,UO_0000016,,31.0
20225,,,2642869,[],CHEMBL1026108,Antibacterial activity against Staphylococcus aureus ATCC 9144 at 100 ug/disk after 24 hrs by paper disk diffusion technique,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158339,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,813712,=,1,1,=,,IZ,mm,,29.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,29.0
20226,,,2642979,[],CHEMBL1026122,Antibacterial activity against Klebsiella pneumoniae ATCC 11298 after 24 hrs by agar streak dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158339,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,813712,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.1
20227,,,2647587,[],CHEMBL1028529,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 hrs by agar dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158387,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,814778,=,1,1,=,,MIC,ug.mL-1,,0.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.3
20228,,,2647588,[],CHEMBL1028530,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 18 hrs by agar dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158387,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,814778,=,1,1,=,,MIC,ug.mL-1,,0.3,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.3
20229,,,2647589,[],CHEMBL1028532,Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs by agar dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158387,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,814778,=,1,1,=,,MIC,ug.mL-1,,0.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.3
20230,,,2647590,[],CHEMBL1028534,Antibacterial activity against Proteus vulgaris ATCC 13315 after 18 hrs by agar dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158387,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,814778,=,1,1,=,,MIC,ug.mL-1,,0.3,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.3
20231,,,2647592,[],CHEMBL1028531,Antibacterial activity against Streptococcus agalactiae ATCC 123860 after 18 hrs by agar dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158387,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,814778,=,1,1,=,,MIC,ug.mL-1,,0.6,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.6
20232,,,2647598,[],CHEMBL1028533,Antibacterial activity against Klebsiella pneumoniae ATCC 33495 after 18 hrs by agar dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158387,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,814778,=,1,1,=,,MIC,ug.mL-1,,1.3,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.3
20233,,Not Active,2648051,[],CHEMBL1028535,Antifungal activity against Candida albicans ATCC 20260 after 18 hrs by agar dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158387,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,814778,,1,0,,,MIC,,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,,,,
20234,,,2653865,[],CHEMBL1023480,Antibacterial activity against Staphylococcus aureus after 24 hrs by tube dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158415,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,813905,=,1,0,=,,-logMIC,,,2.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,-logMIC,,,,2.03
20235,,,2653866,[],CHEMBL1023481,Antibacterial activity against Bacillus subtilis after 24 hrs by tube dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158415,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,813905,=,1,0,=,,-logMIC,,,2.33,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,-logMIC,,,,2.33
20236,,,2653867,[],CHEMBL1023482,Antibacterial activity against Escherichia coli after 24 hrs by tube dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158415,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,813905,=,1,0,=,,-logMIC,,,2.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,-logMIC,,,,2.03
20237,,,2653868,[],CHEMBL1023483,Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by tube dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158415,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,813905,=,1,0,=,,-logMIC,,,2.62,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,-logMIC,,,,2.62
20238,,,2654821,[],CHEMBL1026949,Antibacterial activity against Pseudomonas aeruginosa by twofold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158420,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,815637,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,12.5
20239,,,2654850,[],CHEMBL1026950,Antibacterial activity against Staphylococcus aureus by twofold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158420,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,815637,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,25.0
20240,,,2654879,[],CHEMBL1026951,Antibacterial activity against Salmonella typhi by twofold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158420,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,815637,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,50.0
20241,,,2654908,[],CHEMBL1026952,Antibacterial activity against Escherichia coli by twofold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158420,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,815637,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,25.0
20242,,,2656092,[],CHEMBL1035319,Antibacterial activity against Staphylococcus aureus NCTC 6571 after 24 hrs by agar cup diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158424,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,816208,=,1,1,=,,MIC,ug.mL-1,,52.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,52.4
20243,,,2656112,[],CHEMBL1035318,Antibacterial activity against Bacillus subtilis after 24 hrs by agar cup diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158424,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,816208,=,1,1,=,,MIC,ug.mL-1,,0.61,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.61
20244,,,2656132,[],CHEMBL1035315,Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by agar cup diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158424,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,816208,=,1,1,=,,MIC,ug.mL-1,,30.8,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,30.8
20245,,,2656832,[],CHEMBL1035317,Antibacterial activity against Escherichia coli C-600 after 24 hrs by agar cup diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158424,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,816208,=,1,1,=,,MIC,ug.mL-1,,1.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.2
20246,,,2658910,[],CHEMBL1033671,Antibacterial activity against Escherichia coli ATCC 35218 after 18 to 24 hrs by alamar blue assay,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151952,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,8.0,0,http://www.openphacts.org/units/Nanomolar,818521,=,1,1,=,,IC50,nM,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IC50,uM,UO_0000065,,0.01
20247,,,2658912,[],CHEMBL1033669,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 after 18 to 24 hrs by alamar blue assay,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151952,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,6.4,0,http://www.openphacts.org/units/Nanomolar,818521,=,1,1,=,,IC50,nM,,400.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IC50,uM,UO_0000065,,0.4
20248,,,2658913,[],CHEMBL1033670,Antibacterial activity against Staphylococcus aureus ATCC 29213 by alamar blue assay,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151952,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,6.4,0,http://www.openphacts.org/units/Nanomolar,818521,=,1,1,=,,IC50,nM,,400.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IC50,uM,UO_0000065,,0.4
20249,,,2658916,[],CHEMBL1033672,Antibacterial activity against Mycobacterium intracellular ATCC 23068 after 68 to 72 hrs by alamar blue assay,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151952,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,5.82,0,http://www.openphacts.org/units/Nanomolar,818521,=,1,1,=,,IC50,nM,,1500.0,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,IC50,uM,UO_0000065,,1.5
20250,,,2660384,[],CHEMBL1052264,Drug resistance in 0.03 ug/ml pretreated Pseudomonas aeruginosa PAO1 H103 assessed as logarithmic enhancement of CFU at 2 times MIC after overnight incubation by adaptive resistance assay,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,Activity,,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,1.0
20251,,Not Active,2660385,[],CHEMBL1052265,Antimicrobial activity in 0.01 ug/ml pretreated Pseudomonas aeruginosa PAO1 H103 at 2 times MIC after overnight incubation by adaptive resistance assay,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
20252,,,2660386,[],CHEMBL1052266,Effect on morphological change in Pseudomonas aeruginosa PAO1 H103 assessed as elongation in cell length at 0.1 times MIC by Grams staining-based light microscopy (Rvb=2.8 um),F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Micrometer,817422,=,1,0,=,,Activity,um,,3.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,um,UO_0000017,,3.0
20253,,,2660387,[],CHEMBL1052267,Effect on morphological change in Pseudomonas aeruginosa PAO1 H103 assessed as elongation in cell length at 0.3 times MIC by Grams staining-based light microscopy (Rvb=2.8 um),F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Micrometer,817422,=,1,0,=,,Activity,um,,3.6,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,um,UO_0000017,,3.6
20254,,,2660388,[],CHEMBL1052268,Effect on morphological change in Pseudomonas aeruginosa PAO1 H103 assessed as elongation in cell length at 1 times MIC by Grams staining-based light microscopy (Rvb=2.8 um),F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Micrometer,817422,=,1,0,=,,Activity,um,,6.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,um,UO_0000017,,6.5
20255,,,2660389,[],CHEMBL1052269,Effect on morphological change in Pseudomonas aeruginosa PAO1 H103 assessed as elongation in cell length at 0.2 times MIC after 1.5 hrs by Grams staining-based light microscopy (Rvb=2.8 um),F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Micrometer,817422,=,1,0,=,,Activity,um,,4.8,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,um,UO_0000017,,4.8
20256,,,2660390,[],CHEMBL1052270,Effect on morphological change in 0.1 times MIC pretreated Pseudomonas aeruginosa PAO1 H103 assessed as elongation in cell length at 0.2 times MIC after 1.5 hrs by Grams staining-based light microscopy (Rvb=2.8 um),F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Micrometer,817422,=,1,0,=,,Activity,um,,5.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,um,UO_0000017,,5.4
20257,,,2660391,[],CHEMBL1052271,Effect on morphological change in 0.3 times MIC pretreated Pseudomonas aeruginosa PAO1 H103 assessed as elongation in cell length at 0.2 times MIC after 1.5 hrs by Grams staining-based light microscopy (Rvb=2.8 um),F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Micrometer,817422,=,1,0,=,,Activity,um,,7.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,um,UO_0000017,,7.0
20258,,,2660392,[],CHEMBL1052272,Effect on chaperones and heat shock proteins expression in Pseudomonas aeruginosa PAO1 assessed as alteration in the open reading frames at 0.1 times MIC by microarray analysis,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,817422,=,1,0,=,,Activity,%,,17.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,17.0
20259,,,2660393,[],CHEMBL1052273,Effect on chaperones and heat shock proteins expression in Pseudomonas aeruginosa PAO1 assessed as alteration in the open reading frames at 0.3 times MIC by microarray analysis,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,817422,=,1,0,=,,Activity,%,,17.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,17.0
20260,,,2660394,[],CHEMBL1052974,Effect on chaperones and heat shock proteins expression in Pseudomonas aeruginosa PAO1 assessed as alteration in the open reading frames at 1 times MIC by microarray analysis,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,817422,=,1,0,=,,Activity,%,,33.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,33.0
20261,,Not Evaluated,2660395,[],CHEMBL1052975,"Effect on phage, transposon or plasmid category gene expression in Pseudomonas aeruginosa PAO1 assessed as alteration in the open reading frames by microarray analysis",F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
20262,,,2660396,[],CHEMBL1052976,"Effect on translation, modification, degradation category gene expression in Pseudomonas aeruginosa PAO1 assessed as alteration in the open reading frames 0.3 times MIC by microarray analysis",F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,817422,=,1,0,=,,Activity,%,,26.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,26.0
20263,,,2660397,[],CHEMBL1052977,"Effect on translation, modification, degradation category gene expression in Pseudomonas aeruginosa PAO1 assessed as alteration in the open reading frames 0.1 times MIC by microarray analysis",F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,817422,=,1,0,=,,Activity,%,,12.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,12.0
20264,,,2660398,[],CHEMBL1052263,Drug resistance in 15_H4 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1101 mutant strain with alteration in PA0353 open reading frame assessed as fold increase in susceptibility after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20265,,,2660399,[],CHEMBL1052262,Drug resistance in 74_G10 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1102 mutant strain with alteration in PA0836 open reading frame assessed as fold increase in susceptibility after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20266,,,2660400,[],CHEMBL1052261,Drug resistance in 31_C9 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1104 mutant strain with alteration in PA1803 open reading frame assessed as fold increase in susceptibility after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20267,,,2660401,[],CHEMBL1052260,Drug resistance in 74_D9 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1105 mutant strain with alteration in PA1803 open reading frame assessed as fold increase in susceptibility after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20268,,,2660402,[],CHEMBL1052259,Drug resistance in 24_A2 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1106 mutant strain with alteration in PA1803 open reading frame assessed as fold increase in susceptibility after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20269,,,2660403,[],CHEMBL1052257,Drug resistance in 50_F11 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1107 mutant strain with alteration in PA3082 open reading frame assessed as fold increase in susceptibility after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20270,,,2660404,[],CHEMBL1052258,Drug resistance in 73_E4 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1108 mutant strain with alteration in PA3294 open reading frame assessed as fold increase in susceptibility after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20271,,,2660405,[],CHEMBL1052256,Drug resistance in 69_C12 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1109 mutant strain with alteration in PA3617 open reading frame assessed as fold increase in susceptibility after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20272,,,2660406,[],CHEMBL1052255,Drug resistance in 76_E9 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1110 mutant strain with alteration in PA3777 open reading frame assessed as fold increase in susceptibility after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20273,,,2660407,[],CHEMBL1052253,Drug resistance in 14_E7 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1111 mutant strain with alteration in PA3965 open reading frame assessed as fold increase in susceptibility after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20274,,,2660408,[],CHEMBL1052254,Drug resistance in 51_E8 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1112 mutant strain with alteration in PA4163 open reading frame assessed as fold increase in susceptibility after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20275,,,2660409,[],CHEMBL1052252,Drug resistance in 82_F7 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1113 mutant strain with alteration in PA4316 open reading frame assessed as fold increase in susceptibility after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20276,,,2660410,[],CHEMBL1063886,Drug resistance in 98_C2 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1114 mutant strain with alteration in PA4316 open reading frame assessed as fold increase in susceptibility after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20277,,,2660411,[],CHEMBL1063884,Drug resistance in 81_B12 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1115 mutant strain with alteration in PA4422 open reading frame assessed as fold increase in susceptibility after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20278,,,2660412,[],CHEMBL1063885,Drug resistance in 43_C12 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1116 mutant strain with alteration in PA4466 open reading frame assessed as fold increase in susceptibility after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20279,,,2660413,[],CHEMBL1063883,Drug resistance in 22_C1 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1117 mutant strain with alteration in PA4700 open reading frame assessed as fold increase in susceptibility after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20280,,,2660414,[],CHEMBL1063882,Drug resistance in 73_D6 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1118 mutant strain with alteration in PA4700 open reading frame assessed as fold increase in susceptibility after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20281,,,2660415,[],CHEMBL1063881,Drug resistance in 75_D3 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1119 mutant strain with alteration in PA4756 open reading frame assessed as fold increase in susceptibility after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20282,,,2660416,[],CHEMBL1063880,Drug resistance in 81_D2 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1120 mutant strain with alteration in PA4763 open reading frame assessed as fold increase in susceptibility after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20283,,,2660417,[],CHEMBL1063879,Drug resistance in 6_G1 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1121 mutant strain with alteration in PA4961 open reading frame assessed as fold increase in susceptibility after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20284,,,2660418,[],CHEMBL1063878,Drug resistance in 80_B7 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1122 mutant strain with alteration in PA5016 open reading frame assessed as fold increase in susceptibility after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20285,,,2660419,[],CHEMBL1063877,Drug resistance in 22_C5 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1123 mutant strain with alteration in PA5208 open reading frame assessed as fold increase in susceptibility after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20286,,,2660420,[],CHEMBL1063876,Drug resistance in 53_F11 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1124 mutant strain with alteration in PA5279 open reading frame assessed as fold increase in susceptibility after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20287,,,2660421,[],CHEMBL1063875,Drug resistance in 16_G12 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1125 mutant strain with alteration in PA5345 open reading frame assessed as fold increase in susceptibility after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20288,,,2660422,[],CHEMBL1063874,Drug resistance in 51_C1 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1126 mutant strain with alteration in PA0393 open reading frame assessed as fold increase in resistance after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20289,,,2660423,[],CHEMBL1052978,Drug resistance in 75_F2 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1127 mutant strain with alteration in PA0413 open reading frame assessed as fold increase in resistance after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20290,,,2660424,[],CHEMBL1052979,Drug resistance in 41_C11 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1128 mutant strain with alteration in PA3115 open reading frame assessed as fold increase in resistance after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20291,,,2660425,[],CHEMBL1060400,Drug resistance in 70_H3 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1129 mutant strain with alteration in PA3528 open reading frame assessed as fold increase in resistance after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20292,,,2660426,[],CHEMBL1060401,Drug resistance in 51_E1 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1130 mutant strain with alteration in PA3761 open reading frame assessed as fold increase in resistance after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20293,,,2660427,[],CHEMBL1061279,Drug resistance in 50_D4 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1131 mutant strain with alteration in PA3823 open reading frame assessed as fold increase in resistance after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20294,,,2660428,[],CHEMBL1061280,Drug resistance in 50_D5 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1132 mutant strain with alteration in PA4556 open reading frame assessed as fold increase in resistance after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20295,,,2660429,[],CHEMBL1061281,Drug resistance in 63_H5 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1133 mutant strain with alteration in PA4600 open reading frame assessed as fold increase in resistance after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20296,,,2660430,[],CHEMBL1061282,Drug resistance in 50_C11 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1134 mutant strain with alteration in PA4695 open reading frame assessed as fold increase in resistance after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20297,,,2660431,[],CHEMBL1061283,Drug resistance in 47_B5 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1135 mutant strain with alteration in PA5117 open reading frame assessed as fold increase in resistance after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20298,,,2660432,[],CHEMBL1061284,Drug resistance in 75_F11 allele containing Pseudomonas aeruginosa PAO1 luxCDABE H1136 mutant strain with alteration in PA5455 open reading frame assessed as fold increase in resistance after 24 hrs by plate assay relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.0
20299,,,2660433,[],CHEMBL1061285,Antibacterial activity against wild type Pseudomonas aeruginosa PAO1 H103 after 24 hrs by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817422,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.1
20300,,,2660434,[],CHEMBL1061286,Antibacterial activity against 31_C9 allele containing Pseudomonas aeruginosa PAO1 H1104 mutant strain with lon::lux mutation after 24 hrs by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817422,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.025
20301,,,2660435,[],CHEMBL1061287,Antibacterial activity against 74_D9 allele containing Pseudomonas aeruginosa PAO1 H1105 mutant strain with lon::lux mutation after 24 hrs by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817422,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.025
20302,,,2660436,[],CHEMBL1061288,Antibacterial activity against 24_A2 allele containing Pseudomonas aeruginosa PAO1 H1106 mutant strain with lon::lux mutation after 24 hrs by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817422,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.025
20303,,,2660437,[],CHEMBL1061289,Antibacterial activity against 69_C12 allele containing Pseudomonas aeruginosa PAO1 H1109 mutant strain with recA::lux mutation after 24 hrs by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817422,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.05
20304,,,2660438,[],CHEMBL1061290,Antibacterial activity against 6_G1 allele containing Pseudomonas aeruginosa PAO1 H1121 mutant strain with PA4961::lux mutation after 24 hrs by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817422,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.05
20305,,,2660439,[],CHEMBL1061291,Antibacterial activity against 53_F11 allele containing Pseudomonas aeruginosa PAO1 H1124 mutant strain with PA5279::lux mutation after 24 hrs by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817422,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.05
20306,,,2660440,[],CHEMBL1061292,Antibacterial activity against 16_G12 allele containing Pseudomonas aeruginosa PAO1 H1125 mutant strain with recG::lux mutation after 24 hrs by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817422,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.025
20307,,,2660441,[],CHEMBL1061293,Antibacterial activity against Pseudomonas aeruginosa PAO1 H1105/lon+c mutant strain with lon::lux/lon+ mutation after 24 hrs by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817422,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.1
20308,,,2660442,[],CHEMBL1061294,Antibacterial activity against 70_H3 allele containing Pseudomonas aeruginosa PAO1 H1129 mutant strain with rnt::lux mutation after 24 hrs by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817422,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.4
20309,,,2660443,[],CHEMBL1061295,Antibacterial activity against 63_H5 allele containing Pseudomonas aeruginosa PAO1 H1133 mutant strain with nfxB::lux mutation after 24 hrs by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817422,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.8
20310,,,2660444,[],CHEMBL1061296,Antibacterial activity against 75_F11 allele containing Pseudomonas aeruginosa PAO1 H1136 mutant strain with PA5455::lux mutation after 24 hrs by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817422,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.4
20311,,,2660493,[],CHEMBL1061302,Antibacterial activity against 31_C9 allele containing Pseudomonas aeruginosa PAO1 H1104 mutant strain with lon::lux mutation assessed as fold decrease in MIC after 24 hrs by broth microdilution technique relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,4.0
20312,,,2660494,[],CHEMBL1061303,Antibacterial activity against 74_D9 allele containing Pseudomonas aeruginosa PAO1 H1105 mutant strain with lon::lux mutation assessed as fold decrease in MIC after 24 hrs by broth microdilution technique relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,4.0
20313,,,2660495,[],CHEMBL1061304,Antibacterial activity against 24_A2 allele containing Pseudomonas aeruginosa PAO1 H1106 mutant strain with lon::lux mutation assessed as fold decrease in MIC after 24 hrs by broth microdilution technique relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,4.0
20314,,,2660496,[],CHEMBL1061305,Antibacterial activity against Pseudomonas aeruginosa PAO1 H1105/lon+ mutant strain with lon::lux mutation assessed as fold decrease in MIC after 24 hrs by broth microdilution technique relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,4.0
20315,,Active,2660505,[],CHEMBL1061297,Increase in lon gene expression in Pseudomonas aeruginosa PAO1 H1105 mutant strain with lon::lux mutation assessed as incese in lon::lux fusion at 0.3 times MIC by luminescence assay relative to control,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
20316,,Not Active,2660506,[],CHEMBL1061298,Drug resistance in Pseudomonas aeruginosa PAO1 H1105 assessed as survivality at 0.0075 ug/ml after overnight incubation by adaptive resistance assay,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
20317,,Not Active,2660507,[],CHEMBL1061299,Effect on morphological change in Pseudomonas aeruginosa PAO1 H1105 assessed as elongation in cell length at 0.03 ug/ml by Grams staining-based light microscopy,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
20318,,Not Active,2660508,[],CHEMBL1061300,Effect on morphological change in Pseudomonas aeruginosa PAO1 H1105/lon+ assessed as elongation in cell length at 0.0075 ug/ml by Grams staining-based light microscopy,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
20319,,Active,2660509,[],CHEMBL1061301,Effect on morphological change in Pseudomonas aeruginosa PAO1 H1105/lon+ assessed as restoration of cell division at 0.0075 ug/ml by Grams staining-based light microscopy,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
20320,,,2660510,[],CHEMBL1061306,Increase in open reading frame PA5009 having lipopolysaccharide kinase gene waaP expression in Pseudomonas aeruginosa PAO1 at 0.3 times MIC relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,1.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,1.4
20321,,,2660511,[],CHEMBL1028704,Increase in open reading frame PA5008 having lipopolysaccharide kinase gene wapP expression in Pseudomonas aeruginosa PAO1 at 0.3 times MIC relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,1.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,1.5
20322,,,2660512,[],CHEMBL1028705,Increase in open reading frame PA5009 having lipopolysaccharide kinase gene waaP expression in Pseudomonas aeruginosa PAO1 at 0.1 times MIC relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,1.8,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,1.8
20323,,,2660513,[],CHEMBL1028706,Increase in open reading frame PA5008 having lipopolysaccharide kinase gene wapP expression in Pseudomonas aeruginosa PAO1 at 0.1 times MIC relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,1.9,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,1.9
20324,,,2660514,[],CHEMBL1028707,Increase in open reading frame PA3008 having sulA gene expression in Pseudomonas aeruginosa PAO1 at 0.1 times MIC by microarray analysis relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,2.8,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,2.8
20325,,,2660515,[],CHEMBL1028708,Increase in open reading frame PA3008 having sulA gene expression in Pseudomonas aeruginosa PAO1 at 0.3 times MIC by microarray analysis relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,5.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,5.2
20326,,,2660516,[],CHEMBL1028709,Increase in open reading frame PA3008 having sulA gene expression in Pseudomonas aeruginosa PAO1 at 1 times MIC by microarray analysis relative to wild type,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,817422,=,1,0,=,,FC,,,6.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,6.5
20327,,,2661781,[],CHEMBL1025415,Antibacterial activity against exponential growth culture of methicillin-sensitive Staphylococcus aureus ATCC 29213 grown for 2 hrs in MHBc by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151439,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818126,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
20328,,Active,2661790,[],CHEMBL1027061,Bactericidal activity against 24 hrs cold-arrested exponential growth culture of methicillin-sensitive Staphylococcus aureus ATCC 29213 grown for 2 hrs in MHBc at 2 ug/mL incubated at 37 degC after 2 hrs by time kill study,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151439,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,818126,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
20329,,Active,2661801,[],CHEMBL1025423,Bactericidal activity against high inoculum density exponential growth culture of methicillin-sensitive Staphylococcus aureus ATCC 29213 grown for 2 hrs in MHBc at 10 ug/mL after 24 hrs by time kill study,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151439,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,818126,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
20330,,Not Active,2661803,[],CHEMBL1025427,Bactericidal activity against CCCP-induced metabolically arrested exponential growth culture of methicillin-sensitive Staphylococcus aureus ATCC 29213 grown for 2 hrs in MHBc at 10 ug/mL after 24 hrs by time kill study,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151439,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,818126,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
20331,,Not Active,2661804,[],CHEMBL1025428,Bactericidal activity against erythromycin-induced metabolically arrested exponential growth culture of methicillin-sensitive Staphylococcus aureus ATCC 29213 grown for 2 hrs in MHBc at 10 ug/mL after 24 hrs by time kill study,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151439,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,818126,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
20332,,Not Active,2661806,[],CHEMBL1027060,Bactericidal activity against 1 hr cold-arrested exponential growth culture of methicillin-sensitive Staphylococcus aureus ATCC 29213 grown for 2 hrs in MHBc at 2 ug/mL incubated at 0 degC by time kill study,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151439,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,818126,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
20333,,,2661944,[],CHEMBL1028802,Antimicrobial activity against Dialister micraerophilus by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818319,<=,1,1,<=,,MIC50,ug.mL-1,,0.06,CHEMBL615038,Dialister micraerophilus,Dialister micraerophilus,309120.0,,,MIC50,ug ml-1,UO_0000274,,0.06
20334,,,2662319,[],CHEMBL1023540,Antimicrobial activity against Escherichia coli J53-AzR in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818803,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.015
20335,,,2662327,[],CHEMBL1023541,Antimicrobial activity against Escherichia coli DH10B expressing pCRQB10 in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818803,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
20336,,,2662335,[],CHEMBL1023542,Antimicrobial activity against Escherichia coli DH10B expressing pCR2.1 in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818803,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.004
20337,,,2662343,[],CHEMBL1023543,Antimicrobial activity against Escherichia coli DH10B in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818803,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.004
20338,,,2662987,[],CHEMBL1028802,Antimicrobial activity against Dialister micraerophilus by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818319,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL615038,Dialister micraerophilus,Dialister micraerophilus,309120.0,,,MIC,ug ml-1,UO_0000274,,0.06
20339,,,2663004,[],CHEMBL1028801,Antimicrobial activity against Dialister pneumosintes by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818319,<=,1,1,<=,,MIC90,ug.mL-1,,0.06,CHEMBL615039,Dialister pneumosintes,Dialister pneumosintes,39950.0,,,MIC90,ug ml-1,UO_0000274,,0.06
20340,,,2663021,[],CHEMBL1028801,Antimicrobial activity against Dialister pneumosintes by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818319,<=,1,1,<=,,MIC50,ug.mL-1,,0.06,CHEMBL615039,Dialister pneumosintes,Dialister pneumosintes,39950.0,,,MIC50,ug ml-1,UO_0000274,,0.06
20341,,,2663038,[],CHEMBL1028801,Antimicrobial activity against Dialister pneumosintes by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818319,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL615039,Dialister pneumosintes,Dialister pneumosintes,39950.0,,,MIC,ug ml-1,UO_0000274,,0.06
20342,,,2663059,[],CHEMBL1028802,Antimicrobial activity against Dialister micraerophilus by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818319,<=,1,1,<=,,MIC90,ug.mL-1,,0.06,CHEMBL615038,Dialister micraerophilus,Dialister micraerophilus,309120.0,,,MIC90,ug ml-1,UO_0000274,,0.06
20343,,Not Determined,2663075,[],CHEMBL1028803,Antimicrobial activity against Dialister pneumosintes assessed as susceptibility breakpoint by CLSI method,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,818319,,1,0,,,Activity,,,,CHEMBL615039,Dialister pneumosintes,Dialister pneumosintes,39950.0,,,Activity,,,,
20344,,Not Determined,2663091,[],CHEMBL1028804,Antimicrobial activity against Dialister micraerophilus assessed as susceptibility breakpoint by CLSI method,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,818319,,1,0,,,Activity,,,,CHEMBL615038,Dialister micraerophilus,Dialister micraerophilus,309120.0,,,Activity,,,,
20345,,,2663107,[],CHEMBL1028805,Antimicrobial activity against Dialister pneumosintes assessed as susceptibility breakpoint by CA-SFM method,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818319,<=,1,0,<=,,Activity,ug ml-1,,0.5,CHEMBL615039,Dialister pneumosintes,Dialister pneumosintes,39950.0,,,Activity,ug ml-1,UO_0000274,,0.5
20346,,,2663124,[],CHEMBL1028806,Antimicrobial activity against Dialister micraerophilus assessed as susceptibility breakpoint by CA-SFM method,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818319,<=,1,0,<=,,Activity,ug ml-1,,0.5,CHEMBL615038,Dialister micraerophilus,Dialister micraerophilus,309120.0,,,Activity,ug ml-1,UO_0000274,,0.5
20347,,,2663141,[],CHEMBL1028809,Antimicrobial activity against Dialister propionicifaciens by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818319,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL615040,Dialister propionicifaciens,Dialister propionicifaciens,308994.0,,,MIC,ug ml-1,UO_0000274,,0.06
20348,,,2663158,[],CHEMBL1028810,Antimicrobial activity against Dialister invisus by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818319,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL615037,Dialister invisus,Dialister invisus,218538.0,,,MIC,ug ml-1,UO_0000274,,0.06
20349,,Not Determined,2663175,[],CHEMBL1028811,Antimicrobial activity against Dialister propionicifaciens assessed as susceptibility breakpoint by CLSI method,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,818319,,1,0,,,Activity,,,,CHEMBL615040,Dialister propionicifaciens,Dialister propionicifaciens,308994.0,,,Activity,,,,
20350,,Not Determined,2663192,[],CHEMBL1028812,Antimicrobial activity against Dialister invisus assessed as susceptibility breakpoint by CLSI method,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,818319,,1,0,,,Activity,,,,CHEMBL615037,Dialister invisus,Dialister invisus,218538.0,,,Activity,,,,
20351,,,2663209,[],CHEMBL1028813,Antimicrobial activity against Dialister propionicifaciens assessed as susceptibility breakpoint by CA-SFM method,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818319,<=,1,0,<=,,Activity,ug ml-1,,0.5,CHEMBL615040,Dialister propionicifaciens,Dialister propionicifaciens,308994.0,,,Activity,ug ml-1,UO_0000274,,0.5
20352,,,2663225,[],CHEMBL1028814,Antimicrobial activity against Dialister invisus assessed as susceptibility breakpoint by CA-SFM method,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151441,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818319,<=,1,0,<=,,Activity,ug ml-1,,0.5,CHEMBL615037,Dialister invisus,Dialister invisus,218538.0,,,Activity,ug ml-1,UO_0000274,,0.5
20353,,,2663831,[],CHEMBL953433,Antimicrobial activity against carbapenem-resistant Pseudomonas aeruginosa clinical isolate assessed as resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151445,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,817428,=,1,0,=,,Activity,%,,53.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,53.0
20354,,,2663832,[],CHEMBL953432,Antimicrobial activity against carbapenem-susceptible Pseudomonas aeruginosa clinical isolate assessed as resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151445,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,817428,=,1,0,=,,Activity,%,,25.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,25.0
20355,,,2663872,[],CHEMBL957126,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring pV2GY3 with blaVIM-2 and aac(6)'-32 by E-test,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151445,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817428,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.125
20356,,,2663873,[],CHEMBL958786,Antimicrobial activity against Pseudomonas aeruginosa GY3 producing blaVIM-2 by E-test,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151445,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817428,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
20357,,,2663875,[],CHEMBL958787,Antimicrobial activity against Pseudomonas aeruginosa PAO1 by E-test,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151445,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817428,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.125
20358,,,2663965,[],CHEMBL1023510,Antimicrobial activity against multidrug-resistant Enterobacter cloacae E705 bearing qnrB10 gene with aac(6)-IId-aadA1a integron in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818803,>=,1,1,>=,,MIC,ug.mL-1,,64.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,64.0
20359,,,2663973,[],CHEMBL1023538,Antimicrobial activity against multidrug-resistant Klebsiella pneumoniae M7943 bearing qnrB10 gene with aac(6)-Ib-cr-blaOXA-30 catB3-arr-3 integron in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818803,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,32.0
20360,,,2663981,[],CHEMBL1023539,Antimicrobial activity against multidrug-resistant Escherichia coli M7943-TC2 bearing qnrB10 gene with aac(6)-Ib-cr-blaOXA-30 catB3-arr-3 integron in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818803,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
20361,,,2664486,[],CHEMBL1058652,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 100 ATCC 29213 by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.5
20362,,,2664487,[],CHEMBL1058653,Antibacterial activity against methicillin-resistant Staphylococcus aureus 1137 by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,2.0
20363,,,2664488,[],CHEMBL1058654,Antibacterial activity against methicillin-resistant Staphylococcus aureus 2170 by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,2.0
20364,,,2664489,[],CHEMBL1058655,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus 2012 by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,2.0
20365,,,2664490,[],CHEMBL1058656,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus 2018 by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,2.0
20366,,,2664491,[],CHEMBL1058657,"Antibacterial activity against Linezolid, methicillin-resistant Staphylococcus aureus 1725 by microdilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,2.0
20367,,,2664492,[],CHEMBL1058658,"Antibacterial activity against Linezolid, methicillin-resistant Staphylococcus aureus 1651 by microdilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,2.0
20368,,,2664493,[],CHEMBL1058659,Antibacterial activity against community-acquired Staphylococcus aureus 2144 by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,2.0
20369,,,2664494,[],CHEMBL1058660,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 1597 by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC90,ug ml-1,UO_0000274,,0.25
20370,,,2664495,[],CHEMBL1058661,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 1452 by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC90,ug ml-1,UO_0000274,,2.0
20371,,,2664496,[],CHEMBL1058662,Antibacterial activity against Staphylococcus epidermidis 495 by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC90,ug ml-1,UO_0000274,,0.5
20372,,,2664497,[],CHEMBL1058663,Antibacterial activity against vancomycin-resistant Enterococcus faecalis 846 by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,2.0
20373,,,2664498,[],CHEMBL1058664,Antibacterial activity against vancomycin-sensitive Enterococcus faecium 843 by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,2.0
20374,,,2664499,[],CHEMBL1058665,Antibacterial activity against vancomycin-resistant Enterococcus faecium 1254 by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,2.0
20375,,,2664500,[],CHEMBL1058666,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae 866 by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,2.0
20376,,,2664501,[],CHEMBL1058667,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae 940 by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,2.0
20377,,,2664502,[],CHEMBL1058668,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae 748 by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,1.0
20378,,,2664503,[],CHEMBL1058669,Antibacterial activity against quinolone-resistant Streptococcus pneumoniae 376 by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,2.0
20379,,,2664504,[],CHEMBL1058670,Antibacterial activity against quinolone-resistant Streptococcus pneumoniae 379 by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,2.0
20380,,,2664505,[],CHEMBL1058671,Antibacterial activity against multidrug-resistant Streptococcus pneumoniae 933 by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,2.0
20381,,,2664506,[],CHEMBL1058672,Antibacterial activity against Streptococcus pneumoniae 1195 ATCC 49619 by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,1.0
20382,,,2664507,[],CHEMBL1058673,Antibacterial activity against Streptococcus pyogenes 723 by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,0.5
20383,,,2664508,[],CHEMBL1058674,Antibacterial activity against Streptococcus agalactiae 2033 by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC90,ug ml-1,UO_0000274,,1.0
20384,,,2664509,[],CHEMBL1058675,Antibacterial activity against Moraxella catarrhalis 557 by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,=,1,1,=,,MIC90,ug.mL-1,,0.03,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC90,ug ml-1,UO_0000274,,0.03
20385,,,2664510,[],CHEMBL1058676,Antibacterial activity against ampicillin-resistant Haemophilus influenzae 1742 by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,=,1,1,=,,MIC90,ug.mL-1,,0.008,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC90,ug ml-1,UO_0000274,,0.008
20386,,,2664511,[],CHEMBL1058677,Antibacterial activity against Haemophilus influenzae 1224 ATCC 49247 by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,=,1,1,=,,MIC90,ug.mL-1,,0.15,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC90,ug ml-1,UO_0000274,,0.15
20387,,,2664512,[],CHEMBL1058678,Antibacterial activity against Haemophilus parainfluenzae 2319 ATCC 7901 by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,=,1,1,=,,MIC90,ug.mL-1,,0.15,CHEMBL614408,Haemophilus parainfluenzae,Haemophilus parainfluenzae,729.0,,,MIC90,ug ml-1,UO_0000274,,0.15
20388,,,2664513,[],CHEMBL1058679,Antibacterial activity against Escherichia coli 102 ATCC 25922 by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,=,1,1,=,,MIC90,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,0.008
20389,,,2664514,[],CHEMBL1058680,Antibacterial activity against extended spectrum beta-lactamase-producing Escherichia coli 2269 by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,2.0
20390,,,2664515,[],CHEMBL1058681,Antibacterial activity against Klebsiella pneumoniae 2239 by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,=,1,1,=,,MIC90,ug.mL-1,,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,0.03
20391,,,2664516,[],CHEMBL1058682,"Antibacterial activity against ampicillin beta-lactamase, multidrug-resistant Klebsiella pneumoniae 2262 by microdilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,>,1,1,>,,MIC90,ug.mL-1,,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,2.0
20392,,,2664517,[],CHEMBL1058683,Antibacterial activity against Serratia marcescens 1635 by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC90,ug ml-1,UO_0000274,,0.06
20393,,,2664518,[],CHEMBL1051485,Antibacterial activity against Pseudomonas aeruginosa 1473 by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152312,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817909,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,1.0
20394,,,2666026,[],CHEMBL1063023,Antimicrobial activity against Bacillus anthracis,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152337,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,817477,=,1,1,=,,MIC,nM,,200.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,MIC,uM,UO_0000065,,0.2
20395,,,2667050,[],CHEMBL1029496,Antibacterial activity against Escherichia coli isolates isolated from patients with Crohn's disease at 1 ug/disk by susceptibility testing disk method,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,820030,=,1,0,=,,Activity,%,,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,100.0
20396,,,2667057,[],CHEMBL1029500,Antibacterial activity against Escherichia coli isolate HM154 isolated from colonic mucosal biopsies of patient with Crohn's disease after 24 hrs by Etest antibiotic concentration gradient method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820030,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
20397,,,2667058,[],CHEMBL1029501,Antibacterial activity against Escherichia coli isolate HM580 isolated from colonic mucosal biopsies of patient with Crohn's disease after 24 hrs by Etest antibiotic concentration gradient method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820030,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
20398,,,2667059,[],CHEMBL1032012,Antibacterial activity against Escherichia coli isolate HM615 isolated from colonic mucosal biopsies of patient with Crohn's disease after 24 hrs by Etest antibiotic concentration gradient method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820030,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
20399,,,2667060,[],CHEMBL1032013,Antibacterial activity Escherichia coli isolate HM413 isolated from ileo-colonic mucosal biopsies of patient with Crohn's disease after 24 hrs by Etest antibiotic concentration gradient method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820030,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
20400,,,2667061,[],CHEMBL1032014,Antibacterial activity Escherichia coli isolate HM419 isolated from ileo-colonic mucosal biopsies of patient with Crohn's disease after 24 hrs by Etest antibiotic concentration gradient method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820030,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
20401,,,2667062,[],CHEMBL1032015,Antibacterial activity against Escherichia coli isolate HM95 isolated from ileal mucosal biopsies of patient with Crohn's disease after 24 hrs by Etest antibiotic concentration gradient method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820030,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
20402,,,2667063,[],CHEMBL1032016,Antibacterial activity against mucosa-associated Escherichia coli isolate HM428 isolated from patient with irritable bowel syndrome or sporadic polyps after 24 hrs by Etest antibiotic concentration gradient method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820030,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
20403,,,2667064,[],CHEMBL1032017,Antibacterial activity against mucosa-associated Escherichia coli isolate HM454 isolated from patient with irritable bowel syndrome or sporadic polyps after 24 hrs by Etest antibiotic concentration gradient method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820030,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
20404,,,2667065,[],CHEMBL1032018,Antibacterial activity against mucosa-associated Escherichia coli isolate HM456 isolated from patient with irritable bowel syndrome or sporadic polyps after 24 hrs by Etest antibiotic concentration gradient method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820030,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
20405,,Active,2667111,[],CHEMBL1029504,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by Etest antibiotic concentration gradient method,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,820030,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
20406,,Active,2667126,[],CHEMBL1029518,Antibacterial activity against extracellular Escherichia coli isolate HM605 isolated from colonic mucosal biopsies of patient with Crohn's disease at 0.01 to 10 ug/ml after 3 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,820030,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
20407,,,2667131,[],CHEMBL1030268,Antibacterial activity against gentamicin-treated internalized Escherichia coli isolate HM605 in mouse J774A1 cells isolated from colonic mucosal biopsies of patient with Crohn's disease assessed as intracellular killing of bacteria at 10% compound Cmax after 3 hrs,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,820030,=,1,0,=,,Activity,%,,86.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,86.0
20408,,Active,2667132,[],CHEMBL1032827,Antibacterial activity against gentamicin-treated internalized Escherichia coli isolate HM605 in mouse J774A1 cells isolated from colonic mucosal biopsies of patient with Crohn's disease assessed as complete intracellular killing-associated bacterial debris at 0.1 ug/ml after 3 hrs by electron microscopy,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,820030,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
20409,,Active,2667133,[],CHEMBL1032828,Antibacterial activity against extracellular Escherichia coli isolate HM605 isolated from colonic mucosal biopsies of patient with Crohn's disease at 20 ug/ml after 1 hr,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,820030,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
20410,,,2667134,[],CHEMBL1032826,Cytotoxicity against mouse J774A1 cells assessed as release of adenylate kinase at 100 ug/ml after 3 hrs by total cell protein assay relative to control,A,,,BAO_0001103,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,820030,=,1,0,=,,Activity,%,,90.0,CHEMBL614040,Mus musculus,J774.A1,10090.0,,,Activity,%,UO_0000187,,90.0
20411,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,2667148,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '400.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '400.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1032830,Cmax in patient with Crohn's disease at 400 mg administered intravenously,A,,,BAO_0002119,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,820030,=,1,1,=,,Cmax,nM,,12071.83,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,4.0
20412,,,2667157,[],CHEMBL1029508,Antibacterial activity against gentamicin-treated internalized Escherichia coli isolate HM605 isolated from colonic mucosal biopsies of patient with Crohn's disease in mouse J774A1 cells assessed as intracellular killing of bacteria at 4 ug/ml after 3 hrs,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,820030,=,1,0,=,,Activity,%,,99.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,99.5
20413,,,2667158,[],CHEMBL1030273,Cytotoxicity against mouse J774A1 cells assessed as macrophage number at 4 ug/ml after 3 hrs by total cell protein assay,A,,,BAO_0000375,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,820030,=,1,0,=,,Activity,,,99.5,CHEMBL614040,Mus musculus,J774.A1,10090.0,,,Activity,,,,99.5
20414,,,2667506,[],CHEMBL1029502,Antibacterial activity against Escherichia coli isolate HM605 isolated from colonic mucosal biopsies of patient with Crohn's disease after 24 hrs by Etest antibiotic concentration gradient method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820030,=,1,1,=,,MIC,ug.mL-1,,0.006,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.006
20415,,,2667507,[],CHEMBL1029505,Antibacterial activity against Escherichia coli isolate HM605 isolated from colonic mucosal biopsies of patient with Crohn's disease,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820030,=,1,0,=,,MBC,ug ml-1,,0.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.3
20416,,,2667528,[],CHEMBL1030269,Antibacterial activity against gentamicin-treated internalized Escherichia coli isolate LF82 in mouse J774A1 cells isolated from chronic ileal lesions of patient with Crohn's disease assessed as intracellular killing of bacteria at 10% compound Cmax after 3 hrs,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,820030,=,1,0,=,,Activity,%,,87.6,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,87.6
20417,,,2667529,[],CHEMBL1030270,Antibacterial activity against gentamicin-treated internalized Escherichia coli isolate HM580 in mouse J774A1 cells isolated from colonic mucosal biopsies of patient with Crohn's disease assessed as intracellular killing of bacteria at 10% compound Cmax after 3 hrs,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,820030,=,1,0,=,,Activity,%,,90.4,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,90.4
20418,,,2667530,[],CHEMBL1030271,Antibacterial activity against gentamicin-treated internalized Escherichia coli isolate HM615 in mouse J774A1 cells isolated from colonic mucosal biopsies of patient with Crohn's disease assessed as intracellular killing of bacteria at 10% compound Cmax after 3 hrs,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,820030,=,1,0,=,,Activity,%,,83.8,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,83.8
20419,,,2667543,[],CHEMBL1032837,Antibacterial activity against Escherichia coli isolate LF82 isolated from colonic mucosal biopsies of patient with Crohn's disease after 24 hrs by Etest antibiotic concentration gradient method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820030,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
20420,,,2667544,[],CHEMBL1032838,Antibacterial activity against mucosa-associated Escherichia coli isolate HM463 isolated from patient with irritable bowel syndrome or sporadic polyps after 24 hrs by Etest antibiotic concentration gradient method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820030,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
20421,,,2667545,[],CHEMBL1032839,Antibacterial activity against mucosa-associated Escherichia coli isolate HM484 isolated from patient with irritable bowel syndrome or sporadic polyps after 24 hrs by Etest antibiotic concentration gradient method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820030,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
20422,,,2667546,[],CHEMBL1032840,Antibacterial activity against mucosa-associated Escherichia coli isolate HM488 isolated from patient with irritable bowel syndrome or sporadic polyps after 24 hrs by Etest antibiotic concentration gradient method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151474,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820030,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
20423,,,2667549,[],CHEMBL1032844,Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as lowest drug level producing inhibition at 10'6 CFU of inoculum by MGIT 960 susceptibility test,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820036,=,1,0,=,,Activity,ug ml-1,,1.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,,Activity,ug ml-1,UO_0000274,,1.0
20424,,,2667557,[],CHEMBL1032845,Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as lowest drug level producing inhibition at 10'6 CFU of inoculum by agar counting method,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820036,=,1,0,=,,Activity,ug ml-1,,1.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,,Activity,ug ml-1,UO_0000274,,1.0
20425,,,2667565,[],CHEMBL1032846,Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as minimum drug level resulting in no detectable growth at 10'6 CFU of inoculum after 56 days by MGIT 960 susceptibility test,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820036,=,1,0,=,,Activity,ug ml-1,,32.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,,Activity,ug ml-1,UO_0000274,,32.0
20426,,Not Evaluated,2667579,[],CHEMBL1032842,Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as effect on average time to detection of growth at >10'2 CFU of inoculum by MGIT 960 susceptibility test,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,820036,,1,0,,,Activity,,,,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,,Activity,,,,
20427,,Not Evaluated,2667587,[],CHEMBL1032843,Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as effect on average time to detection of growth at 10'5 CFU of inoculum by MGIT 960 susceptibility test,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,820036,,1,0,,,Activity,,,,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,,Activity,,,,
20428,,,2667589,[],CHEMBL1033614,Antituberculosis activity against Mycobacterium paratuberculosis JTC303 isolated from bovine assessed as minimum drug level required for inhibition by MGIT 960 susceptibility test,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820036,=,1,0,=,,Activity,ug ml-1,,2.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,,Activity,ug ml-1,UO_0000274,,2.0
20429,,,2667593,[],CHEMBL1033615,Antituberculosis activity against Mycobacterium paratuberculosis JTC303 isolated from bovine assessed as minimum drug level required for killing after 56 days by MGIT 960 susceptibility test,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820036,=,1,0,=,,Activity,ug ml-1,,8.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,,Activity,ug ml-1,UO_0000274,,8.0
20430,,,2667597,[],CHEMBL1033616,Antituberculosis activity against Mycobacterium paratuberculosis UCF-4 isolated from Crohn's disease patient assessed as minimum drug level required for inhibition by MGIT 960 susceptibility test,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820036,=,1,0,=,,Activity,ug ml-1,,1.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,,Activity,ug ml-1,UO_0000274,,1.0
20431,,,2667601,[],CHEMBL1033617,Antituberculosis activity against Mycobacterium paratuberculosis UCF-4 isolated from Crohn's disease patient assessed as minimum drug level required for killing after 56 days by MGIT 960 susceptibility test,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820036,=,1,0,=,,Activity,ug ml-1,,4.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,,Activity,ug ml-1,UO_0000274,,4.0
20432,,,2667605,[],CHEMBL1033618,Antituberculosis activity against Mycobacterium paratuberculosis UCF-5 isolated from Crohn's disease patient assessed as minimum drug level required for inhibition by MGIT 960 susceptibility test,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820036,=,1,0,=,,Activity,ug ml-1,,2.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,,Activity,ug ml-1,UO_0000274,,2.0
20433,,,2667609,[],CHEMBL1033619,Antituberculosis activity against Mycobacterium paratuberculosis UCF-5 isolated from Crohn's disease patient assessed as minimum drug level required for killing after 56 days by MGIT 960 susceptibility test,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820036,=,1,0,=,,Activity,ug ml-1,,4.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,,Activity,ug ml-1,UO_0000274,,4.0
20434,,,2667613,[],CHEMBL1033620,Antituberculosis activity against Mycobacterium paratuberculosis UCF-7 isolated from Crohn's disease patient assessed as minimum drug level required for inhibition by MGIT 960 susceptibility test,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820036,=,1,0,=,,Activity,ug ml-1,,1.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,,Activity,ug ml-1,UO_0000274,,1.0
20435,,,2667617,[],CHEMBL1033621,Antituberculosis activity against Mycobacterium paratuberculosis UCF-7 isolated from Crohn's disease patient assessed as minimum drug level required for killing after 56 days by MGIT 960 susceptibility test,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820036,=,1,0,=,,Activity,ug ml-1,,4.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,,Activity,ug ml-1,UO_0000274,,4.0
20436,,,2667621,[],CHEMBL1033622,Antituberculosis activity against Mycobacterium paratuberculosis B213 isolated from bovine assessed as minimum drug level required for inhibition by MGIT 960 susceptibility test,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820036,=,1,0,=,,Activity,ug ml-1,,4.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,,Activity,ug ml-1,UO_0000274,,4.0
20437,,,2667625,[],CHEMBL1033623,Antituberculosis activity against Mycobacterium paratuberculosis B213 isolated from bovine assessed as minimum drug level required for killing after 56 days by MGIT 960 susceptibility test,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820036,=,1,0,=,,Activity,ug ml-1,,16.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,,Activity,ug ml-1,UO_0000274,,16.0
20438,,,2667629,[],CHEMBL1033624,Antituberculosis activity against Mycobacterium paratuberculosis B236 isolated from bovine assessed as minimum drug level required for inhibition by MGIT 960 susceptibility test,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820036,=,1,0,=,,Activity,ug ml-1,,4.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,,Activity,ug ml-1,UO_0000274,,4.0
20439,,,2667633,[],CHEMBL1033625,Antituberculosis activity against Mycobacterium paratuberculosis B236 isolated from bovine assessed as minimum drug level required for killing after 56 days by MGIT 960 susceptibility test,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820036,=,1,0,=,,Activity,ug ml-1,,16.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,,Activity,ug ml-1,UO_0000274,,16.0
20440,,,2667637,[],CHEMBL1033626,Antituberculosis activity against Mycobacterium paratuberculosis B238 isolated from bovine assessed as minimum drug level required for inhibition by MGIT 960 susceptibility test,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820036,=,1,0,=,,Activity,ug ml-1,,4.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,,Activity,ug ml-1,UO_0000274,,4.0
20441,,,2667641,[],CHEMBL1033627,Antituberculosis activity against Mycobacterium paratuberculosis B238 isolated from bovine assessed as minimum drug level required for killing after 56 days by MGIT 960 susceptibility test,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820036,=,1,0,=,,Activity,ug ml-1,,16.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,,Activity,ug ml-1,UO_0000274,,16.0
20442,,,2667645,[],CHEMBL1033628,Antituberculosis activity against Mycobacterium avium ATCC 35712 isolated from chicken assessed as minimum drug level required for inhibition by MGIT 960 susceptibility test,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820036,=,1,0,=,,Activity,ug ml-1,,16.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,Activity,ug ml-1,UO_0000274,,16.0
20443,,,2667649,[],CHEMBL1033629,Antituberculosis activity against Mycobacterium avium ATCC 35712 isolated from chicken assessed as minimum drug level required for killing after 56 days by MGIT 960 susceptibility test,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,820036,=,1,0,=,,Activity,ug ml-1,,64.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,Activity,ug ml-1,UO_0000274,,64.0
20444,,,2667706,[],CHEMBL1034512,Antituberculosis activity against Mycobacterium paratuberculosis UCF-7 isolated from Crohn's disease patient assessed as colony counts at 2 ug after 12 days by MGIT 960 susceptibility test,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,820036,=,1,0,=,,log10CFU/ml,,,1.98,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,,log10CFU/ml,,,,1.98
20445,,,2667707,[],CHEMBL1034513,Antituberculosis activity against Mycobacterium paratuberculosis UCF-7 isolated from Crohn's disease patient assessed as colony counts at 4 ug after 12 days by MGIT 960 susceptibility test,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,820036,=,1,0,=,,log10CFU/ml,,,0.76,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,,log10CFU/ml,,,,0.76
20446,,,2667708,[],CHEMBL1032841,Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as viability after 5 to 8 days by MGIT 960 susceptibility test,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151475,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,820036,=,1,0,=,,log10CFU/ml,,,1.0,CHEMBL613087,Mycobacterium avium subsp. paratuberculosis,Mycobacterium avium subsp. paratuberculosis,1770.0,,,log10CFU/ml,,,,1.0
20447,,Not Determined,2668980,[],CHEMBL1027015,Antimicrobial activity against Aspergillus fumigatus ATCC 90906 by alamar blue assay,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151806,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,819394,,1,0,,,MFC,,,,CHEMBL363,Aspergillus fumigatus,Aspergillus fumigatus,746128.0,,,MFC,,,,
20448,,Not Determined,2668990,[],CHEMBL1027015,Antimicrobial activity against Aspergillus fumigatus ATCC 90906 by alamar blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151806,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,819394,,1,0,,,MIC,,,,CHEMBL363,Aspergillus fumigatus,Aspergillus fumigatus,746128.0,,,MIC,,,,
20449,,Not Determined,2669000,[],CHEMBL1027015,Antimicrobial activity against Aspergillus fumigatus ATCC 90906 by alamar blue assay,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151806,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,819394,,1,0,,,IC50,,,,CHEMBL363,Aspergillus fumigatus,Aspergillus fumigatus,746128.0,,,IC50,,,,
20450,,Not Active,2669010,[],CHEMBL1027014,Antimicrobial activity against Mycobacterium intracellular ATCC 23068 by alamar blue assay,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151806,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,819394,,1,0,,,MBC,,,,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,MBC,,,,
20451,,,2669020,[],CHEMBL1027014,Antimicrobial activity against Mycobacterium intracellular ATCC 23068 by alamar blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151806,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819394,=,1,1,=,,MIC,ug.mL-1,,0.63,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,MIC,ug ml-1,UO_0000274,,0.63
20452,,,2669030,[],CHEMBL1027014,Antimicrobial activity against Mycobacterium intracellular ATCC 23068 by alamar blue assay,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151806,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819394,=,1,1,=,,IC50,ug.mL-1,,0.25,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,IC50,ug ml-1,UO_0000274,,0.25
20453,,Not Active,2669040,[],CHEMBL1027013,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 by NCCLS method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151806,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,819394,,1,0,,,MBC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,,,,
20454,,,2669050,[],CHEMBL1027013,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 by NCCLS method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151806,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819394,=,1,1,=,,MIC,ug.mL-1,,0.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.3
20455,,,2669060,[],CHEMBL1027013,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 by NCCLS method,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151806,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819394,=,1,1,=,,IC50,ug.mL-1,,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IC50,ug ml-1,UO_0000274,,0.1
20456,,Not Determined,2669070,[],CHEMBL1027012,Antimicrobial activity against Cryptococcus neoformans ATCC 90113 by NCCLS method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151806,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,819394,,1,0,,,MFC,,,,CHEMBL365,Cryptococcus neoformans,Cryptococcus neoformans,5207.0,,,MFC,,,,
20457,,Not Determined,2669080,[],CHEMBL1027012,Antimicrobial activity against Cryptococcus neoformans ATCC 90113 by NCCLS method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151806,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,819394,,1,0,,,MIC,,,,CHEMBL365,Cryptococcus neoformans,Cryptococcus neoformans,5207.0,,,MIC,,,,
20458,,Not Determined,2669090,[],CHEMBL1027012,Antimicrobial activity against Cryptococcus neoformans ATCC 90113 by NCCLS method,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151806,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,819394,,1,0,,,IC50,,,,CHEMBL365,Cryptococcus neoformans,Cryptococcus neoformans,5207.0,,,IC50,,,,
20459,,Not Determined,2669100,[],CHEMBL1027011,Antimicrobial activity against Candida albicans ATCC 90028 by NCCLS method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151806,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,819394,,1,0,,,MFC,,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MFC,,,,
20460,,Not Determined,2669110,[],CHEMBL1027011,Antimicrobial activity against Candida albicans ATCC 90028 by NCCLS method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151806,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,819394,,1,0,,,MIC,,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,,,,
20461,,Not Determined,2669120,[],CHEMBL1027011,Antimicrobial activity against Candida albicans ATCC 90028 by NCCLS method,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151806,J Nat Prod,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,819394,,1,0,,,IC50,,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,IC50,,,,
20462,,,2671505,[],CHEMBL1035433,Total body clearance in human,A,,,BAO_0002759,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151930,J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,820517,=,1,1,=,,CL,mL.min-1.kg-1,,8.3,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/min.kg,,,8.3
20463,,,2671506,[],CHEMBL1035434,Renal clearance in human,A,,,BAO_0002773,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151930,J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,820517,=,1,1,=,,CL_renal,mL.min-1.kg-1,,6.9,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL_renal,ml/min.kg,,,6.9
20464,,,2674126,[],CHEMBL1031142,"Antibacterial activity against Streptococcus pneumoniae HMC 1068 harboring E85K mutation in quinolone-resistant determining regions of GyrA gene, S79Y, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene showing efflux to ciprofloxacin, levofloxacin by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
20465,,,2674132,[],CHEMBL1031141,"Antibacterial activity against Streptococcus pneumoniae HMC 1062 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
20466,,,2674138,[],CHEMBL1031140,"Antibacterial activity against Streptococcus pneumoniae HMC 4026 harboring S81Y mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
20467,,,2674144,[],CHEMBL1031139,"Antibacterial activity against Streptococcus pneumoniae HMC 2536 harboring S81Y mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
20468,,,2674150,[],CHEMBL1031138,"Antibacterial activity against Streptococcus pneumoniae HMC 2527 harboring S81Y mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
20469,,,2674156,[],CHEMBL1031137,"Antibacterial activity against Streptococcus pneumoniae HMC 1541 harboring S81Y mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
20470,,,2674162,[],CHEMBL1031136,"Antibacterial activity against Streptococcus pneumoniae HMC 1156 harboring S81F and S79F mutation in quinolone-resistant determining regions of GyrA and ParC genes respectively showing efflux to ciprofloxacin, gemifloxacin by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
20471,,,2674168,[],CHEMBL1031135,"Antibacterial activity against Streptococcus pneumoniae HMC 1139 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
20472,,,2674174,[],CHEMBL1026129,"Antibacterial activity against Streptococcus pneumoniae HMC 1078 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
20473,,,2674180,[],CHEMBL1026128,Antibacterial activity against Streptococcus pneumoniae HMC 1077 harboring S81Y and S79F mutation in quinolone-resistant determining regions of GyrA and ParC genes respectively by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
20474,,,2674186,[],CHEMBL1026127,"Antibacterial activity against Streptococcus pneumoniae HMC 1074 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
20475,,,2674192,[],CHEMBL1026126,"Antibacterial activity against Streptococcus pneumoniae HMC 1072 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79Y mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
20476,,,2674198,[],CHEMBL1026125,"Antibacterial activity against Streptococcus pneumoniae HMC 1071 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene and S79F, K137N mutation in QRDR of ParC gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
20477,,,2674204,[],CHEMBL1026124,"Antibacterial activity against Streptococcus pneumoniae HMC 1059 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460N mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
20478,,,2674210,[],CHEMBL1025290,"Antibacterial activity against Streptococcus pneumoniae HMC 1055 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
20479,,,2674216,[],CHEMBL1025289,Antibacterial activity against Streptococcus pneumoniae HMC 5041 harboring S81F and S79F mutation in quinolone-resistant determining regions of GyrA and ParC genes respectively by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
20480,,,2674222,[],CHEMBL1025288,"Antibacterial activity against Streptococcus pneumoniae HMC 2538 harboring S81Y mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene showing efflux to ciprofloxacin, levofloxacin, gatifloxacin by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
20481,,,2674228,[],CHEMBL1025287,"Antibacterial activity against Streptococcus pneumoniae HMC 1150 harboring S81C mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
20482,,,2674234,[],CHEMBL1025286,"Antibacterial activity against Streptococcus pneumoniae HMC 1147 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene showing efflux to gemifloxacin by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
20483,,,2674240,[],CHEMBL1025285,"Antibacterial activity against Streptococcus pneumoniae HMC 1146 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, and D435N mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
20484,,,2674246,[],CHEMBL1025284,"Antibacterial activity against Streptococcus pneumoniae HMC 1076 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, D83N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
20485,,,2674252,[],CHEMBL1025283,"Antibacterial activity against Streptococcus pneumoniae HMC 1073 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
20486,,,2674258,[],CHEMBL1025282,"Antibacterial activity against Streptococcus pneumoniae HMC 1070 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, D83N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
20487,,,2674264,[],CHEMBL1025281,"Antibacterial activity against Streptococcus pneumoniae HMC 1066 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
20488,,,2674923,[],CHEMBL1025280,"Antibacterial activity against Streptococcus pneumoniae HMC 1060 harboring S81F mutation in quinolone-resistant determining regions of GyrA gene, S79F, K137N mutation in QRDR of ParC gene and I460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
20489,,,2674929,[],CHEMBL1025279,"Antibacterial activity against Streptococcus pneumoniae HMC 1058 harboring S79F, K137N mutation in quinolone-resistant determining regions of ParC gene and 460V mutation in QRDR of ParE gene by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
20490,,,2674935,[],CHEMBL1031123,"Antibacterial activity against Streptococcus pneumoniae HMC 1151 harboring D83N, K137N mutation in quinolone-resistant determining regions of ParC gene and I460V mutation in QRDR of ParE gene showing efflux to ciprofloxacin, gemifloxacin by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
20491,,,2674941,[],CHEMBL1031122,"Antibacterial activity against Streptococcus pneumoniae HMC 1149 harboring S81F and S79Y mutation in quinolone-resistant determining regions of GyrA and ParC genes respectively showing efflux to ciprofloxacin, gemifloxacin by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
20492,,,2674949,[],CHEMBL1031121,Antibacterial activity against quinolone-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,32.0
20493,,,2674958,[],CHEMBL1031121,Antibacterial activity against quinolone-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,16.0
20494,,,2674967,[],CHEMBL1031120,Antibacterial activity against quinolone-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,2.0
20495,,,2674976,[],CHEMBL1031120,Antibacterial activity against quinolone-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,1.0
20496,,,2674985,[],CHEMBL1031119,Antibacterial activity against azithromycin-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,2.0
20497,,,2674994,[],CHEMBL1031119,Antibacterial activity against azithromycin-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,1.0
20498,,,2675003,[],CHEMBL1031118,Antibacterial activity against azithromycin-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,16.0
20499,,,2675012,[],CHEMBL1031118,Antibacterial activity against azithromycin-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,2.0
20500,,,2675021,[],CHEMBL1031117,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,16.0
20501,,,2675030,[],CHEMBL1031117,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,2.0
20502,,,2675039,[],CHEMBL1031116,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,2.0
20503,,,2675048,[],CHEMBL1031116,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,1.0
20504,,,2675057,[],CHEMBL1031115,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,16.0
20505,,,2675067,[],CHEMBL1031115,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae ATCC 49619 by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151449,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819148,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,2.0
20506,,,2678180,[],CHEMBL1032876,Antibacterial activity against Pseudomonas aeruginosa isolate 319 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.12
20507,,,2678181,[],CHEMBL1032877,Antibacterial activity against Pseudomonas aeruginosa isolate 320 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
20508,,,2678182,[],CHEMBL1032878,Antibacterial activity against Pseudomonas aeruginosa isolate 322 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.12
20509,,,2678183,[],CHEMBL1032879,Antibacterial activity against Pseudomonas aeruginosa isolate 323 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
20510,,,2678184,[],CHEMBL1032880,Antibacterial activity against Pseudomonas aeruginosa isolate 324 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
20511,,,2678185,[],CHEMBL1032881,Antibacterial activity against Pseudomonas aeruginosa isolate 326 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
20512,,,2678186,[],CHEMBL1032882,Antibacterial activity against Pseudomonas aeruginosa isolate 327 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
20513,,,2678187,[],CHEMBL1032883,Antibacterial activity against Pseudomonas aeruginosa isolate 328 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.12
20514,,,2678188,[],CHEMBL1032884,Antibacterial activity against Pseudomonas aeruginosa isolate 329 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
20515,,,2678189,[],CHEMBL1032885,Antibacterial activity against Pseudomonas aeruginosa isolate 330 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
20516,,,2678190,[],CHEMBL1032886,Antibacterial activity against Pseudomonas aeruginosa isolate 331 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
20517,,,2678191,[],CHEMBL1032887,Antibacterial activity against Pseudomonas aeruginosa isolate 332 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
20518,,,2678192,[],CHEMBL1032888,Antibacterial activity against Pseudomonas aeruginosa isolate 334 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
20519,,,2678193,[],CHEMBL1032889,Antibacterial activity against Pseudomonas aeruginosa isolate 335 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
20520,,,2678194,[],CHEMBL1032890,Antibacterial activity against Pseudomonas aeruginosa isolate 337 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
20521,,,2678195,[],CHEMBL1032891,Antibacterial activity against Pseudomonas aeruginosa isolate 338 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
20522,,,2678196,[],CHEMBL1032892,Antibacterial activity against Pseudomonas aeruginosa isolate 339 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
20523,,,2678197,[],CHEMBL1032893,Antibacterial activity against Pseudomonas aeruginosa isolate 340 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.12
20524,,,2678198,[],CHEMBL1032894,Antibacterial activity against Pseudomonas aeruginosa isolate 341 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
20525,,,2678199,[],CHEMBL1032895,Antibacterial activity against Pseudomonas aeruginosa isolate 344 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
20526,,,2678200,[],CHEMBL1032896,Antibacterial activity against Pseudomonas aeruginosa isolate 345 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.12
20527,,,2678201,[],CHEMBL1032897,Antibacterial activity against Pseudomonas aeruginosa isolate 346 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.6,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.6
20528,,,2678202,[],CHEMBL1032898,Antibacterial activity against Pseudomonas aeruginosa isolate 348 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
20529,,,2678203,[],CHEMBL1032899,Antibacterial activity against Pseudomonas aeruginosa isolate 349 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
20530,,,2678204,[],CHEMBL1032900,Antibacterial activity against Pseudomonas aeruginosa isolate 350 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
20531,,,2678205,[],CHEMBL1033693,Antibacterial activity against Pseudomonas aeruginosa isolate 352 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
20532,,,2678206,[],CHEMBL1033694,Antibacterial activity against Pseudomonas aeruginosa isolate 353 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
20533,,,2678207,[],CHEMBL1033695,Antibacterial activity against Pseudomonas aeruginosa isolate 354 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
20534,,,2678208,[],CHEMBL1033696,Antibacterial activity against Pseudomonas aeruginosa isolate 355 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
20535,,,2678209,[],CHEMBL1033697,Antibacterial activity against Pseudomonas aeruginosa isolate 356 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
20536,,,2678210,[],CHEMBL1033698,Antibacterial activity against Pseudomonas aeruginosa isolate 357 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
20537,,,2678211,[],CHEMBL1033699,Antibacterial activity against Pseudomonas aeruginosa isolate 358 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
20538,,,2678212,[],CHEMBL1033700,Antibacterial activity against Pseudomonas aeruginosa isolate 359 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
20539,,,2678213,[],CHEMBL1033701,Antibacterial activity against Pseudomonas aeruginosa isolate 360 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
20540,,,2678214,[],CHEMBL1033737,Antibacterial activity against Pseudomonas aeruginosa isolate 361 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
20541,,,2678215,[],CHEMBL1033738,Antibacterial activity against Pseudomonas aeruginosa isolate 362 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.12
20542,,,2678216,[],CHEMBL1033702,Antibacterial activity against Pseudomonas aeruginosa isolate 363 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
20543,,,2678217,[],CHEMBL1033703,Antibacterial activity against Pseudomonas aeruginosa isolate 364 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
20544,,,2678218,[],CHEMBL1033704,Antibacterial activity against Pseudomonas aeruginosa isolate 365 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
20545,,,2678219,[],CHEMBL1033705,Antibacterial activity against Pseudomonas aeruginosa isolate 366 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
20546,,,2678220,[],CHEMBL1033706,Antibacterial activity against Pseudomonas aeruginosa isolate 367 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
20547,,,2678221,[],CHEMBL1033707,Antibacterial activity against Pseudomonas aeruginosa isolate 368 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
20548,,,2678222,[],CHEMBL1033708,Antibacterial activity against Pseudomonas aeruginosa isolate 369 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.12
20549,,,2678223,[],CHEMBL1033709,Antibacterial activity against Pseudomonas aeruginosa isolate 370 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
20550,,,2678224,[],CHEMBL1033710,Antibacterial activity against Pseudomonas aeruginosa isolate 371 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
20551,,,2678225,[],CHEMBL1033711,Antibacterial activity against Pseudomonas aeruginosa isolate 372 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
20552,,,2678226,[],CHEMBL1033712,Antibacterial activity against Pseudomonas aeruginosa isolate 373 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
20553,,,2678227,[],CHEMBL1033713,Antibacterial activity against Pseudomonas aeruginosa isolate 374 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
20554,,,2678228,[],CHEMBL1033714,Antibacterial activity against Pseudomonas aeruginosa isolate 375 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.12
20555,,,2678229,[],CHEMBL1033715,Antibacterial activity against Pseudomonas aeruginosa isolate 376 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
20556,,,2678230,[],CHEMBL1033716,Antibacterial activity against Pseudomonas aeruginosa isolate 379 expressing VIM2 beta-lactamase after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,64.0
20557,,,2678231,[],CHEMBL1033717,Antibacterial activity against Acinetobacter baumannii isolate 882 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.0
20558,,,2678232,[],CHEMBL1033718,Antibacterial activity against Acinetobacter baumannii isolate 883 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.25
20559,,,2678233,[],CHEMBL1033719,Antibacterial activity against Acinetobacter baumannii isolate 884 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,128.0
20560,,,2678234,[],CHEMBL1033720,Antibacterial activity against Acinetobacter baumannii isolate 885 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,256.0
20561,,,2678235,[],CHEMBL1033721,Antibacterial activity against Acinetobacter baumannii isolate 886 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
20562,,,2678236,[],CHEMBL1033722,Antibacterial activity against Acinetobacter baumannii isolate 887 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.0
20563,,,2678237,[],CHEMBL1033723,Antibacterial activity against Acinetobacter baumannii isolate 888 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.0
20564,,,2678238,[],CHEMBL1036355,Antibacterial activity against Acinetobacter baumannii isolate 889 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
20565,,,2678239,[],CHEMBL1036356,Antibacterial activity against Acinetobacter baumannii isolate 890 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.0
20566,,,2678240,[],CHEMBL1036357,Antibacterial activity against Acinetobacter baumannii isolate 891 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
20567,,,2678241,[],CHEMBL1036358,Antibacterial activity against Acinetobacter baumannii isolate 892 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,128.0
20568,,,2678242,[],CHEMBL1036359,Antibacterial activity against Acinetobacter baumannii isolate 893 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.25
20569,,,2678243,[],CHEMBL1036360,Antibacterial activity against Acinetobacter baumannii isolate 894 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,2.0
20570,,,2678244,[],CHEMBL1036361,Antibacterial activity against Acinetobacter baumannii isolate 895 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,128.0
20571,,,2678245,[],CHEMBL1036362,Antibacterial activity against Acinetobacter baumannii isolate 896 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
20572,,,2678246,[],CHEMBL1036363,Antibacterial activity against Acinetobacter baumannii isolate 897 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
20573,,,2678247,[],CHEMBL1036364,Antibacterial activity against Acinetobacter baumannii isolate 898 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,128.0
20574,,,2678248,[],CHEMBL1036365,Antibacterial activity against Acinetobacter baumannii isolate 899 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,128.0
20575,,,2678249,[],CHEMBL1036366,Antibacterial activity against Acinetobacter baumannii isolate 900 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.0
20576,,,2678250,[],CHEMBL1036367,Antibacterial activity against Acinetobacter baumannii isolate 901 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,256.0
20577,,,2678251,[],CHEMBL1036368,Antibacterial activity against Acinetobacter baumannii isolate 902 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.25
20578,,,2678252,[],CHEMBL1036369,Antibacterial activity against Acinetobacter baumannii isolate 903 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.0
20579,,,2678253,[],CHEMBL1036370,Antibacterial activity against Acinetobacter baumannii isolate 904 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.0
20580,,,2678254,[],CHEMBL1036371,Antibacterial activity against Acinetobacter baumannii isolate 905 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
20581,,,2678255,[],CHEMBL1036372,Antibacterial activity against Acinetobacter baumannii isolate 906 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.25
20582,,,2678256,[],CHEMBL1036373,Antibacterial activity against Acinetobacter baumannii isolate 907 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
20583,,,2678257,[],CHEMBL1036374,Antibacterial activity against Acinetobacter baumannii isolate 908 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
20584,,,2678258,[],CHEMBL1036375,Antibacterial activity against Acinetobacter baumannii isolate 909 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.25
20585,,,2678259,[],CHEMBL1036376,Antibacterial activity against Acinetobacter baumannii isolate 910 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,4.0
20586,,,2678260,[],CHEMBL1036377,Antibacterial activity against Acinetobacter baumannii isolate 911 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,128.0
20587,,,2678261,[],CHEMBL1036378,Antibacterial activity against Acinetobacter baumannii isolate 912 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,4.0
20588,,,2678262,[],CHEMBL1036379,Antibacterial activity against Acinetobacter baumannii isolate 913 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
20589,,,2678263,[],CHEMBL1036380,Antibacterial activity against Acinetobacter baumannii isolate 914 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
20590,,,2678264,[],CHEMBL1036381,Antibacterial activity against Acinetobacter baumannii isolate 915 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.0
20591,,,2678265,[],CHEMBL1036382,Antibacterial activity against Acinetobacter baumannii isolate 916 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,8.0
20592,,,2678266,[],CHEMBL1036383,Antibacterial activity against Acinetobacter baumannii isolate 917 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
20593,,,2678267,[],CHEMBL1036384,Antibacterial activity against Acinetobacter baumannii isolate 918 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.25
20594,,,2678268,[],CHEMBL1036385,Antibacterial activity against Acinetobacter baumannii isolate 919 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
20595,,,2678269,[],CHEMBL1023598,Antibacterial activity against Acinetobacter baumannii isolate 920 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
20596,,,2678270,[],CHEMBL1023599,Antibacterial activity against Acinetobacter baumannii isolate 921 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.12
20597,,,2678271,[],CHEMBL1036386,Antibacterial activity against Acinetobacter baumannii isolate 922 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.0
20598,,,2678272,[],CHEMBL1036387,Antibacterial activity against Acinetobacter baumannii isolate 923 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
20599,,,2678273,[],CHEMBL1036388,Antibacterial activity against Acinetobacter baumannii isolate 924 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
20600,,,2678274,[],CHEMBL1036389,Antibacterial activity against Acinetobacter baumannii isolate 925 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,128.0
20601,,,2678275,[],CHEMBL1036390,Antibacterial activity against Acinetobacter baumannii isolate 926 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,256.0
20602,,,2678276,[],CHEMBL1023567,Antibacterial activity against Acinetobacter baumannii isolate 927 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.06
20603,,,2678277,[],CHEMBL1023568,Antibacterial activity against Acinetobacter baumannii isolate 928 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.0
20604,,,2678278,[],CHEMBL1023569,Antibacterial activity against Acinetobacter baumannii isolate 929 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
20605,,,2678279,[],CHEMBL1023570,Antibacterial activity against Acinetobacter baumannii isolate 930 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.25
20606,,,2678280,[],CHEMBL1023571,Antibacterial activity against Acinetobacter baumannii isolate 932 expressing OXA-24 and OXA-51 beta-lactamase after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,128.0
20607,,,2678281,[],CHEMBL1023572,Antibacterial activity against Acinetobacter baumannii isolate 934 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,128.0
20608,,,2678282,[],CHEMBL1023573,Antibacterial activity against Acinetobacter baumannii isolate 931 after 24 hrs by CLSI microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1151464,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,819371,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,4.0
20609,,,2680811,[],CHEMBL1061482,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate AG3 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.0,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.0
20610,,,2680812,[],CHEMBL1060597,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate nar 46 harboring DNA gyrase A D87G mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.06
20611,,,2680813,[],CHEMBL1060589,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate CT61 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.125
20612,,,2680814,[],CHEMBL1060590,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate nar 102 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.125
20613,,,2680815,[],CHEMBL1060583,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate D43 harboring DNA gyrase A S83Y mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.25
20614,,,2680816,[],CHEMBL1060584,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate B111 harboring DNA gyrase A S83Y mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.25
20615,,,2680817,[],CHEMBL1060585,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate E86 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.25
20616,,,2680818,[],CHEMBL1060586,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate A102 harboring DNA gyrase A S83Y mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.25
20617,,,2680819,[],CHEMBL1060587,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate C152 harboring DNA gyrase A S83Y mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.25
20618,,,2680820,[],CHEMBL1060591,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate nar 104 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.25
20619,,,2680821,[],CHEMBL1060592,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate nar 107 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.25
20620,,,2680822,[],CHEMBL1060593,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate nar 108 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.25
20621,,,2680823,[],CHEMBL1060594,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate ipt 2 harboring DNA gyrase A D87G mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.25
20622,,,2680824,[],CHEMBL1060604,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate CT144 harboring DNA gyrase A D87G mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.25
20623,,,2680825,[],CHEMBL1061481,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT60 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.25
20624,,,2680826,[],CHEMBL1061493,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate AG176 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.25
20625,,,2680827,[],CHEMBL1061498,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate BL 21801 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.25
20626,,,2680828,[],CHEMBL1061499,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate BL 21095 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.25
20627,,,2680829,[],CHEMBL1061500,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate BL 3769 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.25
20628,,,2680830,[],CHEMBL1060602,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate CT118 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.38
20629,,,2680831,[],CHEMBL1060603,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate CT142 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.38
20630,,,2680832,[],CHEMBL1060605,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate CT145 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.38
20631,,,2680833,[],CHEMBL1061475,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT40 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.38
20632,,,2680834,[],CHEMBL1061488,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate AG16 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.38
20633,,,2680835,[],CHEMBL1061490,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate AG152 harboring DNA gyrase A S83F and D87G mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.38
20634,,,2680836,[],CHEMBL1061491,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate AG168 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.38
20635,,,2680837,[],CHEMBL1061492,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate AG169 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.38
20636,,,2680838,[],CHEMBL1061494,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate AG182 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.38
20637,,,2680839,[],CHEMBL1061496,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate AG259 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.38
20638,,,2680840,[],CHEMBL1061497,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate HTD 798 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.38
20639,,,2680841,[],CHEMBL1060588,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate CT29 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.5
20640,,,2680842,[],CHEMBL1060595,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate nar 28 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.5
20641,,,2680843,[],CHEMBL1060596,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate nar 45 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.5
20642,,,2680844,[],CHEMBL1060598,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate nar 50 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.5
20643,,,2680845,[],CHEMBL1060599,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate nar 51 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.5
20644,,,2680846,[],CHEMBL1060600,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate ipt 32 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.5
20645,,,2680847,[],CHEMBL1060601,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate ipt 33 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.5
20646,,,2680848,[],CHEMBL1060607,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT2 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.5
20647,,,2680849,[],CHEMBL1060608,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT3 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.5
20648,,,2680850,[],CHEMBL1060609,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT9 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.5
20649,,,2680851,[],CHEMBL1060610,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT15 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.5
20650,,,2680852,[],CHEMBL1060611,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT18 harboring DNA gyrase A S83F and D87G mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.5
20651,,,2680853,[],CHEMBL1060612,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT37 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.5
20652,,,2680854,[],CHEMBL1061476,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT42 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.5
20653,,,2680855,[],CHEMBL1061477,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT47 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.5
20654,,,2680856,[],CHEMBL1061478,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT48 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.5
20655,,,2680857,[],CHEMBL1061479,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT49 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.5
20656,,,2680858,[],CHEMBL1061480,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT54 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.5
20657,,,2680859,[],CHEMBL1061483,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate AG5 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.5
20658,,,2680860,[],CHEMBL1061484,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate AG6 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.5
20659,,,2680861,[],CHEMBL1061485,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate AG7 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.5
20660,,,2680862,[],CHEMBL1061486,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate AG8 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.5
20661,,,2680863,[],CHEMBL1061487,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate AG15 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.5
20662,,,2680864,[],CHEMBL1061489,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate AG17 harboring DNA gyrase A S83F mutation by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.5
20663,,,2680865,[],CHEMBL1061495,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate AG258 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152457,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823680,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,,MIC,ug ml-1,UO_0000274,,0.5
20664,,,2684417,[],CHEMBL1055559,Antimicrobial activity against carbapenemase producing Enterobacter sp. by CLSI broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152470,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,824237,>,1,1,>,,MIC90,ug.mL-1,,4.0,CHEMBL612402,Enterobacter sp.,Enterobacter sp.,42895.0,,,MIC90,ug ml-1,UO_0000274,,4.0
20665,,,2684418,[],CHEMBL1055559,Antimicrobial activity against carbapenemase producing Enterobacter sp. by CLSI broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152470,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,824237,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL612402,Enterobacter sp.,Enterobacter sp.,42895.0,,,MIC50,ug ml-1,UO_0000274,,0.5
20666,,,2684438,[],CHEMBL1055556,Antimicrobial activity against Klebsiella sp. by CLSI broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152470,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,824237,>,1,1,>,,MIC90,ug.mL-1,,4.0,CHEMBL612616,Klebsiella sp.,Klebsiella sp.,576.0,,,MIC90,ug ml-1,UO_0000274,,4.0
20667,,,2684439,[],CHEMBL1055556,Antimicrobial activity against Klebsiella sp. by CLSI broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152470,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,824237,>,1,1,>,,MIC50,ug.mL-1,,4.0,CHEMBL612616,Klebsiella sp.,Klebsiella sp.,576.0,,,MIC50,ug ml-1,UO_0000274,,4.0
20668,,,2684464,[],CHEMBL1055561,Antimicrobial activity against carbapenemase producing Enterobacter sp. assessed as resistant isolates by CLSI breakpoint assay,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152470,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,824237,=,1,0,=,,Activity,%,,33.3,CHEMBL612402,Enterobacter sp.,Enterobacter sp.,42895.0,,,Activity,%,UO_0000187,,33.3
20669,,,2684465,[],CHEMBL1055560,Antimicrobial activity against carbapenemase producing Enterobacter sp. assessed as susceptible isolates by CLSI breakpoint assay,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152470,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,824237,=,1,0,=,,Activity,%,,61.9,CHEMBL612402,Enterobacter sp.,Enterobacter sp.,42895.0,,,Activity,%,UO_0000187,,61.9
20670,,,2684466,[],CHEMBL1055558,Antimicrobial activity against Klebsiella sp. assessed as resistant isolates by CLSI breakpoint assay,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152470,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,824237,=,1,0,=,,Activity,%,,79.2,CHEMBL612616,Klebsiella sp.,Klebsiella sp.,576.0,,,Activity,%,UO_0000187,,79.2
20671,,,2684467,[],CHEMBL1055557,Antimicrobial activity against Klebsiella sp. assessed as susceptible isolates by CLSI breakpoint assay,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152470,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,824237,=,1,0,=,,Activity,%,,14.6,CHEMBL612616,Klebsiella sp.,Klebsiella sp.,576.0,,,Activity,%,UO_0000187,,14.6
20672,,,2684468,[],CHEMBL1055555,Antimicrobial activity against carbapenemase producing Enterobacteriaceae assessed as resistant isolates by CLSI breakpoint assay,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152470,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,824237,=,1,0,=,,Activity,%,,60.7,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,,Activity,%,UO_0000187,,60.7
20673,,,2684469,[],CHEMBL1055554,Antimicrobial activity against carbapenemase producing Enterobacteriaceae assessed as susceptible isolates by CLSI breakpoint assay,F,,,BAO_0001103,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152470,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,824237,=,1,0,=,,Activity,%,,50.0,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,,Activity,%,UO_0000187,,50.0
20674,,,2684524,[],CHEMBL1055553,Antimicrobial activity against carbapenemase producing Enterobacteriaceae by CLSI broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152470,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,824237,>,1,1,>,,MIC90,ug.mL-1,,4.0,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,,MIC90,ug ml-1,UO_0000274,,4.0
20675,,,2684525,[],CHEMBL1055553,Antimicrobial activity against carbapenemase producing Enterobacteriaceae by CLSI broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152470,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,824237,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,,MIC50,ug ml-1,UO_0000274,,4.0
20676,,,2687283,[],CHEMBL1057028,Growth inhibition of Pseudomonas aeruginosa PAO1 assessed as survival rate at 0.017 ug/mL after 20 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152491,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,824261,=,1,0,=,,Survival,%,,85.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Survival,%,UO_0000187,,85.0
20677,,,2692450,[],CHEMBL1059716,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 by microbroth dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152380,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,822241,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
20678,,,2692816,[],CHEMBL1059715,Antibacterial activity against Escherichia coli ATCC 25922 by microbroth dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152380,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,822241,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
20679,,,2692833,[],CHEMBL1059714,Antibacterial activity against Enterococcus faecalis ATCC 29212 by microbroth dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152380,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,822241,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
20680,,,2692850,[],CHEMBL1059713,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 by microbroth dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152380,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,822241,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.5
20681,,,2692867,[],CHEMBL1059712,Antibacterial activity against multidrug-resistant Streptococcus pneumoniae clinical isolates by microbroth dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152380,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,822241,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.008
20682,,,2692884,[],CHEMBL1059711,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 by microbroth dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152380,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,822241,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.008
20683,,,2692901,[],CHEMBL1059710,Antibacterial activity against multidrug-resistant Staphylococcus aureus clinical isolates by microbroth dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152380,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,822241,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
20684,,,2692918,[],CHEMBL1059709,Antibacterial activity against Staphylococcus aureus ATCC 25923 by microbroth dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152380,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,822241,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
20685,,,2692946,[],CHEMBL1059717,Antibacterial activity against multidrug-resistant Pseudomonas aeruginosa clinical isolates by microbroth dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152380,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,822241,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
20686,,Active,2711135,[],CHEMBL1063475,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as inhibition of DNA synthesis at 8 times MIC treated 5 mins before [3H]thymidine challenge measured after 30 mins by [3H]thymidine incorporation assay,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152984,J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,826313,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
20687,,,2711142,[],CHEMBL1053372,"Antibacterial activity against Escherichia coli 1596 containing gyrA L83 and parC I80, G84 mutants assessed as increase in MIC by Etest relative to MIC for Escherichia coli 1608 containing gyrA mutant",F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152985,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,826318,=,1,0,=,,Ratio,,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,1.0
20688,,,2711148,[],CHEMBL1053371,"Antibacterial activity against Escherichia coli 1608 containing gyrA L83, L87 mutants assessed as increase in MIC by Etest relative to MIC for wild type Escherichia coli 1609",F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152985,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,826318,=,1,0,=,,Ratio,,,5.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,5.0
20689,,,2711149,[],CHEMBL1052655,Antibacterial activity against Salmonella containing gyrA double mutant and parC mutant assessed as increase in compound MIC,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152985,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,826318,=,1,0,=,,Ratio,,,30.0,CHEMBL614446,Salmonella,Salmonella,590.0,,,Ratio,,,,30.0
20690,,,2711150,[],CHEMBL1052654,Antibacterial activity against Escherichia coli clinical isolate containing gyrA double mutant and parC mutant assessed as increase in MIC,F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152985,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,826318,=,1,0,=,,Ratio,,,12.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,12.0
20691,,,2711158,[],CHEMBL1053374,"Antibacterial activity against Escherichia coli SKM9 containing gyrA L83, Y87 and parC L80 mutants assessed as increase in MIC by Etest relative to MIC for Escherichia coli 1596 containing gyrA L83 and parC I80 mutants",F,,,BAO_0000193,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152985,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,826318,=,1,0,=,,Ratio,,,9.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,9.0
20692,,,2711168,[],CHEMBL1053378,Antimicrobial activity against Escherichia coli J53 AzR by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152987,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826504,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.008
20693,,,2711169,[],CHEMBL1051008,Antimicrobial activity against extended-spectrum-beta-lactamase-producing Klebsiella transconjugant TK1 isolate expressing quinolone resistance-mediating gene aac(6')-Ib-cr by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152987,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826504,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC,ug ml-1,UO_0000274,,0.125
20694,,,2711170,[],CHEMBL1051009,Antimicrobial activity against extended-spectrum-beta-lactamase-producing Klebsiella transconjugant TK2 isolate expressing quinolone resistance-mediating gene aac(6')-Ib-cr by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152987,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826504,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC,ug ml-1,UO_0000274,,0.125
20695,,,2711171,[],CHEMBL1051010,Antimicrobial activity against extended-spectrum-beta-lactamase-producing Klebsiella transconjugant TK3 isolate expressing quinolone resistance-mediating gene aac(6')-Ib-cr by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152987,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826504,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC,ug ml-1,UO_0000274,,0.125
20696,,,2711536,[],CHEMBL1054153,Antimicrobial activity against extended-spectrum-beta-lactamase-producing Klebsiella transconjugant TK4 isolate expressing quinolone resistance-mediating gene aac(6')-Ib-cr by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152987,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826504,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC,ug ml-1,UO_0000274,,0.125
20697,,,2711537,[],CHEMBL1054154,Antimicrobial activity against extended-spectrum-beta-lactamase-producing Klebsiella transconjugant TK5 isolate expressing quinolone resistance-mediating gene aac(6')-Ib-cr by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152987,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826504,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC,ug ml-1,UO_0000274,,0.125
20698,,,2711538,[],CHEMBL1054155,Antimicrobial activity against extended-spectrum-beta-lactamase-producing Klebsiella transconjugant TK6 isolate expressing quinolone resistance-mediating gene aac(6')-Ib-cr by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152987,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826504,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC,ug ml-1,UO_0000274,,0.125
20699,,,2711539,[],CHEMBL1054156,Antimicrobial activity against extended-spectrum-beta-lactamase-producing Klebsiella transconjugant TK7 isolate expressing quinolone resistance-mediating gene aac(6')-Ib-cr by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152987,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826504,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC,ug ml-1,UO_0000274,,0.125
20700,,,2711540,[],CHEMBL1054157,Antimicrobial activity against extended-spectrum-beta-lactamase-producing Klebsiella transconjugant TK8 isolate expressing quinolone resistance-mediating gene aac(6')-Ib-cr by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152987,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826504,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC,ug ml-1,UO_0000274,,0.125
20701,,,2711541,[],CHEMBL1054158,Antimicrobial activity against extended-spectrum-beta-lactamase-producing Klebsiella transconjugant TK9 isolate expressing quinolone resistance-mediating gene aac(6')-Ib-cr by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152987,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826504,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC,ug ml-1,UO_0000274,,0.125
20702,,,2711542,[],CHEMBL1054159,Antimicrobial activity against extended-spectrum-beta-lactamase-producing Klebsiella transconjugant TK10 isolate expressing quinolone resistance-mediating gene aac(6')-Ib-cr by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152987,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826504,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC,ug ml-1,UO_0000274,,0.125
20703,,,2711543,[],CHEMBL1054160,Antimicrobial activity against extended-spectrum-beta-lactamase-producing Klebsiella transconjugant TK11 isolate expressing quinolone resistance-mediating gene aac(6')-Ib-cr by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152987,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826504,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC,ug ml-1,UO_0000274,,0.125
20704,,,2711544,[],CHEMBL1054161,Antimicrobial activity against extended-spectrum-beta-lactamase-producing Klebsiella transconjugant TK12 isolate expressing quinolone resistance-mediating gene aac(6')-Ib-cr by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152987,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826504,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC,ug ml-1,UO_0000274,,0.125
20705,,,2711545,[],CHEMBL1054162,Antimicrobial activity against extended-spectrum-beta-lactamase-producing Klebsiella transconjugant TK13 isolate expressing quinolone resistance-mediating gene aac(6')-Ib-cr by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152987,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826504,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC,ug ml-1,UO_0000274,,0.125
20706,,,2711546,[],CHEMBL1054944,Antimicrobial activity against extended-spectrum-beta-lactamase-producing Klebsiella transconjugant TK14 isolate expressing quinolone resistance-mediating gene aac(6')-Ib-cr by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152987,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826504,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC,ug ml-1,UO_0000274,,0.125
20707,,,2711547,[],CHEMBL1054945,Antimicrobial activity against extended-spectrum-beta-lactamase-producing Klebsiella transconjugant TK15 isolate expressing quinolone resistance-mediating gene aac(6')-Ib-cr by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152987,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826504,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC,ug ml-1,UO_0000274,,0.125
20708,,,2711548,[],CHEMBL1054946,Antimicrobial activity against extended-spectrum-beta-lactamase-producing Klebsiella transconjugant TK16 isolate expressing quinolone resistance-mediating gene aac(6')-Ib-cr by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152987,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826504,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC,ug ml-1,UO_0000274,,0.125
20709,,,2711549,[],CHEMBL1054947,Antimicrobial activity against extended-spectrum-beta-lactamase-producing Klebsiella transconjugant TK17 isolate expressing quinolone resistance-mediating gene aac(6')-Ib-cr by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152987,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826504,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC,ug ml-1,UO_0000274,,0.125
20710,,,2711550,[],CHEMBL1054948,Antimicrobial activity against extended-spectrum-beta-lactamase-producing Klebsiella transconjugant TK18 isolate expressing quinolone resistance-mediating gene aac(6')-Ib-cr by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152987,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826504,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC,ug ml-1,UO_0000274,,0.125
20711,,,2711551,[],CHEMBL1054949,Antimicrobial activity against extended-spectrum-beta-lactamase-producing Klebsiella transconjugant TK19 isolate expressing quinolone resistance-mediating gene aac(6')-Ib-cr by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152987,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826504,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC,ug ml-1,UO_0000274,,0.125
20712,,,2711552,[],CHEMBL1054950,Antimicrobial activity against extended-spectrum-beta-lactamase-producing Klebsiella transconjugant TK20 isolate expressing quinolone resistance-mediating gene aac(6')-Ib-cr by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152987,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826504,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC,ug ml-1,UO_0000274,,0.125
20713,,,2711553,[],CHEMBL1054951,Antimicrobial activity against extended-spectrum-beta-lactamase-producing Klebsiella transconjugant TK21 isolate expressing quinolone resistance-mediating gene aac(6')-Ib-cr by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152987,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826504,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC,ug ml-1,UO_0000274,,0.125
20714,,,2711554,[],CHEMBL1054952,Antimicrobial activity against extended-spectrum-beta-lactamase-producing Klebsiella transconjugant TK22 isolate expressing quinolone resistance-mediating gene aac(6')-Ib-cr by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152987,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826504,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC,ug ml-1,UO_0000274,,0.125
20715,,,2711555,[],CHEMBL1054953,Antimicrobial activity against extended-spectrum-beta-lactamase-producing Klebsiella transconjugant TK23 isolate expressing quinolone resistance-mediating gene aac(6')-Ib-cr by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152987,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826504,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC,ug ml-1,UO_0000274,,0.125
20716,,,2711556,[],CHEMBL1054954,Antimicrobial activity against extended-spectrum-beta-lactamase-producing Klebsiella transconjugant TK24 isolate expressing quinolone resistance-mediating gene aac(6')-Ib-cr by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152987,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826504,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC,ug ml-1,UO_0000274,,0.125
20717,,,2711557,[],CHEMBL1054955,Antimicrobial activity against extended-spectrum-beta-lactamase-producing Klebsiella transconjugant TK25 isolate expressing quinolone resistance-mediating gene aac(6')-Ib-cr by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152987,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826504,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC,ug ml-1,UO_0000274,,0.125
20718,,,2711822,[],CHEMBL1051720,Antimicrobial activity against Proteus mirabilis JIE273 expressing 16S rRNA methyltransferase RmtC,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152992,Antimicrob Agents Chemother,2008.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,827177,>,1,1,>,,MIC,ug.mL-1,,2.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,2.0
20719,,,2713627,[],CHEMBL1051024,Antibacterial activity against Staphylococcus aureus ATCC 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153072,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,827998,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
20720,,,2713651,[],CHEMBL1051025,Antibacterial activity against multidrug resistant Staphylococcus aureus BAA-39,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153072,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,827998,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
20721,,,2713900,[],CHEMBL1058932,Antibacterial activity against Escherichia coli MTCC 119 after overnight incubation by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153011,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826074,=,1,1,=,,MIC,ug.mL-1,,1.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.2
20722,,,2713901,[],CHEMBL1058933,Antibacterial activity against Shigella flexneri MTCC 1457 after overnight incubation by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153011,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826074,=,1,1,=,,MIC,ug.mL-1,,1.4,CHEMBL614396,Shigella flexneri,Shigella flexneri,623.0,,,MIC,ug ml-1,UO_0000274,,1.4
20723,,,2713902,[],CHEMBL1059740,Antibacterial activity against Pseudomonas aeruginosa MTCC 741 after overnight incubation by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153011,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826074,=,1,1,=,,MIC,ug.mL-1,,1.8,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.8
20724,,,2713903,[],CHEMBL1059741,Antibacterial activity against Staphylococcus aureus MTCC 740 after overnight incubation by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153011,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,826074,=,1,1,=,,MIC,ug.mL-1,,0.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.9
20725,,,2714036,[],CHEMBL1051026,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153072,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,827998,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
20726,,,2714060,[],CHEMBL1051027,Antibacterial activity against Staphylococcus epidermidis ATCC 12228,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153072,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,827998,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.12
20727,,,2714084,[],CHEMBL1051028,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis ATCC 51625,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153072,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,827998,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.12
20728,,,2714108,[],CHEMBL1051029,Antibacterial activity against Streptococcus pneumoniae ATCC 6301,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153072,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,827998,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
20729,,,2714132,[],CHEMBL1051030,Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51575,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153072,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,827998,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
20730,,,2714156,[],CHEMBL1051031,Antibacterial activity against vancomycin-resistant Enterococcus faecium ATCC 700221,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153072,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,827998,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,64.0
20731,,,2714180,[],CHEMBL1051032,Antibacterial activity against Bacillus subtilis ATCC 23857,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153072,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,827998,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.12
20732,,,2714203,[],CHEMBL1051033,Antibacterial activity against Bacillus cereus ATCC 11778,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153072,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,827998,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,ug ml-1,UO_0000274,,0.12
20733,,,2714226,[],CHEMBL1051034,Antibacterial activity against Bacillus fragilis ATCC 23745,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153072,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,827998,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,0.5
20734,,,2714248,[],CHEMBL1051035,Antibacterial activity against Clostridium perfringens ATCC 10388,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153072,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,827998,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC,ug ml-1,UO_0000274,,0.25
20735,,,2722827,[],CHEMBL1060038,Free drug level in one-compartment pharmacodynamic system administered at simulated oral dose regimen of 750 mg in human every 12 hrs for 10 days,A,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153545,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829534,=,1,0,=,,Fu,ug ml-1,,2.23,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Fu,ug ml-1,UO_0000274,,2.23
20736,,,2722840,[],CHEMBL1060026,Antimicrobial activity against Streptococcus pneumoniae Spn-058 by broth macrodilution technique in presence of 5% lysed horse blood,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153545,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829534,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
20737,,,2722841,[],CHEMBL1060026,Antimicrobial activity against Streptococcus pneumoniae Spn-058 by broth macrodilution technique in presence of 5% lysed horse blood,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153545,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829534,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MBC,ug ml-1,UO_0000274,,1.0
20738,,,2722845,[],CHEMBL1060037,Free steady state AUC (0 to 24 hrs) in one-compartment pharmacodynamic system administered at simulated oral dose regimen of 750 mg in human every 12 hrs for 10 days,A,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153545,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,829534,=,1,1,=,,fAUC,ng.hr.mL-1,,25900.0,CHEMBL612558,,ADMET,,,,fAUC,mg.hr/L,,,25.9
20739,,,2722846,[],CHEMBL1060039,Half life in one-compartment pharmacodynamic system administered at simulated oral dose regimen of 750 mg in human every 12 hrs for 10 days,A,,,BAO_0002115,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153545,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Hour,829534,=,1,1,=,,T1/2,hr,,4.0,CHEMBL612558,,ADMET,,,,t1/2,hr,UO_0000032,,4.0
20740,,,2722848,[],CHEMBL1060027,Antimicrobial activity against Streptococcus pneumoniae Spn-RC2 by broth macrodilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153545,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829534,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
20741,,Active,2722861,[],CHEMBL1055149,Antimicrobial activity against Streptococcus pneumoniae Spn-058 infected in one-compartment pharmacodynamic system assessed as reduction in bacterial density administered at simulated oral dose regimen of 750 mg in human every 12 hrs measured on day 1,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153545,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,829534,,1,0,,,Activity,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,,,,
20742,,Not Active,2722862,[],CHEMBL1055150,Antimicrobial activity against Streptococcus pneumoniae Spn-058 infected in one-compartment pharmacodynamic system assessed as regrowth of bacteria administered at simulated oral dose regimen of 750 mg in human every 12 hrs measured on day 2,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153545,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,829534,,1,0,,,Activity,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,,,,
20743,,Active,2722863,[],CHEMBL1055952,Antimicrobial activity against Streptococcus pneumoniae Spn-058 infected in one-compartment pharmacodynamic system assessed as prevention of regrowth administered ciprofloxacin at simulated oral dose regimen of 750 mg in human every 12 hrs measured on day 10,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153545,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,829534,,1,0,,,Activity,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,,,,
20744,,Active,2722874,[],CHEMBL1055156,Antimicrobial activity against Streptococcus pneumoniae Spn-RC2 infected in one-compartment pharmacodynamic system assessed as regrowth of bacteria administered at simulated at 750 mg dosage regimen every 12 hrs measured on day 3,F,,,BAO_0000375,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153545,Antimicrob Agents Chemother,2007.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,829534,,1,0,,,Activity,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,,,,
20745,,,2910324,[],CHEMBL1045686,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1154152,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,846813,=,1,1,=,,MIC,ug.mL-1,,6250.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/ml,UO_0000274,,6.25
20746,,,2910331,[],CHEMBL1045687,Antibacterial activity against Escherichia coli ATTC 25922 after 24 hrs by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1154152,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,846813,=,1,1,=,,MIC,ug.mL-1,,6250.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/ml,UO_0000274,,6.25
20747,,,2910345,[],CHEMBL1045688,Antibacterial activity against Pseudomonas aeruginosa ATTC 27853 after 24 hrs by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1154152,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,846813,=,1,1,=,,MIC,ug.mL-1,,6250.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mg/ml,UO_0000274,,6.25
20748,,,2910359,[],CHEMBL1045689,Antibacterial activity against Klebsiella sp. after 24 hrs by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1154152,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,846813,=,1,1,=,,MIC,ug.mL-1,,6250.0,CHEMBL612616,Klebsiella sp.,Klebsiella sp.,576.0,,,MIC,mg/ml,UO_0000274,,6.25
20749,,,2910469,[],CHEMBL1045686,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154152,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,846813,=,1,1,=,,IZ,mm,,23.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,23.0
20750,,,2910471,[],CHEMBL1045689,Antibacterial activity against Klebsiella sp. after 24 hrs by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154152,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,846813,=,1,1,=,,IZ,mm,,24.0,CHEMBL612616,Klebsiella sp.,Klebsiella sp.,576.0,,,IZ,mm,UO_0000016,,24.0
20751,,,2910484,[],CHEMBL1045688,Antibacterial activity against Pseudomonas aeruginosa ATTC 27853 after 24 hrs by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154152,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,846813,=,1,1,=,,IZ,mm,,28.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,IZ,mm,UO_0000016,,28.0
20752,,,2910485,[],CHEMBL1045687,Antibacterial activity against Escherichia coli ATTC 25922 after 24 hrs by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154152,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,846813,=,1,1,=,,IZ,mm,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IZ,mm,UO_0000016,,32.0
20753,,,2911767,[],CHEMBL1038607,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 to 20 hrs by twofold tube dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154099,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,846395,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
20754,,,2911768,[],CHEMBL1038608,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 18 to 20 hrs by twofold tube dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154099,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,846395,=,1,1,=,,MIC,ug.mL-1,,0.7,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.7
20755,,,2911769,[],CHEMBL1038609,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 after 18 to 20 hrs by twofold tube dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154099,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,846395,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.19
20756,,,2911770,[],CHEMBL1038610,Antibacterial activity against Escherichia coli ATCC 25922 after 18 to 20 hrs by twofold tube dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154099,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,846395,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.19
20757,,Not Determined,2912909,[],CHEMBL1049217,Antibacterial activity against Salmonella typhi MTCC 733 after 20 hrs by two fold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154066,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,846082,,1,0,,,MIC,,,,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,,,,
20758,,Not Determined,2912915,[],CHEMBL1049216,Antibacterial activity against Pseudomonas aeruginosa MTCC 741 after 20 hrs by two fold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154066,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,846082,,1,0,,,MIC,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,,,,
20759,,Not Determined,2912928,[],CHEMBL1048382,Antibacterial activity against Streptococcus mutans MTCC 890 after 20 hrs by two fold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154066,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,846082,,1,0,,,MIC,,,,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,,MIC,,,,
20760,,,2912940,[],CHEMBL1048383,Antibacterial activity against Escherichia coli ATCC 25922 after 20 hrs by two fold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154066,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,846082,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
20761,,,2912941,[],CHEMBL1048381,Antibacterial activity against Bacillus subtilis MTCC 121 after 20 hrs by two fold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154066,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,846082,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,1.0
20762,,,2912942,[],CHEMBL1048380,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 20 hrs by two fold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154066,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,846082,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
20763,,,2914642,[],CHEMBL1049269,Antitumor activity against human PC3 cells after 5 days by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1154114,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,847498,=,1,1,=,,IC50,nM,,143000.0,CHEMBL390,Homo sapiens,PC-3,9606.0,,,IC50,uM,UO_0000065,,143.0
20764,,,2914674,[],CHEMBL1049270,Antitumor activity against human U373MG cells after 5 days by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154114,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,4.02,0,http://www.openphacts.org/units/Nanomolar,847498,=,1,1,=,,IC50,nM,,96000.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,IC50,uM,UO_0000065,,96.0
20765,,,2914706,[],CHEMBL1049271,Antitumor activity against human LoVo cells after 5 days by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154114,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,4.05,0,http://www.openphacts.org/units/Nanomolar,847498,=,1,1,=,,IC50,nM,,89000.0,CHEMBL614721,Homo sapiens,LoVo,9606.0,,,IC50,uM,UO_0000065,,89.0
20766,,,2914738,[],CHEMBL1049272,Antitumor activity against human A549 cells after 5 days by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1154114,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,847498,=,1,1,=,,IC50,nM,,280000.0,CHEMBL392,Homo sapiens,A549,9606.0,,,IC50,uM,UO_0000065,,280.0
20767,,,2914770,[],CHEMBL1050047,Antitumor activity against human MCF7 cells after 5 days by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1154114,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,847498,=,1,1,=,,IC50,nM,,476000.0,CHEMBL387,Homo sapiens,MCF7,9606.0,,,IC50,uM,UO_0000065,,476.0
20768,,,2914802,[],CHEMBL1050054,Inhibition of human HeLa cell proliferation assessed as bromodeoxyuridine incorporation during DNA synthesis after 48 hrs by ELISA,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1154114,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,847498,=,1,1,=,,IC50,nM,,800000.0,CHEMBL399,Homo sapiens,HeLa,9606.0,,,IC50,uM,UO_0000065,,800.0
20769,,,2914803,[],CHEMBL1050055,Inhibition of human MG63 cell proliferation assessed as bromodeoxyuridine incorporation during DNA synthesis after 48 hrs by ELISA,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1154114,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,847498,=,1,1,=,,IC50,nM,,480000.0,CHEMBL614347,Homo sapiens,MG-63,9606.0,,,IC50,uM,UO_0000065,,480.0
20770,,,2914804,[],CHEMBL1050056,Inhibition of human NCI-H460 cell proliferation by sulphorodhamine B assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154114,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,4.22,0,http://www.openphacts.org/units/Nanomolar,847498,=,1,1,=,,IC50,nM,,60000.0,CHEMBL396,Homo sapiens,NCI-H460,9606.0,,,IC50,uM,UO_0000065,,60.0
20771,,,2914805,[],CHEMBL1050068,Inhibition of human K562 cell proliferation by sulphorodhamine B assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1154114,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,847498,>,1,1,>,,IC50,nM,,150000.0,CHEMBL385,Homo sapiens,K562,9606.0,,,IC50,uM,UO_0000065,,150.0
20772,,,2914806,[],CHEMBL1050069,Induction of apoptosis in human NCI-H460 cells at 120 uM by sulphorodhamine B assay,F,,,BAO_0001103,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154114,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,847498,=,1,0,=,,Activity,%,,35.0,CHEMBL396,Homo sapiens,NCI-H460,9606.0,,,Activity,%,UO_0000187,,35.0
20773,,,2914807,[],CHEMBL1050070,Inhibition of topoisomerase 2-mediated DNA relaxation activity in human HeLa cells by Oomori method,B,,,BAO_0000181,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154114,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Micromolar,847498,=,1,0,=,,Activity,uM,,104.0,CHEMBL1806,Homo sapiens,DNA topoisomerase II alpha,9606.0,,,Activity,uM,UO_0000064,,104.0
20774,,,2914847,[],CHEMBL1050057,Inhibition of human HeLa cell proliferation,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1154114,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,847498,=,1,1,=,,IC50,nM,,270000.0,CHEMBL399,Homo sapiens,HeLa,9606.0,,,IC50,uM,UO_0000065,,270.0
20775,,,2914848,[],CHEMBL1050058,Inhibition of human MCF7 cell proliferation by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1154114,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,847498,=,1,1,=,,IC50,nM,,199000.0,CHEMBL387,Homo sapiens,MCF7,9606.0,,,IC50,uM,UO_0000065,,199.0
20776,,,2914849,[],CHEMBL1050059,Inhibition of human MCF7 cell proliferation after 5 days by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154114,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,4.12,0,http://www.openphacts.org/units/Nanomolar,847498,=,1,1,=,,IC50,nM,,76000.0,CHEMBL387,Homo sapiens,MCF7,9606.0,,,IC50,uM,UO_0000065,,76.0
20777,,,2914850,[],CHEMBL1050060,Inhibition of human A431 cell proliferation by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1154114,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,847498,=,1,1,=,,IC50,nM,,135000.0,CHEMBL614069,Homo sapiens,A-431,9606.0,,,IC50,uM,UO_0000065,,135.0
20778,,,2914851,[],CHEMBL1050061,Inhibition of human EJ cell proliferation by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1154114,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,847498,=,1,1,=,,IC50,nM,,202000.0,CHEMBL614292,Homo sapiens,EJ,9606.0,,,IC50,uM,UO_0000065,,202.0
20779,,,2914852,[],CHEMBL1050062,Inhibition of human SW480 cell proliferation by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1154114,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,847498,=,1,1,=,,IC50,nM,,128000.0,CHEMBL612544,Homo sapiens,SW480,9606.0,,,IC50,uM,UO_0000065,,128.0
20780,,,2914853,[],CHEMBL1050063,Inhibition of human KB cell proliferation by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1154114,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,847498,=,1,1,=,,IC50,nM,,160000.0,CHEMBL398,Homo sapiens,KB,9606.0,,,IC50,uM,UO_0000065,,160.0
20781,,,2914854,[],CHEMBL1050064,Inhibition of human SK-MEL cell proliferation by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1154114,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,847498,=,1,1,=,,IC50,nM,,196000.0,CHEMBL614914,Homo sapiens,SK-MEL,9606.0,,,IC50,uM,UO_0000065,,196.0
20782,,,2914855,[],CHEMBL1050065,Inhibition of mouse MC3T3-E1 cell proliferation after 48 to 72 hrs,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1154114,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,847498,=,1,1,=,,IC50,nM,,120000.0,CHEMBL4296463,Mus musculus,MC3T3-E1,10090.0,,,IC50,uM,UO_0000065,,120.0
20783,,,2914856,[],CHEMBL1050066,Inhibition of mouse NIH/3T3 cell proliferation by MTT assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1154114,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,847498,>,1,1,>,,IC50,nM,,1000000.0,CHEMBL612558,,ADMET,,,,IC50,uM,UO_0000065,,1000.0
20784,,,2914895,[],CHEMBL1050053,Toxicity in ip dosed B6D2F1 mouse assessed as maximum tolerated dose after 28 days,T,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154114,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,847498,>,1,0,>,,MTD,mg Kg-1,,80.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,MTD,mg Kg-1,UO_0000308,,80.0
20785,,,2914904,[],CHEMBL1050067,Inhibition of chinese hamster V79 cell proliferation assessed as bromodeoxyuridine incorporation during DNA synthesis after 48 hrs by ELISA,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1154114,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,847498,>,1,1,>,,IC50,nM,,1000000.0,CHEMBL614074,Cricetulus griseus,V79,10029.0,,,IC50,uM,UO_0000065,,1000.0
20786,,,2917605,[],CHEMBL1040408,Inhibition of NorA efflux pump in Staphylococcus aureus 1199B assessed as accumulation of ethidium bromide after 24 hrs by broth checkerboard method,B,,,BAO_0002146,BAO_0000357,single protein format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154079,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,847145,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL5114,Staphylococcus aureus,Quinolone resistance protein norA,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
20787,,,2920151,[],CHEMBL1043064,Antibacterial activity against Staphylococcus aureus by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154090,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,845840,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
20788,,,2920168,[],CHEMBL1043065,Antibacterial activity against Escherichia coli by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154090,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,845840,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
20789,,,2920185,[],CHEMBL1043066,Antibacterial activity against Klebsiella pneumoniae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154090,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,845840,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
20790,,,2922257,[],CHEMBL1045764,Antibacterial activity against Escherichia coli ATTC 25922 at 1 mg/ml after 24 hrs by well-diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154788,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,848489,=,1,1,=,,IZ,mm,,20.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,DIZ,mm,UO_0000016,,20.0
20791,,,2922276,[],CHEMBL1045765,Antibacterial activity against Klebsiella pneumoniae ATCC 10031 at 1 mg/ml after 24 hrs by well-diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154788,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,848489,=,1,1,=,,IZ,mm,,21.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,DIZ,mm,UO_0000016,,21.0
20792,,,2922295,[],CHEMBL1047515,Antibacterial activity against Bacillus cereus ATTC 10702 at 1 mg/ml after 24 hrs by well-diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154788,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,848489,=,1,1,=,,IZ,mm,,18.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,DIZ,mm,UO_0000016,,18.0
20793,,,2922314,[],CHEMBL1047516,Antibacterial activity against Salmonella Typhimurium ATTC 23564 at 1 mg/ml after 24 hrs by well-diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154788,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,848489,=,1,1,=,,IZ,mm,,23.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,DIZ,mm,UO_0000016,,23.0
20794,,,2931666,[],CHEMBL1062934,Antibacterial activity against Bacillus subtilis ATCC 11774 after 24 hrs by disc diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154781,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,848272,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,10.0
20795,,,2931667,[],CHEMBL1062933,Antibacterial activity against Bacillus subtilis ATCC 11774 at 15 ug/ml after 24 hrs by disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154781,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,848272,=,1,1,=,,IZ,mm,,22.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,IZ,mm,UO_0000016,,22.0
20796,,,2931668,[],CHEMBL1062932,Antibacterial activity against Escherichia coli ATCC 25922 at 10 ug/ml after 24 hrs by disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154781,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,848272,=,1,1,=,,IZ,mm,,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IZ,mm,UO_0000016,,25.0
20797,,,2931669,[],CHEMBL1062931,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by disc diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154781,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,848272,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,10.0
20798,,,2931670,[],CHEMBL1062930,Antibacterial activity against Staphylococcus aureus ATCC 25923 at 10 ug/ml after 24 hrs by disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154781,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,848272,=,1,1,=,,IZ,mm,,21.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,21.0
20799,,,2931671,[],CHEMBL1062929,Antibacterial activity against Staphylococcus aureus ATCC 25923 at after 24 hrs by disc diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154781,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,848272,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,10.0
20800,,,2931672,[],CHEMBL1062928,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 at 10 ug/ml after 24 hrs by disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154781,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,848272,=,1,1,=,,IZ,mm,,23.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,IZ,mm,UO_0000016,,23.0
20801,,,2931673,[],CHEMBL1062919,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by disc diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154781,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,848272,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,10.0
20802,,,2932473,[],CHEMBL1049392,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154782,J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,848276,=,1,1,=,,IC50,ug.mL-1,,1.18,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,IC50,ug ml-1,UO_0000274,,1.18
20803,,,2934207,[],CHEMBL1052819,Antibacterial activity against Staphylococcus aureus ATCC 29737 after 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154609,Eur J Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,851853,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
20804,,,2934242,[],CHEMBL1052820,Antibacterial activity against Staphylococcus epidermidis ATCC 12229 after 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154609,Eur J Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,851853,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.0
20805,,,2934277,[],CHEMBL1052821,Antibacterial activity against Escherichia coli ATCC 8739 after 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154609,Eur J Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,851853,=,1,1,=,,MIC,ug.mL-1,,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.01
20806,,,2934312,[],CHEMBL1052822,Antibacterial activity against Salmonella Typhimurium ATCC 1639 after 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154609,Eur J Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,851853,=,1,1,=,,MIC,ug.mL-1,,0.01,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.01
20807,,,2934347,[],CHEMBL1052823,Antibacterial activity against Pseudomonas aeruginosa ATCC 90277 after 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154609,Eur J Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,851853,=,1,1,=,,MIC,ug.mL-1,,0.01,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.01
20808,,,2941531,[],CHEMBL1056082,Antibacterial activity against Staphylococcus aureus NCIM 2602 at 50 ug/ml by agar cup plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154632,Eur J Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,848960,=,1,1,=,,IZ,mm,,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,25.0
20809,,,2941532,[],CHEMBL1056083,Antibacterial activity against Bacillus subtilis NCIM 2613 at 50 ug/ml by agar cup plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154632,Eur J Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,848960,=,1,1,=,,IZ,mm,,18.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,IZ,mm,UO_0000016,,18.0
20810,,,2941533,[],CHEMBL1056084,Antibacterial activity against Escherichia coli NCIM 2666 at 50 ug/ml by agar cup plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154632,Eur J Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,848960,=,1,1,=,,IZ,mm,,30.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IZ,mm,UO_0000016,,30.0
20811,,,2941534,[],CHEMBL1056085,Antibacterial activity against Pseudomonas desmolytica NCIM 2028 at 50 ug/ml by agar cup plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154632,Eur J Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,848960,=,1,1,=,,IZ,mm,,18.0,CHEMBL615080,Delftia acidovorans,Delftia acidovorans,80866.0,,,IZ,mm,UO_0000016,,18.0
20812,,,2945885,[],CHEMBL1054404,Antibacterial activity against Staphylococcus aureus after 24 hrs by two fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154591,Eur J Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,850438,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,25.0
20813,,,2945886,[],CHEMBL1054405,Antibacterial activity against Escherichia coli after 24 hrs by two fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154591,Eur J Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,850438,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,25.0
20814,,,2945887,[],CHEMBL1054406,Antibacterial activity against Klebsiella pneumoniae after 24 hrs by two fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154591,Eur J Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,850438,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,25.0
20815,,,2945888,[],CHEMBL1054407,Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by two fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154591,Eur J Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,850438,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,12.5
20816,,,2945889,[],CHEMBL1054408,Antibacterial activity against Salmonella typhi after 24 hrs by two fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154591,Eur J Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,850438,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,50.0
20817,,,2946537,[],CHEMBL1041442,Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in erythrocytes after 96 hrs by [3H]hypoxanthine incorporation assay,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154702,J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,5.0,0,http://www.openphacts.org/units/Nanomolar,849460,=,1,1,=,,IC50,nM,,10100.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,microM,UO_0000065,,10.1
20818,,,2946540,[],CHEMBL1041443,Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in erythrocytes after 96 hrs by [3H]hypoxanthine incorporation assay,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154702,J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,4.85,0,http://www.openphacts.org/units/Nanomolar,849460,=,1,1,=,,IC50,nM,,14100.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,microM,UO_0000065,,14.1
20819,,,2946543,[],CHEMBL1041440,Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154702,J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,4.34,0,http://www.openphacts.org/units/Nanomolar,849460,=,1,1,=,,IC50,nM,,45900.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,microM,UO_0000065,,45.9
20820,,,2946544,[],CHEMBL1041441,Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1154702,J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,849460,=,1,1,=,,IC50,nM,,119300.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,microM,UO_0000065,,119.3
20821,,,2946552,[],CHEMBL1041446,"Therapeutic index, ratio of IC50 for concanavalin-stimulated BALB/c mice (Mus musculus) splenocytes to IC50 for Plasmodium falciparum W2 after 48 hrs",A,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154702,J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,849460,>,1,0,>,,Ratio IC50,,,0.3,CHEMBL612558,,ADMET,,,,Ratio IC50,,,,0.3
20822,,,2946553,[],CHEMBL1041445,"Therapeutic index, ratio of IC50 for concanavalin-stimulated BALB/c mice (Mus musculus) splenocytes to IC50 for Plasmodium falciparum 3D7",A,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154702,J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,849460,>,1,0,>,,Ratio IC50,,,0.8,CHEMBL612558,,ADMET,,,,Ratio IC50,,,,0.8
20823,,,2946557,[],CHEMBL1041444,Cytotoxicity against concanavalin-stimulated BALB/c mouse splenocytes after 72 hrs by resazurin dye reduction method,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154702,J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,849460,>,1,1,>,,IC50,nM,,40000.0,CHEMBL612558,,ADMET,,,,IC50,microM,UO_0000065,,40.0
20824,,,2946567,[],CHEMBL1044091,Antimalarial activity against chloroquine-sensitive Plasmodium falciparum IMT10500 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154702,J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,4.13,0,http://www.openphacts.org/units/Nanomolar,849460,=,1,1,=,,IC50,nM,,74800.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,microM,UO_0000065,,74.8
20825,,,2946572,[],CHEMBL1044092,Antimalarial activity against chloroquine-sensitive Plasmodium falciparum IMTL1 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154702,J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,4.38,0,http://www.openphacts.org/units/Nanomolar,849460,=,1,1,=,,IC50,nM,,41300.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,microM,UO_0000065,,41.3
20826,,,2946577,[],CHEMBL1044090,Antimalarial activity against chloroquine-sensitive Plasmodium falciparum IMTVo1 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154702,J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,4.29,0,http://www.openphacts.org/units/Nanomolar,849460,=,1,1,=,,IC50,nM,,51600.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,microM,UO_0000065,,51.6
20827,,,2946582,[],CHEMBL1044093,Antimalarial activity against chloroquine-sensitive Plasmodium falciparum PA infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154702,J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,4.34,0,http://www.openphacts.org/units/Nanomolar,849460,=,1,1,=,,IC50,nM,,45500.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,microM,UO_0000065,,45.5
20828,,,2946587,[],CHEMBL1044094,Antimalarial activity against chloroquine-sensitive Plasmodium falciparum FCR3 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154702,J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,4.13,0,http://www.openphacts.org/units/Nanomolar,849460,=,1,1,=,,IC50,nM,,74300.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,microM,UO_0000065,,74.3
20829,,,2946592,[],CHEMBL1044095,Antimalarial activity against chloroquine-sensitive Plasmodium falciparum FCM29 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154702,J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,4.34,0,http://www.openphacts.org/units/Nanomolar,849460,=,1,1,=,,IC50,nM,,45600.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,microM,UO_0000065,,45.6
20830,,,2946597,[],CHEMBL1044096,Antimalarial activity against chloroquine-sensitive Plasmodium falciparum IMT K2 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154702,J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,4.09,0,http://www.openphacts.org/units/Nanomolar,849460,=,1,1,=,,IC50,nM,,80800.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,microM,UO_0000065,,80.8
20831,,,2947303,[],CHEMBL1038492,Antitubercular activity against Mycobacterium tuberculosis H37Rv after 28 days by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154648,Eur J Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,850723,=,1,1,=,,MIC,nM,,4710.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,microM,UO_0000065,,4.71
20832,,,2949961,[],CHEMBL1037612,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 18 to 24 hrs by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154603,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,851542,=,1,1,=,,MIC,ug.mL-1,,0.86,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.86
20833,,,2949962,[],CHEMBL1037613,Antibacterial activity against Vancomycin-resistant Enterococcus ATCC 51299 after 18 to 24 hrs by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154603,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,851542,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC,ug ml-1,UO_0000274,,0.8
20834,,,2949963,[],CHEMBL1037614,Antibacterial activity against Escherichia coli ATCC 25922 after 18 to 24 hrs by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154603,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,851542,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.2
20835,,,2949964,[],CHEMBL1037615,Antibacterial activity against Shigella dysenteriae after 18 to 24 hrs by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1154603,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,851542,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL612619,Shigella dysenteriae,Shigella dysenteriae,622.0,,,MIC,ug ml-1,UO_0000274,,0.2
20836,,,2978379,[],CHEMBL1043582,Hepatic clearance in human,A,,,BAO_0002759,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,861544,=,1,1,=,,CL,mL.min-1.kg-1,,1.4,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/min.kg,,,1.4
20837,,,2978513,[],CHEMBL1043588,Volume of distribution at steady state in human,A,,,BAO_0003041,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,861544,=,1,1,=,,Vdss,L.kg-1,,2.1,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vdss,L/Kg,UO_0000197,,2.1
20838,,,2979871,[],CHEMBL1043583,Renal clearance in human,A,,,BAO_0002773,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,861544,=,1,1,=,,CL_renal,mL.min-1.kg-1,,6.9,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL_renal,ml/min.kg,,,6.9
20839,,,2979911,[],CHEMBL1043581,Total clearance in human,A,,,BAO_0002759,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,861544,=,1,1,=,,CL,mL.min-1.kg-1,,8.3,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/min.kg,,,8.3
20840,,,2990128,[],CHEMBL1046150,Permeability at pH 6.5 by PAMPA method,A,,,BAO_0002808,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1156784,J Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,863542,=,1,0,=,,permeability,10'-6 cm/s,,2.8,CHEMBL612558,,ADMET,,,,permeability,10'-6 cm/s,,,2.8
20841,,,2990161,[],CHEMBL1046151,Oral bioavailability in human,A,,,BAO_0003042,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1156784,J Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Percent,863542,=,1,1,=,,F,%,,70.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,F,%,UO_0000187,,70.0
20842,,,2993376,[],CHEMBL1043584,Oral bioavailability in human,A,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,861544,=,1,0,=,,F_fraction,,,0.69,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,F_fraction,,,,0.69
20843,,,2993419,[],CHEMBL1043580,Fraction unbound in human plasma,A,,,BAO_0000179,BAO_0000366,cell-free format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,861544,=,1,1,=,,Fu,,,0.7,CHEMBL613652,Rattus norvegicus,Plasma,10116.0,,,Fu,,,,0.7
20844,,,2993467,[],CHEMBL1043585,Fraction absorbed in human,A,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,861544,=,1,0,=,,Fa,,,0.75,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Fa,,,,0.75
20845,,,2994966,[],CHEMBL1043587,Fraction escaping hepatic elimination in human,A,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,861544,=,1,0,=,,Fh,,,0.94,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Fh,,,,0.94
20846,,,2996273,[],CHEMBL1043586,Fraction escaping gut-wall elimination in human,A,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1156824,J Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,861544,=,1,0,=,,Fg,,,0.98,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Fg,,,,0.98
20847,,,2998752,[],CHEMBL1045436,Antimicrobial activity against Staphylococcus aureus ATCC 11632 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155277,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856982,<=,1,1,<=,,MIC,ug.mL-1,,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,5.0
20848,,,2998778,[],CHEMBL1045437,Antimicrobial activity against Streptococcus faecalis ATCC 14506 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155277,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856982,<=,1,1,<=,,MIC,ug.mL-1,,5.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,5.0
20849,,,2998803,[],CHEMBL1045438,Antimicrobial activity against Bacillus subtilis ATCC 60511 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155277,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856982,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,1.0
20850,,,2998828,[],CHEMBL1045439,Antimicrobial activity against Klebsiella pneumoniae ATCC 10031 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155277,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856982,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.0
20851,,,2998853,[],CHEMBL1045440,Antimicrobial activity against Escherichia coli ATCC 10145 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155277,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856982,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
20852,,,2998878,[],CHEMBL1045441,Antimicrobial activity against Pseudomonas aeruginosa ATCC 10145 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155277,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856982,<=,1,1,<=,,MIC,ug.mL-1,,5.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,5.0
20853,,,2999430,[],CHEMBL1049014,Antimicrobial activity against Bacillus cereus ATCC 11778 after 18 hrs by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,854870,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,ug ml-1,UO_0000274,,1.0
20854,,,2999443,[],CHEMBL1049015,Antimicrobial activity against Enterococcus hirae ATCC 10541 after 18 hrs by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,854870,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614623,Enterococcus hirae,Enterococcus hirae,1354.0,,,MIC,ug ml-1,UO_0000274,,0.5
20855,,,2999456,[],CHEMBL1049016,Antimicrobial activity against Micrococcus luteus ATCC 9341 after 18 hrs by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,854870,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,0.5
20856,,,2999469,[],CHEMBL1049017,Antimicrobial activity against Micrococcus luteus ATCC 10240 by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,854870,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,0.5
20857,,,2999482,[],CHEMBL1049018,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 136/6 by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,854870,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
20858,,,2999495,[],CHEMBL1049019,Antimicrobial activity against Methicillin susceptible Staphylococcus aureus 206/7 by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,854870,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
20859,,,2999508,[],CHEMBL1049020,Antimicrobial activity against Methicillin susceptible Staphylococcus aureus 207/7 by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,854870,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
20860,,,2999521,[],CHEMBL1049021,Antimicrobial activity against Methicillin susceptible Staphylococcus aureus 208/7 by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,854870,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
20861,,,2999534,[],CHEMBL1049022,Antimicrobial activity against Methicillin susceptible Staphylococcus aureus 212/7 by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,854870,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
20862,,,2999547,[],CHEMBL1042885,Antimicrobial activity against Methicillin susceptible Staphylococcus aureus 213/7 by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,854870,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
20863,,,2999560,[],CHEMBL1042886,Antimicrobial activity against Methicillin susceptible Staphylococcus aureus 237/7 by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,854870,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
20864,,,2999573,[],CHEMBL1042887,Antimicrobial activity against Methicillin susceptible Staphylococcus aureus 238/7 by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,854870,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
20865,,,2999586,[],CHEMBL1042888,Antimicrobial activity against Methicillin susceptible Staphylococcus aureus 239/7 by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,854870,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
20866,,,2999599,[],CHEMBL1042889,Antimicrobial activity against Methicillin susceptible Staphylococcus aureus 242/7 by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,854870,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
20867,,,2999612,[],CHEMBL1042890,Antimicrobial activity against Methicillin susceptible Staphylococcus aureus 243/7 by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,854870,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
20868,,,2999625,[],CHEMBL1042891,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 140/6 by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,854870,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
20869,,,2999638,[],CHEMBL1042892,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 141/6 by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,854870,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
20870,,,2999651,[],CHEMBL1042893,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 143/6 by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,854870,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
20871,,,2999664,[],CHEMBL1042894,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 144/6 by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,854870,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
20872,,,2999677,[],CHEMBL1042895,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 146/6 by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,854870,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
20873,,,2999690,[],CHEMBL1042896,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 200/7 by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,854870,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
20874,,,2999703,[],CHEMBL1042897,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 217/7 by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,854870,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
20875,,,2999716,[],CHEMBL1042898,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 218/7 by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,854870,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
20876,,,2999729,[],CHEMBL1042899,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 236/7 by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,854870,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
20877,,Not Active,2999736,[],CHEMBL1049002,Antimicrobial activity against Enterococcus hirae ATCC 10541 at 5 ug after 18 hrs by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,854870,,1,0,,,DIZ,,,,CHEMBL614623,Enterococcus hirae,Enterococcus hirae,1354.0,,,DIZ,,,,
20878,,,3000349,[],CHEMBL1047231,Antimicrobial activity against Staphylococcus aureus NCTC 4163 at 5 ug after 18 hrs by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,854870,=,1,1,=,,IZ,mm,,26.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,26.0
20879,,,3000350,[],CHEMBL1048999,Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 at 5 ug after 18 hrs by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,854870,=,1,1,=,,IZ,mm,,30.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,DIZ,mm,UO_0000016,,30.0
20880,,,3000351,[],CHEMBL1049000,Antimicrobial activity against Bacillus subtilis ATCC 6633 at 5 ug after 18 hrs by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,854870,=,1,1,=,,IZ,mm,,40.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,DIZ,mm,UO_0000016,,40.0
20881,,,3000352,[],CHEMBL1049001,Antimicrobial activity against Bacillus cereus ATCC 11778 at 5 ug after 18 hrs by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,854870,=,1,1,=,,IZ,mm,,20.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,DIZ,mm,UO_0000016,,20.0
20882,,,3000353,[],CHEMBL1049003,Antimicrobial activity against Micrococcus luteus ATCC 9341 at 5 ug after 18 hrs by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,854870,=,1,1,=,,IZ,mm,,22.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,DIZ,mm,UO_0000016,,22.0
20883,,,3000354,[],CHEMBL1049004,Antimicrobial activity against Micrococcus luteus ATCC 10240 at 5 ug after 18 hrs by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,854870,=,1,1,=,,IZ,mm,,24.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,DIZ,mm,UO_0000016,,24.0
20884,,,3000355,[],CHEMBL1049005,Antimicrobial activity against Staphylococcus aureus ATCC 25923 at 5 ug after 18 hrs by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,854870,=,1,1,=,,IZ,mm,,26.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,26.0
20885,,,3000356,[],CHEMBL1049006,Antimicrobial activity against Staphylococcus aureus ATCC 6538 at 5 ug after 18 hrs by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,854870,=,1,1,=,,IZ,mm,,28.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,28.0
20886,,,3000357,[],CHEMBL1049007,Antimicrobial activity against Staphylococcus aureus ATCC 29213 at 5 ug after 18 hrs by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,854870,=,1,1,=,,IZ,mm,,22.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,22.0
20887,,,3000369,[],CHEMBL1049008,Antimicrobial activity against Staphylococcus aureus NCTC 4163 after 18 hrs by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,854870,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
20888,,,3000382,[],CHEMBL1049009,Antimicrobial activity against Staphylococcus aureus ATCC 25923 after 18 hrs by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,854870,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
20889,,,3000395,[],CHEMBL1049010,Antimicrobial activity against Staphylococcus aureus ATCC 6538 after 18 hrs by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,854870,<,1,1,<,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
20890,,,3000408,[],CHEMBL1049011,Antimicrobial activity against Staphylococcus aureus ATCC 29213 after 18 hrs by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,854870,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
20891,,,3000421,[],CHEMBL1049012,Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,854870,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,4.0
20892,,,3000434,[],CHEMBL1049013,Antimicrobial activity against Bacillus subtilis ATCC 6633 after 18 hrs by twofold dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155271,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,854870,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,2.0
20893,,,3015554,[],CHEMBL1041000,Antimicrobial activity against Staphylococcus aureus NCIM 5021 after 24 hrs by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155338,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,855220,=,1,1,=,,IZ,mm,,30.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,30.0
20894,,,3015560,[],CHEMBL1040999,Antimicrobial activity against Bacillus subtilis NCIM 2010 after 24 hrs by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155338,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,855220,=,1,1,=,,IZ,mm,,33.7,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,IZ,mm,UO_0000016,,33.7
20895,,Not Active,3015597,[],CHEMBL1040998,Antioxidant activity assessed as DPPH radical scavenging after 30 mins,F,,,BAO_0000375,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155338,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,855220,,1,0,,,Activity,,,,CHEMBL613712,,Radical scavenging activity,,,,Activity,,,,
20896,,,3016840,[],CHEMBL1041025,Antibacterial activity against ciprofloxacin susceptible Staphylococcus aureus subsp. aureus ATCC 13709 by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155341,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,855163,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
20897,,,3016841,[],CHEMBL1041026,Antibacterial activity against ciprofloxacin susceptible Streptococcus pneumoniae ATCC 49619 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155341,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,855163,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
20898,,,3016842,[],CHEMBL1041027,Antibacterial activity against ciprofloxacin susceptible Escherichia coli ATCC 25922 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155341,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,855163,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
20899,,,3016843,[],CHEMBL1041028,Antibacterial activity against ciprofloxacin resistant Streptococcus pneumoniae OC5462 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155341,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,855163,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
20900,,,3016844,[],CHEMBL1041029,Antibacterial activity against ciprofloxacin resistant Streptococcus pneumoniae OC5458 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155341,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,855163,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
20901,,,3016845,[],CHEMBL1041030,Antibacterial activity against ciprofloxacin resistant Streptococcus pneumoniae OC5465 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155341,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,855163,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
20902,,,3016972,[],CHEMBL1041031,Antimicrobial activity against Staphylococcus aureus subsp. aureus ATCC 13709 infected in po dosed Swiss Webster mouse treated 1 hr after infection measured fter 3 days,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155341,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,855163,=,1,1,=,,ED50,mg.kg-1,,10.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,10.8
20903,,,3016973,[],CHEMBL1041032,Antimicrobial activity against Staphylococcus aureus subsp. aureus ATCC 13709 infected in sc dosed Swiss Webster mouse treated 1 hr after infection measured fter 3 days,F,,,BAO_0003036,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155341,Bioorg Med Chem Lett,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,855163,=,1,1,=,,ED50,mg.kg-1,,1.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,1.4
20904,,,3019794,[],CHEMBL1049868,Antifungal activity against Aspergillus fumigatus NCIM 902 by serial plate dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155347,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,857441,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL363,Aspergillus fumigatus,Aspergillus fumigatus,746128.0,,,MIC,ug ml-1,UO_0000274,,6.25
20905,,,3019839,[],CHEMBL1049865,Antifungal activity against recultured Penicillium marneffei by serial plate dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155347,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,857441,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL612994,Talaromyces marneffei,Talaromyces marneffei,37727.0,,,MIC,ug ml-1,UO_0000274,,6.25
20906,,,3019854,[],CHEMBL1049860,Antibacterial activity against recultured Klebsiella pneumoniae after 16 to 18 hrs by serial plate dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155347,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,857441,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,6.25
20907,,,3019868,[],CHEMBL1049859,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 16 to 18 hrs by serial plate dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155347,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,857441,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,6.25
20908,,,3019882,[],CHEMBL1049858,Antibacterial activity against Escherichia coli ATCC 25922 after 16 to 18 hrs by serial plate dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155347,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,857441,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,6.25
20909,,,3019903,[],CHEMBL1049857,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 16 to 18 hrs by serial plate dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155347,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,857441,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,6.25
20910,,,3019921,[],CHEMBL1049867,Antifungal activity against Aspergillus flavus NCIM 524 by serial plate dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155347,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,857441,=,1,1,=,,MIC,ug.mL-1,,3.125,CHEMBL614955,Aspergillus flavus,Aspergillus flavus,5059.0,,,MIC,ug ml-1,UO_0000274,,3.125
20911,,,3019922,[],CHEMBL1049866,Antifungal activity against recultured Trichophyton mentagrophytes by serial plate dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155347,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,857441,=,1,1,=,,MIC,ug.mL-1,,3.125,CHEMBL613162,Trichophyton mentagrophytes,Trichophyton mentagrophytes,523103.0,,,MIC,ug ml-1,UO_0000274,,3.125
20912,,,3020000,[],CHEMBL1049869,Antifungal activity against recultured Penicillium marneffei at MIC after 3 to 4 days by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155347,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,857441,=,1,1,=,,IZ,mm,,20.0,CHEMBL612994,Talaromyces marneffei,Talaromyces marneffei,37727.0,,,IZ,mm,UO_0000016,,20.0
20913,,,3020001,[],CHEMBL1049861,Antibacterial activity against Staphylococcus aureus ATCC 25923 at MIC after 3 to 4 days by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155347,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,857441,=,1,1,=,,IZ,mm,,22.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,22.0
20914,,,3020002,[],CHEMBL1049864,Antibacterial activity against recultured Klebsiella pneumoniae at MIC after 3 to 4 days by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155347,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,857441,=,1,1,=,,IZ,mm,,23.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,IZ,mm,UO_0000016,,23.0
20915,,,3020003,[],CHEMBL1049871,Antifungal activity against Aspergillus flavus NCIM 524 at MIC after 3 to 4 days by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155347,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,857441,=,1,1,=,,IZ,mm,,25.0,CHEMBL614955,Aspergillus flavus,Aspergillus flavus,5059.0,,,IZ,mm,UO_0000016,,25.0
20916,,,3020004,[],CHEMBL1037514,Antifungal activity against Aspergillus fumigatus NCIM 902 at MIC after 3 to 4 days by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155347,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,857441,=,1,1,=,,IZ,mm,,25.0,CHEMBL363,Aspergillus fumigatus,Aspergillus fumigatus,746128.0,,,IZ,mm,UO_0000016,,25.0
20917,,,3020005,[],CHEMBL1049863,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 at MIC after 3 to 4 days by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155347,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,857441,=,1,1,=,,IZ,mm,,25.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,IZ,mm,UO_0000016,,25.0
20918,,,3020006,[],CHEMBL1049870,Antifungal activity against recultured Trichophyton mentagrophytes at MIC after 3 to 4 days by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155347,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,857441,=,1,1,=,,IZ,mm,,27.0,CHEMBL613162,Trichophyton mentagrophytes,Trichophyton mentagrophytes,523103.0,,,IZ,mm,UO_0000016,,27.0
20919,,,3020007,[],CHEMBL1049862,Antibacterial activity against Escherichia coli ATCC 25922 at MIC after 3 to 4 days by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1155347,Eur J Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,857441,=,1,1,=,,IZ,mm,,30.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IZ,mm,UO_0000016,,30.0
20920,,,3062015,[],CHEMBL1046026,Antibacterial activity against Mycobacterium intracellular by alamar blue assay,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152671,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,5.98,0,http://www.openphacts.org/units/Nanomolar,873628,=,1,1,=,,IC50,nM,,1056.0,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,IC50,uM,UO_0000065,,1.056
20921,,,3070513,[],CHEMBL1066048,Antibacterial activity against Staphylococcus aureus FDA 209-P after 18 hrs by twofold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875130,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.05
20922,,,3070526,[],CHEMBL1066049,Antibacterial activity against Staphylococcus epidermidis 56500 after 18 hrs by twofold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875130,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.2
20923,,,3070539,[],CHEMBL1066050,Antibacterial activity against Streptococcus pneumoniae J-24 after 18 hrs by twofold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875130,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.39
20924,,,3070552,[],CHEMBL1066051,Antibacterial activity against Streptococcus pyogenes G-36 after 18 hrs by twofold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875130,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,1.56
20925,,,3070565,[],CHEMBL1066052,Antibacterial activity against Streptococcus mitis IID685 after 18 hrs by twofold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875130,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC,ug ml-1,UO_0000274,,0.78
20926,,,3070578,[],CHEMBL1066053,Antibacterial activity against Enterococcus faecalis ATCC 19433 after 18 hrs by twofold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875130,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.78
20927,,,3071166,[],CHEMBL1044210,Antibacterial activity against Staphylococcus aureus after 24 hrs by twofold serial dilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152508,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Micromolar,874669,=,1,0,=,,Activity,uM,,1.63,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,uM,UO_0000064,,1.63
20928,,,3071167,[],CHEMBL1044211,Antibacterial activity against Bacillus subtilis after 24 hrs by twofold serial dilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152508,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Micromolar,874669,=,1,0,=,,Activity,uM,,1.09,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,Activity,uM,UO_0000064,,1.09
20929,,,3071168,[],CHEMBL1044212,Antibacterial activity against Serratia marcescens after 24 hrs by twofold serial dilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152508,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Micromolar,874669,=,1,0,=,,Activity,uM,,1.63,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,Activity,uM,UO_0000064,,1.63
20930,,,3071169,[],CHEMBL1044213,Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by twofold serial dilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152508,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Micromolar,874669,=,1,0,=,,Activity,uM,,1.36,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,uM,UO_0000064,,1.36
20931,,,3071170,[],CHEMBL1044214,Antibacterial activity against Escherichia coli after 24 hrs by twofold serial dilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152508,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Micromolar,874669,=,1,0,=,,Activity,uM,,1.36,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,uM,UO_0000064,,1.36
20932,,,3071603,[],CHEMBL1066054,Antibacterial activity against Escherichia coli NIHJ after 18 hrs by twofold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875130,<=,1,1,<=,,MIC,ug.mL-1,,0.003,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.003
20933,,,3071616,[],CHEMBL1066055,Antibacterial activity against Klebsiella pneumoniae type 2 after 18 hrs by twofold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875130,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.025
20934,,,3071629,[],CHEMBL1066056,Antibacterial activity against Pseudomonas aeruginosa PAO1 after 18 hrs by twofold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875130,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.05
20935,,,3071642,[],CHEMBL1066064,"Antibacterial activity against levofloxacin, methicillin-resistant Staphylococcus aureus after 18 hrs by twofold microbroth dilution method",F,,,BAO_0003035,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875130,>,1,1,>,,MIC50,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,64.0
20936,,,3071649,[],CHEMBL1066064,"Antibacterial activity against levofloxacin, methicillin-resistant Staphylococcus aureus after 18 hrs by twofold microbroth dilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875130,>,1,1,>,,MIC80,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC80,ug ml-1,UO_0000274,,64.0
20937,,,3071656,[],CHEMBL1066064,"Antibacterial activity against levofloxacin, methicillin-resistant Staphylococcus aureus after 18 hrs by twofold microbroth dilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875130,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,64.0
20938,,,3071682,[],CHEMBL1066703,Inhibition of Staphylococcus aureus wild type DNA topoisomerase 4,B,,,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875130,=,1,1,=,,IC50,ug.mL-1,,1.24,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,1.24
20939,,,3071695,[],CHEMBL1066706,Inhibition of Staphylococcus aureus wild type DNA gyrase,B,,,BAO_0000190,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875130,=,1,1,=,,IC50,ug.mL-1,,13.4,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,,IC50,ug ml-1,UO_0000274,,13.4
20940,,,3071697,[],CHEMBL1066705,Selectivity ratio of IC50 for Staphylococcus aureus DNA topoisomerase 4 Ser80Phe mutant to IC50 for Staphylococcus aureus wild type DNA topoisomerase 4,B,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,875130,=,1,0,=,,Ratio IC50,,,18.06,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,,18.06
20941,,,3071699,[],CHEMBL1066708,Selectivity ratio of IC50 for Staphylococcus aureus DNA gyrase Ser84Leu mutant to IC50 for Staphylococcus aureus wild type DNA gyrase,B,,,BAO_0000179,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,875130,>,1,0,>,,Ratio IC50,,,19.1,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,,19.1
20942,,,3071702,[],CHEMBL1066704,Inhibition of Staphylococcus aureus DNA topoisomerase 4 Ser80Phe mutant,B,,,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875130,=,1,1,=,,IC50,ug.mL-1,,22.4,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,22.4
20943,,,3071708,[],CHEMBL1066707,Inhibition of Staphylococcus aureus DNA gyrase Ser84Leu mutant,B,P20831,S84L,BAO_0000190,BAO_0000019,assay format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1152592,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,875130,>,1,1,>,,IC50,ug.mL-1,,256.0,CHEMBL2424506,Staphylococcus aureus,DNA gyrase subunit A,1280.0,,,IC50,ug ml-1,UO_0000274,,256.0
20944,,,3083843,[],CHEMBL1072575,Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153210,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,872472,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,25.0
20945,,,3083859,[],CHEMBL1072574,Antibacterial activity against Escherichia coli after 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153210,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,872472,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,25.0
20946,,,3083874,[],CHEMBL1072573,Antibacterial activity against Vibrio cholerae after 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153210,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,872472,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,,MIC,ug ml-1,UO_0000274,,50.0
20947,,,3083890,[],CHEMBL1072572,Antibacterial activity against beta-Hemolytic streptococcus after 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153210,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,872472,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,MIC,ug ml-1,UO_0000274,,50.0
20948,,,3083906,[],CHEMBL1072571,Antibacterial activity against Staphylococcus aureus after 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153210,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,872472,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,25.0
20949,,,3087368,[],CHEMBL1072707,Antibacterial activity against Mycobacterium intracellular ATCC 23068 by Franzblau method,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153083,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,5.9,0,http://www.openphacts.org/units/Nanomolar,876726,=,1,1,=,,IC50,nM,,1270.0,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,IC50,uM,UO_0000065,,1.27
20950,,,3087387,[],CHEMBL1072704,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 by modified CLSI/NCCLS method,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153083,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,6.44,0,http://www.openphacts.org/units/Nanomolar,876726,=,1,1,=,,IC50,nM,,360.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IC50,uM,UO_0000065,,0.36
20951,,,3087388,[],CHEMBL1072703,Antibacterial activity against Staphylococcus aureus ATCC 29213 by modified CLSI/NCCLS method,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153083,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,6.44,0,http://www.openphacts.org/units/Nanomolar,876726,=,1,1,=,,IC50,nM,,360.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IC50,uM,UO_0000065,,0.36
20952,,,3087402,[],CHEMBL1072706,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 by modified CLSI/NCCLS method,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153083,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,6.66,0,http://www.openphacts.org/units/Nanomolar,876726,=,1,1,=,,IC50,nM,,220.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,IC50,uM,UO_0000065,,0.22
20953,,,3087412,[],CHEMBL1072705,Antibacterial activity against Escherichia coli ATCC 35218 by modified CLSI/NCCLS method,F,,,BAO_0000190,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1153083,Bioorg Med Chem,2009.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,8.0,0,http://www.openphacts.org/units/Nanomolar,876726,=,1,1,=,,IC50,nM,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IC50,uM,UO_0000065,,0.01
20954,,,3092009,[],CHEMBL1065129,Antibacterial activity against Staphylococcus aureus after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,>,1,1,>,,MIC90,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,mg/L,UO_0000274,,4.0
20955,,,3092010,[],CHEMBL1065128,Antibacterial activity against Escherichia coli XL-1Blue after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,>,1,1,>,,MIC90,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,mg/L,UO_0000274,,4.0
20956,,,3092011,[],CHEMBL1065127,Antibacterial activity against Escherichia coli JM110 after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,>,1,1,>,,MIC90,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,mg/L,UO_0000274,,4.0
20957,,,3092012,[],CHEMBL1065126,Antibacterial activity against Escherichia coli JM109 after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,>,1,1,>,,MIC90,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,mg/L,UO_0000274,,4.0
20958,,,3092013,[],CHEMBL1065125,Antibacterial activity against Escherichia coli HB101 after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,<,1,1,<,,MIC90,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,mg/L,UO_0000274,,0.25
20959,,,3092014,[],CHEMBL1065124,Antibacterial activity against Escherichia coli Top10 after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,<,1,1,<,,MIC90,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,mg/L,UO_0000274,,0.25
20960,,,3092015,[],CHEMBL1065123,Antibacterial activity against Escherichia coli isolate 7 after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,>,1,1,>,,MIC90,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,mg/L,UO_0000274,,4.0
20961,,,3092016,[],CHEMBL1065122,Antibacterial activity against Escherichia coli isolate 13 after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,>,1,1,>,,MIC90,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,mg/L,UO_0000274,,4.0
20962,,,3092017,[],CHEMBL1065121,Antibacterial activity against Escherichia coli isolate 21 after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,mg/L,UO_0000274,,4.0
20963,,,3092018,[],CHEMBL1065120,Antibacterial activity against Escherichia coli isolate 32 after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,mg/L,UO_0000274,,2.0
20964,,,3092019,[],CHEMBL1074834,Antibacterial activity against Escherichia coli isolate 95 expressing GyrA S83L mutant after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,mg/L,UO_0000274,,1.0
20965,,,3092020,[],CHEMBL1074835,Antibacterial activity against Escherichia coli isolate 115 expressing GyrA S83L mutant after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,mg/L,UO_0000274,,0.5
20966,,,3092021,[],CHEMBL1074836,Antibacterial activity against Escherichia coli isolate 85 expressing GyrA S83L mutant after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,mg/L,UO_0000274,,0.5
20967,,,3092022,[],CHEMBL1074838,Antibacterial activity against Escherichia coli isolate 41 after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,<,1,1,<,,MIC90,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,mg/L,UO_0000274,,0.25
20968,,,3092023,[],CHEMBL1074837,Antibacterial activity against Escherichia coli isolate 24 after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,<,1,1,<,,MIC90,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,mg/L,UO_0000274,,0.25
20969,,,3092024,[],CHEMBL1074839,Antibacterial activity against Escherichia coli isolate 191 expressing qnr S1 gene after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,mg/L,UO_0000274,,1.0
20970,,,3092025,[],CHEMBL1074840,"Antibacterial activity against Escherichia coli isolate 9 expressing qnr B19 gene, GyrA D87G, ParC S80I mutant after 24 hrs by twofold serial dilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,>,1,1,>,,MIC90,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,mg/L,UO_0000274,,4.0
20971,,,3092026,[],CHEMBL1074841,Antibacterial activity against Escherichia coli isolate 50 expressing qnr B19 gene after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,<,1,1,<,,MIC90,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,mg/L,UO_0000274,,0.25
20972,,,3092027,[],CHEMBL1074842,Antibacterial activity against Escherichia coli isolate 47 expressing qnr B19 gene after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,<,1,1,<,,MIC90,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,mg/L,UO_0000274,,0.25
20973,,,3092028,[],CHEMBL1074843,Antibacterial activity against Klebsiella pneumoniae isolate 173 after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,>,1,1,>,,MIC90,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,mg/L,UO_0000274,,4.0
20974,,,3092029,[],CHEMBL1074844,Antibacterial activity against Klebsiella pneumoniae isolate 91 after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,>,1,1,>,,MIC90,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,mg/L,UO_0000274,,4.0
20975,,,3092030,[],CHEMBL1074847,Antibacterial activity against Klebsiella pneumoniae isolate 134 after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,<,1,1,<,,MIC90,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,mg/L,UO_0000274,,0.25
20976,,,3092031,[],CHEMBL1074848,Antibacterial activity against Klebsiella pneumoniae isolate 92 after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,<,1,1,<,,MIC90,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,mg/L,UO_0000274,,0.25
20977,,,3092032,[],CHEMBL1074849,"Antibacterial activity against Klebsiella pneumoniae isolate 370 expressing qnr B19 gene, GyrA D87G mutant after 24 hrs by twofold serial dilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,>,1,1,>,,MIC90,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,mg/L,UO_0000274,,4.0
20978,,,3092033,[],CHEMBL1074850,"Antibacterial activity against Klebsiella pneumoniae isolate 328 expressing qnr B19 gene, GyrA D87G mutant after 24 hrs by twofold serial dilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,>,1,1,>,,MIC90,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,mg/L,UO_0000274,,4.0
20979,,,3092034,[],CHEMBL1064833,"Antibacterial activity against Klebsiella pneumoniae isolate 16 expressing qnr B19 gene, GyrA D87G mutant after 24 hrs by twofold serial dilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,mg/L,UO_0000274,,2.0
20980,,,3092035,[],CHEMBL1064834,Antibacterial activity against Klebsiella pneumoniae isolate 204 expressing qnr B19 gene after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,=,1,1,=,,MIC90,ug.mL-1,,0.75,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,mg/L,UO_0000274,,0.75
20981,,,3092036,[],CHEMBL1064835,"Antibacterial activity against Klebsiella pneumoniae isolate 172 expressing qnr B19 gene, GyrA D87G mutant after 24 hrs by twofold serial dilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,<,1,1,<,,MIC90,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,mg/L,UO_0000274,,0.25
20982,,,3092037,[],CHEMBL1066894,"Antibacterial activity against Klebsiella pneumoniae isolate 110 expressing qnr B19 gene, GyrA D87G mutant after 24 hrs by twofold serial dilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,<,1,1,<,,MIC90,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,mg/L,UO_0000274,,0.25
20983,,,3092038,[],CHEMBL1066895,Antibacterial activity against Klebsiella pneumoniae isolate 97 expressing qnr B19 gene after 24 hrs by twofold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,<,1,1,<,,MIC90,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,mg/L,UO_0000274,,0.25
20984,,,3092039,[],CHEMBL1066869,"Antibacterial activity against Klebsiella pneumoniae isolate 5 expressing qnr B19 gene, GyrA D87G mutant after 24 hrs by twofold serial dilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1157738,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,882494,<,1,1,<,,MIC90,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,mg/L,UO_0000274,,0.25
20985,,,3093657,[],CHEMBL1070143,Antibacterial activity against methicillin-resistant Staphylococcus aureus BAA-44 after 16 to 20 hrs by microdilution susceptibility test,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1159075,Bioorg Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,883753,=,1,1,=,,MIC,nM,,12500.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,12.5
20986,,,3093695,[],CHEMBL1070144,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 16 to 20 hrs by microdilution susceptibility test,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1159075,Bioorg Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,883753,=,1,1,=,,MIC,nM,,391.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,nM,UO_0000065,,391.0
20987,,,3093696,[],CHEMBL1070145,Antibacterial activity against Staphylococcus aureus ATCC 29740 after 16 to 20 hrs by microdilution susceptibility test,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1159075,Bioorg Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/Nanomolar,883753,=,1,1,=,,MIC,nM,,391.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,nM,UO_0000065,,391.0
20988,,Not Determined,3093712,[],CHEMBL1070146,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 16 to 20 hrs by microdilution susceptibility test,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1159075,Bioorg Med Chem,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,883753,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
20989,,,3100633,[],CHEMBL1071790,Antimicrobial activity against Mycobacterium vaccae IMET 10670 at 2 mM after overnight incubation by agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158519,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,882886,=,1,1,=,,IZ,mm,,19.0,CHEMBL613224,Mycolicibacterium vaccae,Mycolicibacterium vaccae,1810.0,,,DIZ,mm,UO_0000016,,19.0
20990,,,3100651,[],CHEMBL1071788,Antimicrobial activity against Escherichia coli ATCC 25922 at 2 mM after overnight incubation by agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158519,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,882886,=,1,1,=,,IZ,mm,,31.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,DIZ,mm,UO_0000016,,31.0
20991,,,3100669,[],CHEMBL1071787,Antimicrobial activity against Pseudomonas aeruginosa K799/61 mutant at 2 mM after overnight incubation by agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158519,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,882886,=,1,1,=,,IZ,mm,,39.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,DIZ,mm,UO_0000016,,39.0
20992,,,3100687,[],CHEMBL1071786,Antimicrobial activity against wild type Pseudomonas aeruginosa K799 at 2 mM after overnight incubation by agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158519,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,882886,=,1,1,=,,IZ,mm,,35.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,DIZ,mm,UO_0000016,,35.0
20993,,,3100705,[],CHEMBL1071785,Antimicrobial activity against vancomycin-resistant Enterococcus faecalis 1528 at 2 mM after overnight incubation by agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158519,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,882886,=,1,1,=,,IZ,mm,,15.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,DIZ,mm,UO_0000016,,15.0
20994,,,3100723,[],CHEMBL1071784,Antimicrobial activity against Enterococcus faecalis ATCC 49532 at 2 mM after overnight incubation by agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158519,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,882886,=,1,1,=,,IZ,mm,,13.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,DIZ,mm,UO_0000016,,13.0
20995,,,3100741,[],CHEMBL1071783,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 143/93 at 2 mM after overnight incubation by agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158519,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,882886,=,1,1,=,,IZ,mm,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,0.0
20996,,,3100759,[],CHEMBL1071782,Antimicrobial activity against wild type Staphylococcus aureus SG 511 at 2 mM after overnight incubation by agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158519,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,882886,=,1,1,=,,IZ,mm,,24.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,24.0
20997,,,3100777,[],CHEMBL1071781,Antimicrobial activity against Micrococcus luteus ATCC 10240 at 2 mM after overnight incubation by agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158519,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,882886,=,1,1,=,,IZ,mm,,0.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,DIZ,mm,UO_0000016,,0.0
20998,,,3101855,[],CHEMBL1071780,Antimicrobial activity against Bacillus subtilis ATCC 6633 at 2 mM after overnight incubation by agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1158519,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://qudt.org/vocab/unit#Millimeter,882886,=,1,1,=,,IZ,mm,,29.5,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,DIZ,mm,UO_0000016,,29.5
20999,,,3102566,[],CHEMBL1066868,Antibacterial activity against Enterococcus faecalis,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1159108,Bioorg Med Chem Lett,2010.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,885734,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,16.0
